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Derrick E. Johnson 
AUTOREGULATORY AND STRUCTURAL CONTROL OF CAMKII 
SUBSTRATE SPECIFICITY 
Calcium/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a multimeric 
holoenzyme composed of 8–14 subunits from four closely related isoforms (α, β, γ, δ). 
CaMKII plays a strategic, multifunctional role in coupling the universal second messenger 
calcium with diverse cellular processes including metabolism, cell cycle control, and 
synaptic plasticity. CaMKII exhibits broad substrate specificity, targeting numerous 
substrates with diverse phosphorylation motifs. Binding of the calcium sensor CaM to the 
autoregulatory domain (ARD) of CaMKII functions to couple kinase activation with 
calcium signaling. Important sites of autophosphorylation, namely T287 and T306/7 (δ-
isoform numbering), reside within the ARD and control either CaM dependence or ability 
to bind to CaMKII respectively, thus determining various activation states of the kinase. 
Because autophosphorylation is critical to the function of CaMKII in vivo, we sought to 
determine the relationship between the activation state of the kinase and substrate 
selectivity. We show that the ARD of activated CaMKII tunes substrate selectivity by 
competing for substrate binding to the catalytic domain, thus functioning as a selectivity 
filter. Specifically, in the absence of T287 autophosphorylation, substrate phosphorylation 
is limited to high-affinity, consensus substrates. T287 autophosphorylation restores maximal 
kinase activation and broad substrate selectivity by disengaging ARD filtering. The unique 
multimeric architecture of CaMKII is an ideal sensor which encodes calcium-spike 
frequency into graded levels of subunit activation/autophosphorylation within the 
holoenzyme. We find that differential activation states of the holoenzyme produce distinct 
vii 
substrate phosphorylation profiles. Maximal holoenzyme activation/autophosphorylation 
leads to further broadening of substrate specificity beyond the effect of 
autophosphorylation alone, which is consistent with multivalent avidity. Thus, the ability 
of calcium-spike frequency to regulate T287 autophosphorylation and holoenzyme 
activation permits cellular activity to dictate switch-like behavior in substrate selectivity 
that is required for diverse cellular responses by CaMKII.  
 
 
Andy Hudmon, Ph.D. - Chair  
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CHAPTER 1. Introduction 
  
2 
1.1 Overview 
One of the fundamental roles of the brain is to encode information within the vast 
neuronal circuitry in response to external stimuli for recollection in the future. We often 
take learning and memory for granted, not giving a second thought to the incredible gift 
we have been given. Nevertheless, a growing population of people experience various 
forms of memory disorders. These may be the result of neurodegenerative diseases such as 
Alzheimer’s, or the result of traumatic brain injury (TBI), vascular disease, etc. The World 
Health Organization estimates that 47.5 million people worldwide suffer from dementia, 
with another 7.7 million new cases each year (WHO Fact sheet N°362, March 2015). The 
overall cost on society in 2010 alone was an estimated 1% of the worldwide gross domestic 
product (GDP), or US$ 604 billion. 
At the cellular level, the processes of learning and memory are manifested by the 
strengthening and weakening of neuronal connections; known as long-term potentiation 
(LTP) and long-term depression (LTD), respectively. The generation of LTP and LTD 
occur within the post-synaptic neuron (though presynaptic modes of generation have also 
been described) as the signals from the presynaptic neuron are integrated in the 
macromolecular signaling complex known as the post-synaptic density (PSD). This 
structure contains key transmembrane receptors and ion channels that convert the 
extracellular signals into intracellular signaling cascades that modulate synaptic plasticity. 
Alteration of protein function within the cell is crucial for the proper regulation of cellular 
processes. One way in which this is achieved is through enzymes which modify other 
proteins/substrates. Kinases are an important class of enzymes which phosphorylate 
proteins, DNA, or other enzymes; that is they transfer a phosphate group from ATP (or 
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GTP) to a substrate. It is one of the most studied types of modifying enzymes (termed post-
translational modification or PTM when associated with proteins) as this small 
modification can lead to essential changes in the substrate/protein function including 
activation/deactivation, binding/unbinding to downstream targets, folding/unfolding, etc. 
The pathways or cascades that these types of enzymes are generally a part of can be 
switched on by second messengers such as calcium upon release from intracellular stores 
or through various ion channels. 
 
1.2 Calcium Signaling 
Calcium signaling, with calcium acting as a nearly universal second messenger, has 
long been known to be a major regulatory pathway in many cellular processes including 
neuronal excitability, cell motility, exocytosis, muscle contraction, and gene transcription 
(Berridge, Lipp et al. 2000). Intracellular calcium is buffered and sequestered to rather low 
levels (~100 nM) and typical only varies from ~100 hundred nM up to one µM (Sabatini, 
Oertner et al. 2002). Cells, including neurons, tightly regulate calcium homeostasis, as 
aberrant calcium signaling events lead to various detrimental outcomes. Dysregulation of 
calcium signaling is a prevalent characteristic of many forms of neurodegenerative diseases 
(Berridge 2012). Increases in intracellular calcium associated with normal synaptic activity 
stimulate calcium-sensitive proteins, such as the ubiquitous calmodulin (CaM), which 
subsequently activates a variety of other downstream signaling effectors. However, it is 
not merely the amplitude of the calcium signal, but also the localization and the frequency 
of the stimulus (and the changes in the frequency) that lead to differing cellular actions and 
physiological outcomes (Boulware and Marchant 2008). One key class of signaling 
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molecules that is modulated by neuronal activity and subsequent calcium/calmodulin 
activation is the calcium/calmodulin-dependent protein kinases (CaMK); a group of 
multifunctional serine/threonine kinases comprised of CaMKI, CaMKII, and CaMKIV.  
 
1.3 CaMKII: A Historical Perspective 
Among the CaMK class, CaMKII has been in the spotlight of research related to 
regulatory mechanisms of learning and memory. CaMKII is highly enriched in the brain 
where it contributes up to around 1-2% of the total protein (Lisman, Schulman et al. 2002); 
a level of expression more like a cytoskeletal protein than an enzyme. While found 
ubiquitously expressed throughout the cell (or neuron), CaMKII was found to be enriched 
in the PSDs of excitatory synapses. Early reports identified a kinase similar to CaMKII that 
was integral to the PSD and was hence known as the major PSD protein (mPSDp) (Grab, 
Carlin et al. 1981, Kelly and Montgomery 1982). Subsequent studies found that this kinase 
was in fact CaMKII (Kelly, McGuinness et al. 1984). The close association of CaMKII to 
the PSD makes sense in light of CaMKII knock-out studies in mice that were the first to 
show alteration in learning and memory (Silva, Paylor et al. 1992). The localization of 
CaMKII in the PSD places it in an ideal position to regulate synaptic plasticity. It is known 
that CaMKII targets, phosphorylates, and regulates a large number of substrates within the 
PSD (Figure 1.1) (Yoshimura, Aoi et al. 2000, Yoshimura, Shinkawa et al. 2002). 
Additionally, CaMKII phosphorylates proteins involved in the release of neurotransmitter 
in the presynaptic terminal (Hinds, Goussakov et al. 2003, Liu, Chen et al. 2007). Many 
studies over the course of the past 25 years have established that CaMKII plays important 
structural and signaling roles in synaptic plasticity, the cellular correlates of learning and 
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memory, by regulating the generation of long-term potentiation (LTP) (Silva, Stevens et 
al. 1992, Lisman, Yasuda et al. 2012) and more recently long-term depression (LTD). In 
addition to its role in synaptic plasticity, this multifunctional kinase plays a role in many 
cellular processes, regulating processes as diverse as carbohydrate, amino acid and lipid 
metabolism, neurotransmitter synthesis and release, ion channels, receptors, transcription 
and translation, cytoskeletal organization, cell cycle control and calcium homoeostasis 
(Hudmon and Schulman 2002). CaMKII targets diverse phosphorylation motifs within a 
host of different substrates. Thus, this kinase has been known to have broad substrate 
specificity.  
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Figure 1.1 CaMKII action at the neuronal junction. 
Illustration of a simplified neuronal connection (i.e. the synapse). The axon from a presynaptic 
neuron interfaces with a dendrite from a postsynaptic neuron to form the synapse or synaptic 
junction. The region below the cell surface facing the synaptic cleft of either the pre- and post-
synaptic termini (inset) contain two structural important environments in which CaMKII 
functions (i.e. the active zone and the post-synaptic density (PSD), respectively). While the active 
zone has vesicles containing neurotransmitter waiting to be released, the PSD is made of the 
necessary receptors, channels, etc. required for responding to neurotransmitters. 
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The importance of CaMKII was further tied to the enzyme’s ability to escape the 
required binding of Ca2+/CaM for enzymatic activity, through an autophosphorylation 
event in the regulatory domain that occurs in response to the amplitude of frequency of 
Ca2+ stimulation (De Koninck and Schulman 1998). By extending the activity beyond the 
stimulating action of the Ca2+ transient, this kinase has the ability to behave in a way that 
has been described as a form of a “molecular memory switch” (Hanson, Meyer et al. 1994, 
Lisman, Schulman et al. 2002) and to do so as a Ca2+ frequency decoder. In order to fully 
appreciate these features of the kinase, it is important to consider the architecture of the 
holoenzyme as well as the structural components of each of the subunits. 
 
1.4 CaMKII Isoforms, Cellular Distribution, and Holoenzyme Structure 
CaMKII is a family of kinases with four isoforms (α, β, γ, δ) encoded by separate genes 
in mammals with high sequence conservation between species. The four isoforms are 
expressed variably in different tissues in cell-, developmental-, and subcellular-specific 
manners. CaMKIIγ and CaMKIIδ are expressed in many cell-types and tissues. For 
example, CaMKIIδ is the predominantly expressed isoform in cardiomyocytes and has 
been well-studied for its role in normal cardiac physiology as well as pathophysiological 
issues such as arrhythmias, contractile dysfunction, and heart failure (Hund and Mohler 
2015). CaMKIIα and CaMKIIβ can be found in various tissues types, but they are 
predominantly expressed in the neurons. While CaMKIIγ and CaMKIIδ are also found in 
lower levels in neurons, they are expressed in other cell types in the brain such as astrocytes 
(Vallano, Beaman-Hall et al. 2000). In addition, CaMKII in other organisms such as 
Drosophila melanogaster and Caenorhabditis elegans, which are both highly conserved, 
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have been shown to regulate a variety of important functions such as those related to 
learning and memory (Griffith, Verselis et al. 1993), synaptic plasticity (Wang, Renger et 
al. 1994), heart rate and arrhythmias (Santalla, Valverde et al. 2014), photoreceptor 
function (Lu, Leung et al. 2009), and neuronal mitochondrial maintenance (Jiang, Hsu et 
al. 2015). 
All four mammalian CaMKII isoforms have similar domain organization (Chao, 
Stratton et al. 2011); each subunit containing a catalytic, autoregulatory, and association 
(hub or oligomerization) domain (Figure 1.2A) (Hudmon and Schulman 2002). In addition, 
the sequences possess a high degree of conservation (Figure 1.3). Alternative splicing for 
each isoform generates multiple variants of each isoform totaling ~40 mammalian variants 
(Tombes, Faison et al. 2003). These variations generally occur in the variable insert linker 
region located between the autoregulatory and hub domains, and can confer multiple 
functions such as F-actin binding or nuclear localization (reviewed in (Gray and Heller 
Brown 2014)) as well as alter the kinases frequency response to calcium transients (Bayer, 
De Koninck et al. 2002). The holoenzyme (consisting of varying ratios of multiple isoforms 
(Bennett, Erondu et al. 1983, Yamauchi, Ohsako et al. 1989, Kolb, Hudmon et al. 1998, 
Brocke, Chiang et al. 1999)) is formed by the assembly of 12-14 hub domains into a 
hexameric or heptadecameric doublet configuration with catalytic domains projecting out 
from the central hub core (Kolodziej, Hudmon et al. 2000, Chao, Stratton et al. 2011). 
However, there is some discrepancy between positioning of the catalytic domain; early 
studies involving cryo-EM reconstructions (Kolodziej, Hudmon et al. 2000) show the 
catalytic domain extended in an axial orientation whereas in the recent crystal structure of 
the dodecameric holoenzyme they are tightly nestled to the hub domain in a more 
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equatorial arrangement (Chao, Stratton et al. 2011). While the construct used to generate 
the first crystal structure of a CaMKII holoenzyme utilized a short linker region between 
the autoregulatory and hub domains, reconstructions from small-angle x-ray scattering 
(SAXS) analysis with either the short or a longer linker suggested an equatorial orientation 
in solution (Kolodziej, Hudmon et al. 2000). Though the catalytic and hub domains are 
intrinsically ordered structures, the autoregulatory domain, linker, and variable inserts are 
much less structurally ordered. In fact, based on various experimental data including 
electron paramagnetic resonance (EPR) (Hoffman, Stein et al. 2011), the autoregulatory 
domain appears to undergo transitions between order and disorder in response to Ca2+/CaM 
binding and various activation states. The autoregulatory domain itself can be divided into 
several segments, designated R1 to R3 (Figure 1.2A) (Chao, Pellicena et al. 2010). 
Sequence analysis of the various linkers and alternatively spliced inserts from the different 
isoforms all exhibit high levels of predicted intrinsic disorder (PONDR-Fit) (Figure 1.2B). 
Hence, the holoenzyme construct used to generate the first full-length crystal structure 
benefited from a lack of the flexible linker region.  
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Figure 1.2 CaMKII domains and intrinsic order/disorder predictions. 
(A) Linear schematic of a single subunit within the CaMKII holoenzyme (delta isoform) 
representing the catalytic domain (green), autoregulatory domain (ARD) (blue), and hub domain 
(gray). Expanded view shows the ARD (blue) with subdivisions R1 (T287 containing region) and 
R2/R3 (CaM binding and T306/7 region) (Chao, Pellicena et al. 2010). (B) Sequence analysis for 
the four CaMKII isoforms show the predicted intrinsically disordered/ordered regions with the 
protein using PONDR (VSL2 variant) (Obradovic, Peng et al. 2005, Peng, Radivojac et al. 2006).
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Figure 1.3 Sequence alignment of CaMKII isoforms. 
Multiple sequence alignment performed using CLUSTAL Omega (v1.2.1) for the canonical 
sequence obtained from UniProt. 
CaMKIIα -MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER 59 
CaMKIIβ MATTVTCTRFTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER 60 
CaMKIIγ MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLER 60 
CaMKIIδ MASTTTCTRFTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER 60 
          :* ******::***:*::***********:*  : :********************** 
 
CaMKIIα EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 119 
CaMKIIβ EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI 120 
CaMKIIγ EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 120 
CaMKIIδ EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI 120 
        ********** *************.***:****************************:** 
 
CaMKIIα LEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179 
CaMKIIβ LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGY 180 
CaMKIIγ LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGY 180 
CaMKIIδ LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGY 180 
        **:* * *   :*************** ****************:*:************* 
 
CaMKIIα LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239 
CaMKIIβ LSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDT 240 
CaMKIIγ LSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDT 240 
CaMKIIδ LSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 240 
        ********: ******:***********************:******************* 
 
CaMKIIα VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 299 
CaMKIIβ VTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKL 300 
CaMKIIγ VTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKL 300 
CaMKIIδ VTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKL 300 
        ******:***:******:***** :******:.:****** *******:**:******** 
 
CaMKIIα KGAILTTMLATRNFSGGKSGGNKKSDG--------------------------------- 326 
CaMKIIβ KGAILTTMLATRNFSVGRQTTAPATMSTAASGTTMGLVEQAKSLLNKKADGVKPQTNSTK 360 
CaMKIIγ KGAILTTMLVSRNFSAAKSLLNKKSDGG---------VKKRKS---SSSVHLMPQSNN-K 347 
CaMKIIδ KGAILTTMLATRNFSAAKSL-LKKPDG--------------------------------- 326 
        *********.:**** .:.       .                                  
 
CaMKIIα ------------------------------VKESSESTNTTIEDEDTK------------ 344 
CaMKIIβ NSAAATSPKGTLPPAALEPQTTVIHNPVDGIKESSDSANTTIEDEDAKAPRVPDILSSVR 420 
CaMKIIγ NSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKARSPEGRSSRDR 407 
CaMKIIδ ------------------------------VKESTESSNTTIEDEDVK------------ 344 
                                      :* *::* *** **** *             
 
CaMKIIα ------------------------------------------------------------ 
CaMKIIβ RGSGAPEAEGPLPCPSPAPFSPLPAPSPRISDILNSVRRGSGTPEAEGPLSAGPPPCLSP 480 
CaMKIIγ T----------------------------------------------AP-S--------- 411 
CaMKIIδ ------------------------------------------------------------ 
                                                                        
 
CaMKIIα ----------------------------------------------------VRKQEIIK 352 
CaMKIIβ ALLGPLSSPSPRISDILNSVRRGSGTPEAEGPSPVGPPPCPSPTIPGPLPTPSRKQEIIK 540 
CaMKIIγ ----------------------------------AGM-----QPQPSLCSSAMRKQEIIK 432 
CaMKIIδ ----------------------------------------------------ARKQEIIK 352 
                                                             ******* 
 
CaMKIIα VTEQLIEAISNGDFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHT 412 
CaMKIIβ TTEQLIEAVNNGDFEAYAKICDPGLTSFEPEALGNLVEGMDFHRFYFENLLAKNSKPIHT 600 
CaMKIIγ ITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHT 492 
CaMKIIδ VTEQLIEAINNGDFEAYTKICDPGLTAFEPEALGNLVEGMDFHRFYFENALSKSNKPIHT 412 
         *******:.*****:*:*:****:*:************:***:*****  ::..**:** 
 
CaMKIIα TILNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGA 472 
CaMKIIβ TILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWQNVHFHCSGA 660 
CaMKIIγ TILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGA 552 
CaMKIIδ IILNPHVHLVGDDAACIAYIRLTQYMDGSGMPKTMQSEETRVWHRRDGKWQNVHFHRSGS 472 
         *****:*::*:::*******:***:*. * *:* ***************  **:* **: 
 
CaMKIIα PSVLPH--------------------- 478 
CaMKIIβ PVAPLQ--------------------- 666 
CaMKIIγ PAAPLQ--------------------- 558 
CaMKIIδ PTVPIKPPCIPNGKENFSGGTSLWQNI 499 
        * .  :                     
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CaMKII is similar to other monomeric multifunctional Ca2+/CaM activated protein 
kinases (CaMKI and CaMKIV) in that it has an autoregulatory domain that is disinhibited 
by Ca2+/CaM binding (Figure 1.4); however, it is structurally quite different in that CaMKII 
has a multimeric architecture and does not require phosphorylation by an upstream CaMK 
kinase (CaMKK) in an activation loop for maximal activity (Lee and Edelman 1995, 
Tokumitsu, Enslen et al. 1995). CaMKII does undergo autophosphorylation in its 
autoregulatory domain by a special intermolecular-intraholoenzyme autophosphorylation 
reaction (Hanson, Meyer et al. 1994, Rich and Schulman 1998). The catalytic domain 
resembles a prototypical Ser/Thr kinase domain with a characteristic kinase fold in which 
the N-terminal portion consists mainly of anti-parallel beta sheets while the C-terminal 
portion is comprised mostly of alpha-helical segments. All the isoforms of CaMKII are 
nearly identical within the catalytic surface and substrate binding region of catalytic 
domain, (Figure 1.5). 
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Figure 1.4 Structure of autoinhibited versus activated CaMKII. 
(A) Illustration of the CaMKII holoenzyme with detailed view of the catalytic domain. X-ray 
crystal structure shows monomeric human CaMKIIδ11-309 (PDB ID: 2VN9) in the autoinhibited 
state with the ARD (blue) and modified to include ATP in the active site (PDB ID: 1ATP). (B) 
hCaMKIIδ11-335 activated (PDB ID: 2WEL) by calcium (red spheres) and calmodulin (CaM) 
(magenta) and exposing T287 (white) for autophosphorylation.  
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Figure 1.5 Structural alignment of CaMKII catalytic domains. 
Structural alignment of CaMKII’s catalytic domain and autoregulatory domain (ARD) from X-
ray crystal structures of the autoinhibited state; hCaMKIIα13-302 (PDB ID: 2VZ6; COLOR), 
hCaMKIIβ11-303 (PDB ID: 3BHH; COLOR), hCaMKIIγ5-317 (PDB ID: 2V7O; COLOR), and 
hCaMKIIδ11-309 (PDB ID: 2VN9; blue).  
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1.5 Activation States of CaMKII  
Under basal conditions, CaMKII exists in an autoinhibited state in which the 
autoregulatory domain occludes the catalytic surface; blocking substrate access to the 
active site and preventing substrate phosphorylation. Removal of the regulatory domain 
via proteolytic digestion or mutational truncation yields a fully active catalytic fragment 
devoid of the required activation by calmodulin (CaM) (Levine and Sahyoun 1987, 
Kwiatkowski and King 1989, Yamagata, Czernik et al. 1991, Cruzalegui, Kapiloff et al. 
1992). CaM is a highly conserved, ubiquitous, eukaryotic protein that functions as the 
major calcium transducer in the cell. Made up of four Ca2+-binding sites (EF-hands) with 
two in each lobe (N-terminal and C-terminal) connected by a flexible linker, CaM binding 
to Ca2+ leads to structural changes that increase CaM’s affinity for its targets, one of which 
is CaMKII. Thus, CaMKII activation occurs following increased intracellular Ca2+ 
concentrations through the binding of Ca2+/CaM to the CaM-binding domain of the 
autoregulatory domain which allows for the disengagement of the active site by the 
autoregulatory domain. Activation of each catalytic subunit within the holoenzyme 
requires the stoichiometric binding of Ca2+/CaM for maximal activity; the degree of bound 
Ca2+/CaM correlating with the level of substrate phosphorylation (Katoh and Fujisawa 
1991, Meyer, Hanson et al. 1992). Prolonged activation through the binding of Ca2+/CaM, 
can lead to autophosphorylation of T287 (β, γ , δ numbering used throughout this 
dissertation; CaMKIIα numbering is T286), producing an autonomous form of the kinase 
(i.e. retained catalytic activity after CaM dissociation) (Lai, Nairn et al. 1986, Lou, Lloyd 
et al. 1986, Miller and Kennedy 1986, Lai, Nairn et al. 1987, Miller, Patton et al. 1988, 
Schworer, Colbran et al. 1988, Lou and Schulman 1989, Waxham, Aronowski et al. 1990). 
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The ability of CaMKII to retain enzymatic activity following the loss of its activator 
(Ca2+/CaM) has led to the idea of CaMKII being a “memory switch” (Hanson, Meyer et al. 
1994). T287 autophosphorylation is thought to disengage the autoregulatory domain from 
interacting with the autoinhibitory groove of the catalytic surface (Figure 1.3B). 
Autonomous (Ca2+-independent) activity can reach 100% of the Ca2+-dependent activity 
in in vitro assays with saturating levels of its activator Ca2+/CaM. However, though the 
basal level of autonomous activity is dependent on the method and handling of tissue 
preparations and measurements of CaMKII activity (Lengyel, Cammarota et al. 2001), the 
level of autonomous activity generated in neurons by various stimulation protocols appears 
to reach 15-50% of the total CaMKII activity (Gorelick, Wang et al. 1988, MacNicol, 
Jefferson et al. 1990, Molloy and Kennedy 1991, Lengyel, Cammarota et al. 2001). These 
observations of submaximal CaMKII autophosphorylation are consistent with the studies 
by Persechini and colleagues that suggest free CaM is limiting in cells (Estep, Alexander 
et al. 1989, Persechini and Stemmer 2002). For this reason, it is likely that substrate 
phosphorylation by CaMKII operates under conditions of autophosphorylated and non-
autophosphorylated subunits when Ca2+ is elevated in cells.  
CaMKII is known to exhibit autophosphorylation at multiple sites and to varying 
degrees in vivo. Like T287, T306/307 (β, γ, δ numbering used throughout this dissertation; 
CaMKIIα numbering is T305/306) reside within the autoregulatory domain of CaMKII; 
however, unlike T287 these residues lie within CaM binding domain (Figure 1.2A). The 
state of autophosphorylation for these sites has been shown to be important for synaptic 
plasticity and learning and memory. A consequence of their location in the CaM binding 
domain is that autophosphorylation at T306/307 prevents subsequent CaM binding (Colbran 
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1993). Therefore, if this autophosphorylation event occurs prior to Ca2+/CaM activation, 
the corresponding CaMKII subunit cannot be activated in the future unless the site is 
dephosphorylated or the autoregulatory domain is cleaved. However, if T287 
autophosphorylation occurs first, a rapid phosphorylation of T306/307 ensues if Ca2+/CaM is 
removed (e.g. with the addition of EGTA). It is this state of the kinase that contributes to 
the enzymatic activity described as “autonomous” activity or when Ca2+-independent 
activity is reported following T287 autophosphorylation. 
 
1.6 Frequency Decoding/Tuning via Alternative Splicing and Isoform Differences 
 In the mid-1990’s, Mayford and colleagues used transgenic mice containing CaMKII 
with a T287 phosphomimetic substitution to show that T287 autophosphorylation played an 
important role in regulating the frequency-dependent synaptic plasticity outputs of LTP 
and LTD (Mayford, Wang et al. 1995). Specifically, CaMKII was shown to modulate the 
frequency-response of CaMKII in hippocampal synapses; mice overexpressing CaMKII 
T286D exhibited normal LTP with high frequency stimulation. However, a shift in the 
threshold for LTD generation toward higher frequencies (10 Hz) was observed for mutant 
mice than typically required for wild-type mice (1 Hz). How this kinase is able to perform 
these important regulatory functions became a major focus in the field, as minor changes 
in the frequency of Ca2+ transients can lead to diverse cellular outputs (Boulware and 
Marchant 2008). The CaMKII holoenzyme was subsequently found to encode calcium-
spike frequency into T287 autophosphorylation; a switch-like property influenced by 
calcium-spike duration and amplitude both in vitro (De Koninck and Schulman 1998) and 
in vivo (Eshete and Fields 2001). Furthermore, studies comparing different CaMKII 
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isoform variants showed that alternative splicing modulates the frequency-dependent 
response (T287 autophosphorylation and autonomous activity) (Bayer, De Koninck et al. 
2002). Alternative splicing in CaMKII is predominantly associated with changes in the 
length of the linker region between the ARD and the hub domain (Figure 1.2A). Thus, even 
though the catalytic surface and substrate binding region of catalytic domains for all 
CaMKII isoforms are nearly identical, sensitivities for activation and autophosphorylation 
can be regulated by genetic encoding of linker length. A more recent study characterizing 
the first crystal structure of the holoenzyme also explored the mechanism of this tunable 
model of activation (Chao, Stratton et al. 2011). Their work suggests that the holoenzyme 
exists in an equilibrium between a compact and extended state in its autoinhibited form. In 
particular, the catalytic domain was either nestled close to the hub domain or projected 
away from the hub domain while being tethered by the ARD and linker region. SAXS 
analysis revealed that with a longer linker region, the kinase adopts a more extended 
conformation. Consistent with their model in which a more extended equilibrium state 
exposes the ARD (and CaM binding domain) for longer periods of time, reduced 
concentrations of Ca2+/CaM were required to activate and autophosphorylate CaMKII. 
However, it must be noted that the compact state used to generate the crystal structure used 
a kinase lacking a typical linker region (though it was from a splice variant of beta) in 
addition to having a mutation in the ARD presumably to stabilize hydrophobic contacts. 
  
1.7 Role of T287 Autophosphorylation in Synaptic Plasticity 
Autophosphorylation of Thr287 is required for the function of CaMKII in synaptic 
plasticity and learning and memory as mouse models expressing non-autophosphorylatable 
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(A287) or phosphomimetic (D287) mutants alter both the generation of LTP and spatial 
learning in animals (Silva, Paylor et al. 1992, Silva, Stevens et al. 1992, Cho, Giese et al. 
1998). Although the role of autonomous activity in regulating synaptic plasticity and 
learning is unknown, early studies speculated that autonomous activity generation served 
as a “molecular switch” of previous neuronal activation states to lead to a form of molecular 
memory (Lisman 1985, Miller and Kennedy 1986, Lisman 1994). Autophosphorylation 
was also found to regulate CaM binding affinity by creating further access to the 
autoregulatory domain; resulting in maximized CaM contacts with the CaM target domain 
and leading to >1000-fold increase in affinity (Meyer, Hanson et al. 1992, Putkey and 
Waxham 1996, Singla, Hudmon et al. 2001). Autophosphorylation also regulates CaMKII 
translocation and interaction with its substrates. Neuronal activation induces GFP-CaMKII 
to translocate from the cytoplasm to the presynaptic active zone (Tao-Cheng, Dosemeci et 
al. 2006) and the post-synaptic density (PSD) (Strack, Choi et al. 1997, Shen and Meyer 
1999, Dosemeci, Tao-Cheng et al. 2001). The active zone is a macromolecular complex 
essential for docking and release of neurotransmitter vesicles (Figure 1.1) into the synaptic 
cleft. The PSD is a tightly-packed macromolecular structure of cytoskeletal, scaffolding, 
effectors, and receptors/ion channels required for responding to the presynaptic release of 
neurotransmitters from the receiving dendritic spine of the post-synaptic neuron (Sheng 
and Hoogenraad 2007, Swulius, Kubota et al. 2010). The mechanism of active zone 
recruitment of CaMKII is unknown; however, the GluN2B (formally referred to as NR2B) 
subunit of the NMDA receptor channel has been shown to be important for CaMKII 
binding to the PSD (Strack and Colbran 1998, Leonard, Bayer et al. 2002). Studies have 
found that autophosphorylation enhances CaMKII association with GluN2B, suggesting 
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that GluN2B could function to target autophosphorylated CaMKII to the PSD (Strack and 
Colbran 1998, Leonard, Bayer et al. 2002). Indeed, while autophosphorylation is not 
required for CaMKII translocation to the PSD, it is required for a delayed dissociation from 
this subcellular compartment as evidenced by the reduced retention times observed with 
autophosphorylation deficient CaMKII (T287A) (Shen and Meyer 1999, Bayer, LeBel et al. 
2006). In fact, a recent knock-in study using a mutant form of GluN2B deficient in CaMKII 
binding has shown that although CaMKII translocation is normal, CaMKII retention, LTP, 
and behavior are disrupted (Halt, Dallapiazza et al. 2012). The phosphorylation site of 
GluN2B (Ser1303), which is important for CaMKII translocation to the PSD (Omkumar, 
Kiely et al. 1996, Strack, McNeill et al. 2000, Halt, Dallapiazza et al. 2012), conforms to a 
classical consensus phosphorylation motif for CaMKII. Classical CaMKII substrates have 
been found by oriented peptide libraries to follow a consensus motif (KRQQSFDLF) 
(Songyang, Blechner et al. 1994, Songyang, Lu et al. 1996); a sequence which also happens 
to mimic the autoregulatory domain of CaMKII. The role of GluN2B regulation by 
CaMKII in LTP and learning is unknown, as CaMKII phosphorylation produced small 
changes in this receptor’s function directly. Which CaMKII substrates in the PSD are 
important for LTP and learning is hotly debated; however, the AMPA glutamate receptor 
subtype phosphorylation by CaMKII has been shown to be one substrate in particular that 
is critical for LTP. LTP requires enhanced AMPA receptor function and increased 
trafficking of GluA1 receptors to the PSD (Benke, Luthi et al. 1998, Malinow and Malenka 
2002, Holmes and Grover 2006, Shepherd and Huganir 2007); two processes that CaMKII 
phosphorylation has been shown to regulate (Lu, Isozaki et al. 2010, Kristensen, Jenkins 
et al. 2011). 
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1.8 Structural Changes upon Activation  
In addition to the holoenzyme structure (3SOA) (Chao, Stratton et al. 2011), several x-
ray crystal structures of a monomeric catalytic domain along with the autoregulatory 
domain have been produced in various activation states. Knapp’s lab (Rellos, Pike et al. 
2010) produced structures of the autoinhibited catalytic domains from human CaMKII; 
CaMKIIα13-302 (2VZ6), CaMKIIβ11-303 (3BHH), CaMKIIγ5-317 (2V7O), and CaMKIIδ11-309 
(2VN9). Overall, these structures exhibited very little structural differences (2° and 3°) 
(Figure 1.5) as expected by their high sequence similarity (Figure 1.3). They also generated 
CaMKIIδ11-335 (2WEL) in the Ca2+/CaM activated state as well as the oligomerized hub 
domains of CaMKIIδ333-475 (2W2C) and CaMKIIγ387-527 (2UX0). Though the crystal 
structures of the autoinhibited versus activated state only provide two snapshots and not a 
whole dynamic scene depicting activation, they suggest the types of structural 
rearrangements associated with the process. In the autoinhibited state, the autoregulatory 
domain region around T287 adopts an alpha-helical structure and interacts with a 
hydrophobic, autoinhibitory groove that starts at the base of the catalytic surface and 
extends up near the active site positioned at the intersection of the N- and C-terminal lobes. 
Activation via Ca2+/CaM binding displaces the autoregulatory domain, leading to a 
subsequent collapse of the autoinhibitory groove by the shifting of the αD-helix.  
 
1.9 CaM Trapping 
In addition the establishment of Ca2+/CaM-independent activity, T287 
autophosphorylation also leads to an enormous increase in the binding affinity of CaM, 
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termed “CaM trapping” (Meyer, Hanson et al. 1992, Putkey and Waxham 1996, Waxham, 
Tsai et al. 1998, Singla, Hudmon et al. 2001). Using fluorescence emission anisotropy 
coupled with stop-flow device to measure a fluorescently tagged (dansylated) CaM, Meyer 
and colleagues (Meyer, Hanson et al. 1992) were able to show an increase of >3 orders of 
magnitude for the binding of CaM upon T287 autophosphorylation. However, for a mutant 
CaMKIIα lacking the ability to be autophosphorylated (T287A), no trapping phenomena 
was observed (Meyer, Hanson et al. 1992). Of potential importance to the physiological 
role of autophosphorylation is that the autoregulatory domain of CaMKII transitions from 
one of the weakest targets of CaM to one of the strongest CaM-binding interactions 
observed. This trapping seems to ensure the association of CaMKII’s activator and may 
function to sequester CaM which already has limited availability in regions like the PSD; 
possibly prioritizing CaMKII signaling within this cellular compartment. Structurally, 
CaM trapping is not due to the holoenzyme architecture, as it was shown to occur in 
monomeric CaMKII (Meyer, Hanson et al. 1992). The changes in the affinity of the CaM 
were found to be the result of a drastic change in the off-rate (Meyer, Hanson et al. 1992) 
that was modeled using two peptides generated from the autoregulatory domain 
(CaMKII296-312 and CaMKII290-314) coupled with fluorescently labeled CaM (CaMIAEDANS) 
(Putkey and Waxham 1996). Additional analysis using the peptide model (with more 
peptides of varying lengths) revealed that F294 and N295 contribute the most significantly to 
the changes in the dissociation rate mediated specifically through alterations in the off-rate. 
Furthermore, isothermal titration calorimetry (ITC) experiments revealed that differences 
in binding between long (CaMKII291-312) and intermediate (CaMKII296-312) peptides of 
autoregulatory domain (which differentially included FN294/5) was due to enthalpy and not 
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entropy, suggesting that CaM trapping involves the formation of new hydrogen bonds 
instead of the burying of hydrophobic surface area (Tse, Giannetti et al. 2007). Mutational 
analysis also revealed that F294A and N295A led to an increase in the binding of CaM to 
non-T287 autophosphorylated CaMKII (16- or 13-fold decrease is in the dissociation rate 
constant (koff), respectively (Singla, Hudmon et al. 2001), which is thought to be the result 
of decreased autoinhibitory interactions that these residues contribute to prior to 
autophosphorylation. However, these same mutations in the T287 autophosphorylated state 
resulted in 160- and 330-fold decreases in the koff. 
In light of the crystal structures of the apoCaMKII versus Ca2+/CaM-activated form of 
human CaMKIIδ (Figure 1.3) (Rellos, Pike et al. 2010) which display autoinhibition (i.e., 
closed state) versus complete disinhibition of the ARD (i.e., open state) including F294 and 
N295, it remained unclear how CaM trapping is prevented prior to T287 autophosphorylation 
with F294 and N295 contributing significantly to this process. A structural explanation of the 
prior biochemical studies was recently provided via electron paramagnetic resonance 
studies of dynamic conformational changes and CaMKII activation states in solution. This 
work showed that the R2 region (which includes F294 and N295) of the ARD retains contacts 
with the catalytic domain in the Ca2+/CaM-stimulated, yet non-T287 autophosphorylated 
state (CaMKIIm−P) (Hoffman, Stein et al. 2011). Full displacement of the ARD occurs with 
autophosphorylation or phosphomimetic substitution at T287. The tethering of the ARD 
could provide several mechanisms: 1) preventing CaM-trapping, 2) limiting intrasubunit 
autophosphorylation, and 3) limiting substrate access and phosphorylation.  
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1.10 Non-Canonical Activation/Autonomy 
Disruption of the autoregulatory domain interaction with the catalytic surface via 
Ca2+/CaM binding represents the canonical mechanism for direct activation of CaMKII, 
while the canonical mechanism for autonomous activation is through T287 
autophosphorylation which further exposes the catalytic surface and serves to extend the 
activity after CaM dissociation. Yet several other mechanisms have recently been reported 
to fulfill the role of either Ca2+/CaM binding or T287 autophosphorylation. Through 
interactions with the CaM-binding region of the autoregulatory domain, it was shown that 
alpha-actinin-2 could partially activate CaMKII (Jalan-Sakrikar, Bartlett et al. 2012). 
While sequence analysis revealed that the C-terminal domain of alpha-actinin-2 is 
homologous to the C-lobe of CaM, the activation was both Ca2+-independent and substrate-
selective. Similar to Ca2+/CaM binding to CaMKII, phosphorylation of T307 blocked this 
interaction. While the interaction of alpha-actinin-2 appears to partially mimic the 
activation by Ca2+/CaM, another type of non-canonical activation mimics phosphorylation 
of the autoregulatory domain and the autonomous activity thus generated; specifically 
oxidation (Erickson, Joiner et al. 2008, Erickson, He et al. 2011), nitrosylation (Coultrap 
and Bayer 2014), and glycosylation (Erickson, Pereira et al. 2013). The autoregulatory 
domain of CaMKII (Figure 1.2) contains several sites available for post-translation 
modification near T287. Thus multiple signaling pathways funnel into a common mediator 
and are capable of generating a functionally important activation state of CaMKII. 
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1.11 Substrate-Kinase Interactions 
While conserved in lower organisms such as prokaryotes, protein phosphorylation, the 
post-translational modification (PTM) involving the reversible addition of phosphate to 
amino acid side chains within proteins, is the most utilized form of PTM in signal 
transduction and plays a key role in the regulation of almost every type of cellular function 
in eukaryotes (Cohen 2002). Imbalances in the regulation of kinase activity can lead to a 
number of disorders (Roskoski 2015). Therefore protein kinases, the enzymes responsible 
for this reaction, have become one of the most studied classes of therapeutic targets by the 
pharmaceutical industry (Johnson 2009, Zhang, Yang et al. 2009, Dar and Shokat 2011). 
The human kinome is made up of 518 protein kinases, making it the second largest enzyme 
class and third largest protein family representing 1.7% of the human genome (Manning, 
Whyte et al. 2002). Of the 478 which are members of the sequence related superfamily of 
typical eukaryotic protein kinase (ePK) catalytic domains (the other 40 are labeled atypical 
protein kinases (aPKs)), 388 are classified as Ser/Thr kinases, while the others 
phosphorylate Tyr residues (Manning, Whyte et al. 2002). The ePKs all possess structurally 
similar catalytic domains (~290 amino acids) comprised of an N-terminal lobe of mainly 
β-sheets and a larger C-terminal lobe; the active site situated between the two domains. 
Kinases are responsible for maintaining the vast and complex phosphoproteome network; 
considered to include at a minimum ~33% of all cellular proteins (Cohen 2001) and more 
likely in the 40-45% range (Junger and Aebersold 2014); yet the full scope of the complete 
phosphoproteome for any species remains to be experimentally mapped. The many benefits 
to this type of modification, namely that it is catalytically fast, reversible, single/binary 
addition, are only appreciated by the specificity with which these kinases can modify their 
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targets. These can range from one substrate to hundreds of substrates, all while 
distinguishing between the estimated ~500,000-700,000 phosphorylatable sites in a typical 
eukaryotic cell (Ubersax and Ferrell 2007, Lemeer and Heck 2009). For this reason, 
mechanisms regulating substrate selection and specificity are important for understanding 
both the normal physiological actions of a given kinase as well as ways to target the kinase 
for intervention in pathophysiological states. 
Substrate selection among kinases is a complex, multifaceted process with multiple 
different determinants which allow kinases to phosphorylate and regulate signaling 
networks. These factors include the structure of the active site/catalytic cleft, distal docking 
sites, conditional docking sites, targeting subunits, localization, scaffolding, and system-
level effects.  
  
1.11.1 Catalytic/Active Site 
The active site of protein kinases has been shown to be regulated by intrinsic sequences 
or core motifs on substrates that optimize the ionic and hydrophobic characteristics of the 
kinase surface for optimal phosphorylation (Kreegipuu, Blom et al. 1998, Taylor, Kim et 
al. 2005). As mentioned above, roughly 80% of the ePKs phosphorylate at Ser/Thr as 
opposed to Tyr (Manning, Whyte et al. 2002), and accordingly have conserved residues in 
the active site which allow for a smaller aliphatic phosphoacceptor (Taylor, Radzio-
Andzelm et al. 1995) whereas Tyr kinases utilize a separate group of conserved residues 
for large, aromatic residue (Pinna and Ruzzene 1996). Furthermore, the Asp-Phe-Gly 
(DFG) motif, a tripeptide motif within the catalytic site that is highly conserved among 
kinases (Bayliss, Haq et al. 2015), is followed by a residue that has been shown to be a 
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major determinant for the preference for Ser or Thr (though not absolutely), termed the 
DFG+1 residue (Chen, Ha et al. 2014). CaMKII contains a Leu at this site (residue 160 in 
β, γ, δ numbering); therefore, it predicts a preference for Ser over Thr as the 
phosphoacceptor. In addition, it was recently found that the composition of the 
phosphorylation motif, and particularly whether the phosphoacceptor was Ser versus Thr, 
was a key determinant for mTORC1 “substrate quality”; the intrinsic ability for a 
phosphorylatable site to act as a substrate in cells. Due to substrate quality and the related 
concept “relative specificity” (i.e. enzymes have a tendency to differentially and 
preferentially interact with their substrates), specific phosphorylation motifs of mTORC1 
substrates were able to set the sensitivity to various stimuli, thus allowing mTORC1 to 
selectively phosphorylate substrates even with the same stimuli (e.g. differential 
phosphorylation following rapamycin inhibition) (Kang, Pacold et al. 2013, Zeng 2014). 
Moving outside of the phosphoacceptor site (P-site), a significant amount of substrate 
recognition and specificity arises from the amino acids generally within 4-7 residues both 
N- and C-terminally. These sequences which interact proximally to the active site have 
been shown to confer substrate specificity by their intrinsic chemical composition arranged 
into ordered motifs that optimize the ionic and hydrophobic characteristics of the kinase 
surface for optimal phosphorylation (Kreegipuu, Blom et al. 1998, Taylor, Kim et al. 2005). 
Owing to the differences among kinases on their catalytic surface, consensus sequence 
motifs for optimal substrate specificity varies among kinases (though with some overlap) 
and have been identified through various experimental methods. Initially, mutations of 
known substrate sequences provided information regarding the important residue 
composition and position (Daile, Carnegie et al. 1975, Kemp, Bylund et al. 1975, Pearson 
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and Kemp 1991). However, with the advent of oriented peptide libraries, kinases were able 
to be screened in an unbiased manner phosphorylating a pool of ~2.5 billion soluble 
peptides (Songyang, Blechner et al. 1994) and subsequently determining the optimal amino 
acid at each position by correlation to its abundance via Edman degradation sequencing. 
More recent studies have optimized these oriented library approaches, such that they rely 
on radiolabeled [γ-32P] ATP, simplifying the process and allowing for a more rapid 
profiling of kinase specificities (Songyang, Lu et al. 1996, Hutti, Jarrell et al. 2004).  
Like a number of other basophilic kinases (e.g. PKA, PKA, and AMPK), the CaM 
kinase family is classically defined with a preference for an Arg/Lys at the P-3 position (i.e. 
three residues N-terminal to the phosphorylation site). However, neither of the two 
identified CaMKII phosphorylation sites in GluA1 (a subunit of the AMPA receptor) which 
are important for these processes (S831 and S567) look anything like the typical consensus 
phosphorylation site of CaMKII. PSD-95, the main scaffolding protein in the PSD, is yet 
another example of a functionally important CaMKII substrate with a non-consensus 
CaMKII site (S73); phosphorylation at this site prevents spine growth as well as LTP 
(Steiner, Higley et al. 2008). Furthermore, sequence analysis of the CaMKII substrates 
(>200) in PhosphoSitePlus suggests that a majority of the phosphorylation sites would be 
considered poor substrates given the limited similarity many of them possess to the 
consensus motif. However, a poor substrate could still be biologically relevant as a high 
Km could be overcome by direct targeting and a low Vmax could be optimized by the fact 
that small numbers of catalytic events can still produce a biological effect. However, since 
the PSD is replete with protein phosphatases, it is likely that shifting the equilibrium 
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towards a phosphorylation state would require mechanisms to enhance the phosphorylation 
of low-affinity substrates.  
 
1.11.2 Docking Sites/Allosteric Interactions 
Beyond the active site, distal regions of a kinase may serve as docking sites for regions 
of the substrate upstream or downstream of the P-site, leading to an increase in substrate 
specificity. A number of kinases are known to utilize this type of mechanism including 
mitogen-activated protein (MAP) kinases, which play essential roles in the signal 
transduction pathways in the cell. These sites may be quite distant from the 
phosphoacceptor site. In the case of mitogen-activated protein kinase 2 (MK2), a substrate 
for the upstream an MAPK kinase (MAPKK) p38α, a 30aa sequence (aa371-400) 
important for binding is quite removed from the three upstream phosphorylation sites (T222, 
S272, T334) (Lukas, Kroe et al. 2004). The docking site is essential for the formation of a 
tight, high-affinity complex with P38α; the removal of this domain leads to a decrease in 
the catalytic efficiency of MK2 phosphorylation by greater than 2 orders of magnitude 
(Lukas, Kroe et al. 2004). One consequence of the docking site is allowing for an increase 
in the effective concentration of the substrate, thereby yielding an increase in 
phosphorylation. This effect is produced by the bidentate interaction of the substrate with 
the kinase and has been mapped in vitro with other MAPKs (e.g. ERK) using a modified 
SPOTs synthesis method for the generation of immobilized peptide arrays on derivatized 
phosphocellulose membranes (Espanel, Walchli et al. 2003). In this study, double peptide 
synthesis was used to generate both a docking site peptide and a substrate peptide within a 
single SPOT, resulting in both increased binding and phosphorylation of the substrate 
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peptide upon the application of the upstream MAPK. In a somewhat analogous study, 
Naffin et al. showed that bidentate interactions with immobilized peptides had the ability 
to increase the half-lives for peptide-protein complexes >3 orders of magnitude (Naffin, 
Han et al. 2003). However, the substrate localization effect of the docking sites is not the 
only mechanism by which these distal interactions enhance phosphorylation. It was 
recently shown that the p38α docking site interaction regulates the enzymatic activity 
through an allosteric mechanism. Binding of the docking peptides led to allosteric 
structural changes resulting in an increase in the ATP and phosphoacceptor binding 
affinities, resulting in enhanced catalytic turnover (Tokunaga, Takeuchi et al. 2014). Thus, 
substrate specificity is maintained through the specific enhancements afforded by the 
docking site interactions. 
Previous literature has suggested that the catalytic surface contains both a targeting site 
(T-site) and a substrate site (S-site) (Bayer, De Koninck et al. 2001). The T-site includes 
additional contacts on the catalytic surface which the autoregulatory domain of CaMKII 
binds to in the autoinhibited state. It is thought that substrates such as GluN2B and the 
peptide substrate autocamtide-2 (AC-2) which is derived from CaMKII’s autoregulatory 
domain around T287 are able to mimic the autoregulatory domain and interact with the T-
site; an interaction which is also believed to give rise to their increased affinity (Bayer, De 
Koninck et al. 2001, Bayer, LeBel et al. 2006). Specific mutants within the T-site have 
been generated (I205K) which have been shown to only disrupt the targeting of T-site 
binding substrates; whereas those that only interact with the S-site (e.g. Syntide) are not 
affected (Bayer, LeBel et al. 2006). This mutant was also found to decrease translocation 
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to the PSD (Bayer, De Koninck et al. 2001); however, its effect on phosphorylation within 
the PSD is unknown. 
 
1.11.3 Targeting Subunits and Scaffolds 
The docking sites of some kinases resides within the kinase domain while the docking 
peptide resides within the substrate protein, yet there are other kinases which employ 
additional proteins to regulate substrate specificity. These enzyme-interacting proteins are 
classified into various groups with terms such as adaptor (or targeting subunit), docking, 
anchoring, or scaffolding proteins. However, the defining characteristics between some of 
these terms are ambiguous and overlapping. For this reason, Langeberg and Scott 
(Langeberg and Scott 2015) have suggested that adaptor proteins refer to soluble proteins 
which include protein interaction domains, for example the cyclins which form stable 
complexes with cyclin-dependent kinases (CDKs) and modulate substrate selectivity 
(Schulman, Lindstrom et al. 1998, Cheng, Noble et al. 2006). Docking proteins are 
considered to be similar to adaptor proteins, yet include membrane-associating elements or 
motifs (e.g. a pleckstrin homology (PH) domain or myristoylation sequence) in their N-
terminal region (e.g. insulin receptor substrate (IRS) class (IRS1-4)) (Langeberg and Scott 
2015). Scaffolding proteins, having been used often times synonymously with the term 
anchoring proteins, are defined as having at least one of several attributes: 1) They act as 
an organizational tether for multiple successive kinases and/or signaling molecules within 
a signaling cascade; 2) They concentrate and organize enzymatic activity to a defined 
region of action; or 3) They tether opposing enzymes (e.g. kinases and phosphatases) for 
the regulated, coordinated control of effectors molecules. One of the key roles of adaptors, 
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docking proteins, and scaffolding proteins is the localization of kinases; both the 
localization of kinases to regions of the cell as well as with substrate molecules. One effect 
this has is decreasing the volume of the spatial searching of substrates, thereby driving 
substrate selectivity by exclusion of potential substrates. 
The rather unique dodecameric holoenzyme structure of CaMKII essentially allows 
CaMKII to act as its own adaptor protein. As CaMKII is capable of intersubunit 
autophosphorylation at T287, multimerization allows for a substrate molecule, in this case 
the autoregulatory domain for another subunit, to be tethered to the kinase through 
interactions with the association (hub) domains. Like many adaptor proteins which form 
stable complexes with the kinases they interact with, the association domains form rather 
stable holoenzymes. In fact, there is little evidence to suggest that subunits exists in 
monomeric or dimeric forms. Stratton et al. (2014) recently suggest that subunits exchange 
between holoenzymes under certain activation and autophosphorylation states (Stratton, 
Lee et al. 2014, Bhattacharyya, Stratton et al. 2016). However, their model of dimeric pair 
swapping does not necessarily require freely diffusing subunits if the process involves two 
holoenzymes interacting directly during swapping.  
The multimeric architecture of the holoenzyme, sustained by the association domains, 
allows for several important features for CaMKII function. First, it allows for the 
intersubunit autophosphorylation at T287 to occur as an intraholoenzyme event, thereby 
reducing the nature of the bimolecular reaction to an intramolecular one in which the 
concentration of CaMKII and temperature have greatly diminished influences on the rate 
of the reactions. In this way, CaMKII’s unique dodecameric structure and the ability to 
self-regulate its activity through autophosphorylation allows for the integration of 
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intracellular calcium transient signals (as during neuronal activation) into graded levels of 
activation (thereby serving as a “molecular switch” of previous neuronal activation states 
to lead to a form of molecular memory), regardless of the local concentration of CaMKII. 
Second, it allows for a genetically encoded mechanism by which to regulate and modulate 
the threshold for activation/autophosphorylation. Specifically, this has been shown to be 
accomplished by alternative splicing within the linker region connecting the autoregulatory 
domains and the association domains (Bayer, De Koninck et al. 2002, Chao, Stratton et al. 
2011). Third, the dodecameric assembly of the CaMKII holoenzyme affords the kinase the 
ability to interact with multiple substrates or targets simultaneously; a feature which may 
in turn regulate CaMKII enzymatic function and localization. The multivalent interactions 
occurring concurrently within a given timeframe would be expected to have high avidity; 
an accumulated measure of the combined affinities of each interaction. Thus, the 
multimeric nature of the CaMKII holoenzyme would be expected to contribute to the 
substrate specificity of the kinase. 
 
1.11.4 System-level Effects 
The regulatory mechanisms controlling kinase phosphorylation and specificity increase 
in complexity as one moves beyond the typical in vitro methodologies used to study kinase-
substrate relationships and considers in vivo environments which operate under additional 
mechanisms referred to as systems-level effects. Typical reaction conditions for in vitro 
assays often utilize activator and substrate concentrations (including ATP) that are not 
limiting and in which only one phosphorylatable substrate is used. However, many kinases 
have more than one substrate in the cell, which can produce competitive effects on substrate 
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phosphorylation. Preferential interactions of kinases with high affinity substrates would 
tend to limit the available kinase for interactions with lower-affinity substrates. This type 
of effect would tend to lead to increased specificity and/or temporal ordering of substrate 
phosphorylation. Cyclin-dependent kinases (CDKs), specifically Cdk1 has been shown to 
operate under such a mechanism with Wee1 (a nuclear kinase) in yeast and was able to be 
recapitulated with purified components in vitro (Kim and Ferrell 2007). Another system-
level effect shown to direct the specific of kinase interactions is multisite phosphorylation, 
where the combination of numerous nearby phosphorylation events determine the 
recognition and specificity of an interaction. For example, the recognition of the CDK 
inhibitor Sic1 by the ubiquitin ligase SCFCdc4 is determined by the summation of multiple 
low-affinity interaction sites created by multiple phosphorylation events (Tang, Orlicky et 
al. 2012). Other kinases can controlled by the local concentration of immobilized substrates 
such that a higher concentration of substrate allows for kinases to effectively outcompete 
phosphatase activity within a specific environment (Liao, Su et al. 2009). 
CaMKII likely encounters these various forms of system-level effects governing kinase 
specificity. For instance, within the PSD, CaMKII interacts with and phosphorylates >40 
known substrates, some involving multiple sites of phosphorylation (Yoshimura, Aoi et al. 
2000, Yoshimura, Shinkawa et al. 2002). Based on the sequences of the phosphorylation 
sites themselves, many of the sites lack much similarity to the consensus CaMKII 
phosphorylation motif. Thus, it is likely that they are low-affinity substrates and that these 
sites must compete with other high-affinity substrates within the PSD such as GluN2B. 
Many of these PSD substrates are immobilized within the cytoskeletal web of the PSD. 
Thus, the equilibrium between kinase and phosphatase activity would be subject to both 
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the density of the substrate as well as multivalent avidity of the CaMKII holoenzyme. 
Interestingly, as activation of the CaMKII holoenzyme produces graded levels of T287 
autophosphorylation (likely due to different numbers of subunits activated within the 
holoenzyme) in response to the frequency of Ca2+ transients, it is likely that the degree of 
activation alters substrate phosphorylation within these types of environments.  
 
1.12 Research Goals  
CaMKII is a multifunctional kinase with broad substrate specificity involved in many 
different cellular functions. As such, CaMKII has been shown to phosphorylate a vast 
number of substrates including >40 substrates identified in the PSD alone (Yoshimura, Aoi 
et al. 2000, Yoshimura, Shinkawa et al. 2002), with likely many more remaining 
unidentified. In fact, databases such as PhosphoSitePlus, which include known CaMKII 
substrates based on in vivo and in vitro data, list more than 200 unique sites (Hornbeck, 
Kornhauser et al. 2012). This leads to the question of how a single kinase which is known 
to regulate many processes (often with opposing effects/outcomes) through the specific 
phosphorylation of a certain substrate effector, is able to preferentially direct its 
phosphorylation for its intended target. While it is known that autophosphorylation is 
required for certain functional outputs (e.g. LTP), the mechanism by which CaMKII turns 
various activation states into altered substrate selection and therefore disparate forms of 
synaptic plasticity is not known. Furthermore, whether the multimeric nature of the 
CaMKII holoenzyme also produces unique regulation and substrate interactions is 
unknown; however, having multiple catalytic subunits in each holoenzyme could afford 
enhanced substrate and binding partner interactions leading to altered rules for substrate 
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selection and phosphorylation compared to the monomeric kinases (Naffin, Han et al. 
2003). Understanding the various means by which CaMKII substrate selection is regulated 
may provide crucial insight into pathological states of the brain, including ischemic stroke 
and brain trauma, where CaMKII is aberrantly activated and contributes to 
neurodegeneration. 
While CaMKII has been studied for >30 years, the complexity of its holoenzyme 
structure and autoregulation through multisite phosphorylation within its ARD still leaves 
some unanswered questions regarding the translation of activation state into multiple 
downstream effects. The central focus of this work was to explore the impact that T287 
autophosphorylation and/or degree of activation within the holoenzyme has on kinase 
activity. Our data presents a functional consequence of the ARD on the enzymatic activity 
in the absence of T287 autophosphorylation; namely, the narrowing of substrate specificity 
through competition with substrates for access to the catalytic domain. We believe this 
effect may be further modulated by the extent of holoenzyme 
activation/autophosphorylation as multivalent effects can also modulate substrate 
specificity. 
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CHAPTER 2. Control of CaMKII Substrate Selectivity through ARD Substrate 
Filtering and Autophosphorylation 
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2.1 Introduction 
Calcium/calmodulin-dependent protein kinase II (CaMKII) is a multimeric 
holoenzyme (8-14 subunits) generated from four closely related genes (α,β,γ,δ) that is 
implicated in regulating diverse substrates involved in a host of cellular processes from 
metabolism and cell cycle control to calcium homoeostasis and excitable cell activity and 
plasticity (Hudmon and Schulman 2002). Like many CaM-regulated enzymes, binding of 
the calcium sensor calmodulin (CaM) to a target sequence within an autoregulatory domain 
(ARD) activates CaMKII through disinhibition of the ARD. As CaMKII does not possess 
an activation loop as seen in many other kinases, Ca2+/CaM has been considered as a binary 
switch leading to substrate phosphorylation via ARD disinhibition (Figure 1.3). The unique 
multimeric architecture of CaMKII permits coincident CaM-binding within the 
holoenzyme to support an intersubunit autophosphorylation (T286 α-isoform and T287 β,γ,δ 
isoforms) event within its ARD that is essential to CaMKII’s function in vivo (Cho, Giese 
et al. 1998, Giese, Fedorov et al. 1998, Glazewski, Giese et al. 2000, Gustin, Shonesy et 
al. 2011). While recent data suggests that Ca2+/CaM alone is not sufficient to fully displace 
the ARD from the catalytic domain, full displacement occurs following T287 
autophosphorylation (Hoffman, Stein et al. 2011). This autophosphorylation event 
produces enhanced CaM-binding affinity (Meyer, Hanson et al. 1992) and autonomous 
activity (Ca2+/CaM-independent activity) (Schworer, Colbran et al. 1988, Lou and 
Schulman 1989).  
Early knock-out studies in mice found that CaMKIIα is important for both hippocampal 
long-term potentiation (LTP) (Silva, Stevens et al. 1992) and spatial learning (Silva, Paylor 
et al. 1992). Later studies using knock-in animal models that mimic or ablate T287 
39 
autophosphorylation have clearly shown a functional role for this process in vivo (Cho, 
Giese et al. 1998, Giese, Fedorov et al. 1998, Glazewski, Giese et al. 2000, Gustin, Shonesy 
et al. 2011). Specifically, removing the ability to autophosphorylate this site (T286A) 
(Giese, Fedorov et al. 1998) or phosphomimetic mutation (T286D) (Bach, Hawkins et al. 
1995, Mayford, Wang et al. 1995) to generate a constitutive form in the α-isoform impaired 
both hippocampal LTP and spatial learning, though this could be due to issues with 
hippocampal development. This led to studies involving temporally controlled expression 
of the transgenes which further indicate using a T287D mutation that autophosphorylation 
was important for the hippocampal learning and LTP (Mayford, Baranes et al. 1996). 
While the exact functional role of T287 autophosphorylation remains debated; recent 
work suggests that T287 autophosphorylation may mediate opposing forms of neuronal 
plasticity (Shonesy, Jalan-Sakrikar et al. 2014) via differential substrate phosphorylation 
(Coultrap, Freund et al. 2014). This result is particularly surprising considering that 
autophosphorylation was shown by this laboratory to possess a very limited influence on 
catalytic turnover or substrate specificity (Coultrap, Buard et al. 2010, Coultrap, Barcomb 
et al. 2012). However, given that CaMKII is a multifunctional enzyme which 
phosphorylates a number of substrates important for synaptic plasticity (as well as many 
other cellular processes), it seems that changes in kinase output associated with the 
autophosphorylation could be a direct mechanism underlying the biological data in the 
literature. In an effort to resolve the functional consequences of autophosphorylation on 
substrate phosphorylation, we considered the recent electron paramagnetic resonance 
(EPR) data exploring the impact of this process on ARD interactions with the catalytic 
domain. 
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While crystal structures for apoCaMKII and the Ca2+/CaM-activated form of human 
CaMKIIδ (Figure 1.4) (Rellos, Pike et al. 2010) display autoinhibition (i.e. closed state) 
versus complete disinhibition and unfolding of the ARD (i.e. open state), in solution, EPR 
spectroscopy indicates that regions of the ARD continue to interact with the catalytic 
surface even in the Ca2+/CaM-activated, non-T287 autophosphorylated state (CaMKIIm−P) 
(Hoffman, Stein et al. 2011). T287 autophosphorylation in the presence of Ca2+/CaM leads 
to complete destabilization and dissociation of the ARD. Biochemical studies have shown 
that this allows optimal CaM-binding as evidenced by a 20,000-fold enhancement in 
Ca2+/CaM binding affinity (Meyer, Hanson et al. 1992); a state known as CaM-trapping.  
The functional consequences on substrate phosphorylation stemming from partial ARD 
disinhibition in the non-T287 autophosphorylated state remain unclear. A potential 
consequence of such a conformeric equilibrium between ARD and catalytic surface in the 
Ca2+/CaM-bound state (i.e. non-trapped low-affinity state), is that substrate access may be 
gated as the catalytic surface transitions between open and closed states; an intrinsic 
inhibitory mechanism disengaged by autophosphorylation. Thus while 
autophosphorylation and Ca2+/CaM binding maximizes substrate accessibility, substrate 
binding might be expected to shift the catalytic surface from closed to open states, thereby 
enhancing Ca2+/CaM binding in the absence of autophosphorylation (CaMKIIm−P). We 
postulated that mutagenesis or inability to control T287 autophosphorylation could have 
previously masked interactions between autophosphorylation and substrate 
activity/specificity. Therefore, we intended to explore the role of autophosphorylation on 
the activity of the kinase; specifically focused on potential substrate-dependent effects. 
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In this study, we use diverse, validated CaMKII substrates in diffusion-limited and 
diffusion-restricted reactions to show that T287 autophosphorylation underlies a switch-like 
property of the ARD to regulate CaMKII’s substrate specificity. While CaMKII’s catalytic 
domain exhibits broad substrate specificity in the absence of its ARD, phosphorylation is 
restricted to high-affinity substrates in the absence of autophosphorylation. Because T287 
autophosphorylation (and phosphomimetic substitutions) restores maximal activation and 
broad substrate selectivity, we find that the ARD of activated CaMKII tunes substrate 
selectivity by competing for substrate binding to the catalytic domain. Our data suggest 
that calcium-spike frequency encoding (De Koninck and Schulman 1998) into T287 
autophosphorylation permits an autoregulatory switching mechanism to match substrate 
selectivity with diverse cellular responses.  
 
2.2 Materials and Methods 
2.2.1 Expression and Purification of CaMKII and Calmodulin 
Recombinant human CaMKIIδ (NCBI RefSeq: NP_742113.1) with an N-terminal 
6xHN tag was integrated into a baculoroviral construct (BacPAK9-6xHN), amplified in 
Sf9 insect cells, and expressed in Hi5 (T. ni) insect cells (Takeuchi-Suzuki, Tanaka et al. 
1992) (Brickey, Colbran et al. 1990). Site-directed mutagenesis was used to generate 
monomeric hCaMKIIδ1-317 (i.e. CaMKIIm) (by truncation through the addition of stop 
codon at aa318) as well point mutants (see Table 2.1 for a list of primers). Kinases were 
purified under reducing conditions by affinity chromatography (NiNTA resin) followed by 
size exclusion chromatography (Sephacryl S-400 [holoenzyme] or S-300 [CaMKIIm]) 
using an Äkta Purifier (Amersham) (Bradshaw, Hudmon et al. 2002, Ashpole, Herren et 
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al. 2012). SDS-PAGE of the purified proteins revealed a single band with purities >98%. 
A catalytic fragment for hCaMKIIδ was generated by chymotryptic digestion of purified 
holoenzyme (Kwiatkowski and King 1989, Yoshimura, Nomura et al. 1996), followed by 
sequential affinity purification utilizing CaM-sepharose to remove any non-proteolyzed 
subunits with Ni-NTA resin to enrich for the constitutively active catalytic fragment. SDS-
PAGE and western blotting with an anti-phospho-T286/287 antibody (Millipore) verified that 
this fragment lacked the region around T287. Recombinant calmodulin (wt or C75-
containing mutant) was expressed and purified in E.coli as described previously (Singla, 
Hudmon et al. 2001, Gaertner, Kolodziej et al. 2004) via boiling, ammonium sulfate 
precipitation, and phenyl-sepharose affinity chromatography.  
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Table 2.1 Primers for generation of monomeric CaMKII. 
 
Primer Name     Primer Sequence (5' to 3') 
hCaMKII-delta-K318Stop_F  5'-aaggaatttctcagcagcctagagtttgttgaagaaacc-3' 
hCaMKII-delta-K318Stop_R  5'-ggtttcttcaacaaactctaggctgctgagaaattcctt-3' 
hCaMKII-alpha-K317Stop_F  5'-acttctccggagggtagagtgggggaaac-3' 
hCaMKII-alpha-K317Stop_R  5'-gtttcccccactctaccctccggagaagt-3' 
hCaMKII-delta-T287A_F  5'-tgatgcacagacaggaggctgtagactgcttgaag-3' 
hCaMKII-delta-T287A_R  5'-cttcaagcagtctacagcctcctgtctgtgcatca-3' 
hCaMKIIdelta-T287V_F  5'-ccatgatgcacagacaggaggttgtagactgcttgaagaaat-3'
hCaMKIIdelta-T287V_R  5'-atttcttcaagcagtctacaacctcctgtctgtgcatcatgg-3'
hCaMKIIdelta-T287N_F  5'-atgatgcacagacaggagaatgtagactgcttgaag-3' 
hCaMKIIdelta-T287N_R  5'-cttcaagcagtctacattctcctgtctgtgcatcat-3' 
hCaMKII-delta-T287D_F  5'-ccatgatgcacagacaggaggatgtagactgcttgaagaaat-3'
hCaMKII-delta-T287D_R  5'-atttcttcaagcagtctacatcctcctgtctgtgcatcatgg-3'
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2.2.2 Soluble Peptide Substrate Phosphorylation Assays 
Soluble peptide substrates (generally 15mers) were obtained (Biopeptide Co., Inc.) and 
utilized in standard radioactive activity assays. In typical Ca2+/CaM-dependent reactions, 
50-200 µM substrate was used in the presence of 50 mM HEPES pH 7.4, 100 mM NaCl, 
10 mM MgCl2, 0.2 mM CaCl2, 1 μM CaM, 100 μM cold ATP, 60 μCi/ml [γ-32P] ATP, and 
5-10 nM CaMKII (per subunit). In Ca2+/CaM-independent reactions, 5 mM EGTA (or 
BAPTA) was used to chelate free calcium. This constitutive (i.e. autonomous) activity in 
the absence of calcium was expressed a percentage of the Ca2+/CaM-dependent activity. 
Reactions were carried out at 30°C for 1 minute and quenched by spotting onto Whatman 
Grade P81 ion exchange chromatography paper (Whatman, GE Healthcare, Piscataway, 
NJ). The filter papers were washed with 75 mM phosphoric acid 3 times for 5 minutes each 
and subsequently quantified in a scintillation counter (Beckman) via the Cerenkov counting 
method (Roskoski 1983, Hudmon, Aronowski et al. 1996). AC-2), a CaMKII substrate 
derived from the CaMKII T287 autophosphorylation site was used for standard soluble 
peptide substrate reactions. 
  
2.2.3 Pre-Autophosphorylation Reactions 
For reactions involving T287 autophosphorylated CaMKII, a pre-reaction was 
performed in the presence of 20 mM HEPES pH 7.4, 100 mM NaCl, 10 mM MgCl2, 
0.5mM CaCl2, 5 μM CaM, 500 μM cold ATP and 500nM kinase for 10 minutes on ice. In 
Figure 2.17, autonomous CaMKIIm was allowed to undergo complete “burst” 
phosphorylation (i.e. rapid phosphorylation of T306/T307 associated with the removal of 
Ca2+/CaM following prior T287 autophosphorylation. Therefore, following a standard T287 
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autophosphorylation pre-reaction described above, Ca2+/CaM was chelated with 10 mM 
EGTA for 10 minutes at 30°C. Subsequent substrate phosphorylation assays using this 
form of the kinase included 2 mM EGTA in place of additional Ca2+/CaM. 
 
2.2.4 SPOTs Peptide Substrate Phosphorylation Assay 
Peptides were synthesized using the SPOT method (Frank and Overwin 1996, Frank 
2002) onto β-alanine derivatized cellulose membranes via a MultiPep synthesizer (Intavis 
AG, Cologne, Germany). The peptide blots were blocked with 5% BSA in 50 mM HEPES 
pH 7.4, 100 mM NaCl, 1 mM EDTA, and 0.02% NP-40 for 30 minutes followed by three 
washes in 100 mM Tris-HCl pH 7.4. Membranes were subjected to a kinase 
phosphorylation assay in the presence of 50 mM HEPES pH 7.4, 100 mM NaCl, 10 mM 
MgCl2, 0.2 mM CaCl2, 1 μM CaM, 0.2 mg/ml BSA, 1 mM DTT, 100 μM cold ATP, 6-
12 μCi/ml [γ-32P] ATP, and 5-10 nM CaMKII (per subunit). The reactions were incubated 
at room temperature for 4 minutes unless otherwise noted, terminated with three washes 
(100 mM sodium phosphate pH 7.0, 1 M NaCl, 10 mM EDTA) and dried. The extent of 
radioactive phosphate incorporation was quantified using a Fujifilm phosphoimager and 
expressed as photostimulated luminescence (PSL/mm2) for a 1.5 mm x 1.5 mm circle 
centered on each spot. 3-4 replicate spots were averaged for each peptide for a given 
condition with error bars indicating SD, unless otherwise noted. Substrates were collected 
from PhosphoSitePlus corresponding to sites shown to be CaMKII substrates (217 in total) 
via various methods (Hornbeck, Kornhauser et al. 2012). Each 15mer peptide, centered on 
the confirmed CaMKII phosphorylation site (P0), was synthesized via SPOTs method and 
phosphorylated for 10 minutes at room temperature. 
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2.2.5 GST-Fusion Peptide Substrate Phosphorylation Assays 
Short 21mers (55mer for GluN2B) of several CaMKII substrates were subcloned into 
pGEX-6P-1 (Clontech / AscI-PacI version from Well’s lab) and expressed as GST-fusions 
(Ashpole, Herren et al. 2012) in BL21(DE3) E.coli 4 hours at 37°C using 1 mM isopropyl 
1-thio-β-D-galactopyranoside (IPTG). Frozen aliquots of the lysates were made following 
lysis of the cell pellets in 20 mM Tris, pH 7.4, 200 mM NaCl, 1 mM EDTA, 0.1% Tween-
20 and 2X protease inhibitors (Calbiochem, catalog no. 539137). On the day 
experimentation, lysates of the GST-fusion proteins were bound and purified on 
glutathione resin in the presence of 2 mM EDTA and additional 2X protease inhibitors. 
Lysates of the expressed proteins were bound to glutathione beads for 2 hours at 4°C 
followed by extensive washing in 20 mM Tris, pH 7.4, 200 mM NaCl, 1 mM EDTA, 0.1% 
Tween-20 and 1× protease inhibitors to remove unbound protein yielding saturating 
amounts of GST-fusion proteins bound to glutathione resin beads. Phosphorylation of 
GST-fusion proteins (20 µl bed volume) with 10 nM CaMKIIm in the presence of 50 mM 
HEPES pH 7.4, 100 mM NaCl, 10 mM MgCl2, 0.5 mM CaCl2, 5 μM CaM, 100 μM cold 
ATP, 120 μCi/ml [γ-32P] ATP. For the pre-T287 autophosphorylated monomer, 1 µM kinase 
was incubated for 20 minutes on ice in conditions described above. The GST-fusion 
substrates were phosphorylated for 10 minutes at room temperature with shaking. The 
reaction was quenched by the addition of 50 mM HEPES pH 7.4, 400 mM NaCl, 50mM 
EDTA and the beads were washed extensively. Subsequently, the GST-fusions were eluted 
from the beads in 2X LDS sample buffer (with β-mercaptoethanol) at 70 °C for 5 minutes. 
SDS-PAGE of the eluted samples followed by Coomassie staining was used to detect and 
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visualize the total protein while phosphorimaging (FUJIFILM) was used to detect 
phosphorylation using MultiGauge v3.1. GST-fusions of GluN2B1275-1329 
(NASTTKYPQSPTNSKAQKKNRNKLRRQHSYDTFVDLQKEEAALAPRSVSLKDK
GR), Syntide21mer (MPLARTLSVAGLPGKKDWEDE), GluA1839-859 
(MKGFCLIPQQSINEAIRTSTL), Serum Response Factor (SRF)93-113 
(AERRGLKRSLSEMEIGMVVGG), and gp130772-792 (PSVQVFSRSESTQPLLDSEER) 
were used. 
 
2.2.6 Fluorescence measurement of CaMIAEDANS 
Purified CaMC75 was reduced with DTT, dialyzed in 50mM sodium phosphate buffer 
pH 7.0, and labeled with IAEDANS (Molecular Probes). Excess dye was removed from 
with a Sephadex G-25 column (Illustra NAP10) yielding CaMIAEDANS labeled with a ratio 
of 0.8:1 moles of dye per mole of CaM. Fluorescent intensity measurements were acquired 
with a PTI QuantaMaster 400 with excitation at 336 nm at room temperature with emission 
maxima at 490 nm. Slit widths for excitation and emission were 4 mm. For steady-state 
binding, relative intensity measurements, 50 nM CaMIAEDANS in the presence of degassed 
50 mM HEPES pH 7.4, 100 mM NaCl, 1 mM CaCl2, 10 mM MgCl2, 1 mM ADP, 0.1 
mg/ml BSA was measured for as baseline. For CaMKII binding in the absence of substrate, 
100 nM CaMKIIholo was added and expressed as the relative intensity change (30 sec steady 
state average). Substrate-dependent changes in CaM binding were measured via the 
subsequent addition of soluble peptide substrates at a concentration near the determined 
Km value (5 μM for GluN2B and AC2; 50 μM for Syntide). Dissociation rates (Koff) were 
measured following the intensity measurements and initiated via the addition of 2.5 μM 
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(50-fold excess) unlabeled CaM. All data were background corrected for decay of 
CaMIAEDANS alone (linear). Data were analyzed using SigmaPlot (v.12.5) and fit to an 
exponential decay curve [f = y0+a*exp(-b*x)]. 
 
2.2.7 Sequence Analysis via Sequence Logo 
Sequence logos were generated via WebLogo v.2.8.2 (http://weblogo.berkeley.edu) 
(Crooks, Hon et al. 2004) using default settings except that 0 pseudocounts were used for 
small sample correction; each amino acid height is proportional to the sequence 
conservation at the position relative to the phosphoacceptor site (P0). 
 
2.2.8 ScanSite Analysis 
ScanSite scores were obtained using the ScanSite 3beta algorithm 
(http://scansite3.mit.edu) (Obenauer, Cantley et al. 2003). Because the algorithm has a 
minimal length requirement not based on the consensus motif, the residues surrounding 
the phosphorylation site from the actual protein beyond the optimized/defined peptide 
was used for AC-2 and Syntide. For all sites not recognized by ScanSite, a score of 0.7 
was given. 
 
2.2.9 Data Analysis 
One-way analysis of variance (ANOVA) with subsequent Holm-Šídák post-test was 
performed on log-transformed to account for mean-dependent variances; compared to 
control (#). For comparisons of two groups, Student’s t test (*) were used. Statistical 
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analyses were performed using SigmaPlot 12.5. Statistical significance is denoted by the 
number of symbols for different P values (e.g. *P < 0.05, **P < 0.01, ***P<0.001). 
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2.3 Results 
2.3.1 Generation and Characterization of Monomeric CaMKII1-317 (CaMKIIm) 
In order to explore the role of autophosphorylation on CaMKII substrate 
specificity/selectivity in the absence of mutagenesis, we created a monomeric variant 
(hCaMKIIδ1-317, termed CaMKIIm) (Figure 2.1, A to C) devoid of the “hub” domain 
required for multimerization, expressed it in T.ni (Hi5) insect cells, and purified using a 
combination of Ni-NTA affinity chromatography followed by gel filtration (See Materials 
and Methods 2.2.1). SDS-PAGE revealed a highly pure band around the expected 
molecular weight of ~37kDa for CaMKIIm (Figure 2.1C). Because the four CaMKII 
isoforms exhibit identical substrate binding pockets, we chose the delta variant due to its 
enhanced stability in our kinase reactions. A desirable feature of CaMKIIm, is that unlike 
the CaMKII holoenzyme (CaMKIIholo+P) which undergoes a rapid intramolecular 
intersubunit T287 autophosphorylation reaction in saturating Ca2+/CaM conditions (Hanson, 
Meyer et al. 1994), the bi-molecular T287 autophosphorylation event is well-controlled by 
temperature or enzyme concentration. Using a pre-autophosphorylation reaction with 
activators (Ca2+/CaM), Mg2+/ATP, and concentrated kinase (See Materials and Methods 
2.2.3), CaMKIIm can be autophosphorylated at T287 (CaMKIIm+P) as indicated by 
immunoblotting with a phospho-T287-antibody (Figure 2.1D). Autophosphorylation at T287 
of CaMKIIm also produces the expected increase in Ca2+-independent (i.e. autonomous) 
activity as measured using standard radiometric assays (See Materials and Methods 2.2.2) 
when a classical peptide substrate for CaMKII (i.e. autocamtide-2; AC-2) is evaluated 
(Figure 2.1E).  
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Figure 2.1 Characterization of CaMKIIm. 
(A and B) Linear schematic (left) of a single subunit of CaMKII representing the catalytic domain 
(green), autoregulatory domain (ARD) (blue), and hub domain (orange). X-ray crystal structures 
of the CaMKII constructs (right). (A) Full-length hCaMKII delta with crystal structural depicting 
a single subunit and holoenzyme (PDB ID: 3SOA) in the autoinhibited state. (B) Crystal structure
(PDB ID: 2VN9) of monomeric hCaMKII delta residues 1-317 (CaMKIIm) in the autoinhibited 
state. (C) Coomassie-stained SDS-PAGE of CaMKII vs CaMKIIm. (D) Western blot analysis of 
T287 autophosphorylation with (+) or without (-) a pre-autophosphorylation (AutoP) reaction. (E
and F) Enzymatic activity (katal/mol) assays measured via standard soluble peptide 
(Autocamtide-2) assays with radioactive [γ32P]ATP.  Ca2+-dependent (Ca2+/CaM) vs Ca2+-
independent (EGTA) assays were measured for kinase with (+) or without (-) a pre-
autophosphorylation (AutoP) reaction. (E) Activity of CaMKIIm (n = 3). (F) Activity of 
CaMKIIm at the start (0 min) and end (4 min) of the SPOTs assays (n = 3). Error bars in panel (E
and F) denote ±SD. 
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Given the dodecameric nature of the holoenzyme as well as the molecular weight 
difference between a single subunit of CaMKIIholo and CaMKIIm (See Materials and 
Methods 2.2.1), protein concentrations and activity measurements are expressed in molar-
based units (holoenzyme values are expressed per subunit). CaMKIIm undergoes limited 
trans (i.e., bimolecular) autophosphorylation at T287 when activated by Ca2+/CaM at low 
kinase concentrations used in our assays (5-10 nM). We observed an insignificant increase 
in the Ca2+-independent activity measured after 4 minutes at room temperature (Figure 
2.1F). Thus, the trans autophosphorylation event for CaMKIIm can be prevented without 
having to mutate the ARD even under saturating Ca2+/CaM conditions by reaction time or 
[CaMKIIm]. 
 
2.3.2 T287 Autophosphorylation is Associated with Decreased CaMKII Substrate 
Specificity 
To investigate the role of T287 autophosphorylation on CaMKII activity and substrate 
selectivity, we gathered a pool of known CaMKII substrates taken from the 
PhosphoSitePlus database (Hornbeck, Kornhauser et al. 2012). Separated by the CaMKII 
isoform for which the substrate was identified, this database provides the phosphorylation 
motif (15mer centered on the phosphorylation acceptor site = P0) as well as the species 
information for each substrate. Using SPOTs peptide synthesis, we generated arrays of 
these CaMKII substrates. The use of peptides over proteins limits the contribution of non-
catalytic targeting mechanisms, as well as multi-site phosphorylation. We synthesized 
15mer peptide substrates (as typically only 9–12 amino acids make contact with kinase 
active site) and characterized the phosphorylation of multiple substrates simultaneously via 
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SPOTs arrays (see Methods). An advantage of this immobilized substrate assay is that 
diverse substrates can be exposed to identical conditions without high-affinity substrates 
dominating mixed soluble substrate reactions (Ubersax and Ferrell 2007). Given the 
limited space available within a given SPOTs array, redundant substrate sequences were 
removed as well as sites of autophosphorylation within CaMKII. We tested 217 CaMKII 
substrates (Table 2.2) in all. Since many of the substrates lack kinetic descriptions, we 
sought for a way to predict a substrate’s potential affinity based on sequence information. 
The strength of the substrate-kinase interaction is dictated by the sequence composition of 
the phosphorylation motif and its complementarity to the catalytic surface (substrate 
binding pocket). We reasoned that the relative ability of a substrate to be phosphorylated 
should therefore be correlated to its similarity to the consensus motif obtained from a 
degenerate oriented-peptide library (Songyang, Lu et al. 1996). Therefore, we ranked the 
substrates using a position-specific scoring matrix (ScanSite; http://scansite3.mit.edu 
(Obenauer, Cantley et al. 2003)) based on a previously defined CaMKII consensus 
sequence (KRQQSFDLF) obtained from a degenerate oriented-peptide library (Songyang, 
Lu et al. 1996). This comparison provides a relative measure of substrate sequence 
similarity to an optimal substrate. Thus, the best substrates (i.e., high-affinity and extent of 
phosphorylation) should possess lower ScanSite scores (0.0 = identical match); those 
having limited similarity are predicted to be weak substrates (higher Km). We defined 
substrates unrecognized by ScanSite as a value of 0.7.   
Figure 2.2 shows the overall sequence composition and diversity of the 
PhosphoSitePlus CaMKII substrate library, which deviates substantially from the 
previously described high-affinity CaMKII consensus motif. Specifically, over 50% of the 
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previously published substrates for CaMKII were not recognized by ScanSite (and 
therefore given a value of 0.7) as seen in the histogram of ScanSite scores (Figure 2.2A), 
while a sequence logo for the overall library further illustrates the lack of strong positional 
sequence determinants for CaMKII substrate utilization (Figure 2.2B). Given the 
distribution of substrates in Figure 2.2A whereby only a small number of substrates possess 
sequences similar to the optimal CaMKII phosphorylation motif, we expected that very 
few substrates would exhibit large amount of phosphorylation by CaMKII. 
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Figure 2.2 Analysis of PhosphoSitePlus library of CaMKII substrates. 
(A) Histogram of ScanSite scores for all 217 PhosphoSitePlus substrates. CaMKII consensus 
motif similarity indicated by ScanSite score (lower value = greater similarity) if determinable; 
otherwise given a value of 0.7. (B) Sequence logo (WebLogo) for all 217 PhosphoSitePlus 
substrate sequences.  
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Using these peptide substrate arrays, we phosphorylated them under various kinase 
conditions. Radioactive phosphate [32P] incorporation was used as a measure of the extent 
of phosphorylation, expressed in terms of photostimulated luminescence per square 
millimeter (PSL/mm2). Peptide substrates were considered phosphorylated by a given 
kinase state if they exceeded a minimal threshold of 11.5 PSL/mm2, corresponding to the 
average phosphorylation of 10 CaMKII substrates peptides in which the phosphoacceptor 
site was mutated to a non-phosphoacceptor residue (i.e. alanine). Under activating 
conditions of saturating Ca2+/CaM, non-T287 autophosphorylatied kinase (CaMKIIm−P) 
phosphorylated only 35 peptides (Figure 2.3A) within the substrate pool. As expected, the 
best substrates (i.e., greatest phosphorylation) possess lower ScanSite scores. By contrast, 
pre-autophosphorylated CaMKIIm+P phosphorylates 138 substrates (Figure 2.3B), and 
native autophosphorylated holoenzyme CaMKIIholo+P phosphorylates 118 peptides (Figure 
2.3C). While a lack of CaMKII phosphorylation on SPOTs arrays could be influenced by 
synthesis efficiency and reaction conditions, autophosphorylation elicits a dramatic 
increase in both number of substrates phosphorylated and the sequence diversity of 
substrates (Figure 2.4); consistent with a decrease in substrate specificity. This is evident 
in the increase in the number of substrates not recognized by ScanSite (i.e. value of 0.7) 
(5-fold for CaMKIIm+P and CaMKIIholo+P) and the substantial increase in total 
phosphorylation for these substrates elicited by autophosphorylation (7.4-fold versus 10.1-
fold for CaMKIIm+P and CaMKIIholo+P, respectively) (Figure 2.4). 
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Figure 2.3 Autophosphorylation-associated expansion in CaMKII substrate specificity. 
(A-C), CaMKII substrates from PhosphoSitePlus (n = 217) were synthesized via SPOTs and 
phosphorylation measured via [γ-32P] phosphate incorporation for various states of the kinase. 
Substrates phosphorylated above threshold, and their sequences were ranked by ScanSite scores 
(0.7 = not identified by ScanSite) (left panel). Phosphorylated substrates were analyzed using 
WebLogo to evaluate position-specific sequence conservation for all phosphorylated substrates 
(middle) or the top 10 phosphorylated substrates (right). (A) Monomeric CaMKII (CaMKIIm−P)
(blue circles). (B) CaMKIIm+P (green circles). (C) CaMKII holoenzyme (CaMKIIholo+P) (red 
circles). 
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Protein Organism ACC# MW (Da)Residue Site Sequence ScanSiteScore
CaMKIIm−P
Phosphorylation 
(PSL/mm2) 
CaMKIIm+P
Phosphorylation
(PSL/mm2) 
CaMKIIholo+P
Phosphorylation
(PSL/mm2) 
1 14-3-3 beta rat P35213 28054 S60-p VVGARRSsWRVISSI 1 2.45 24.04 46.4
2 14-3-3 beta rat P35213 28054 S65-p RSSWRVIsSIEQKTE 0.651 2.65 9.43 15.2
3 5-LO human P09917 77983 S272-p CSLERQLsLEQEVQQ 0.408 26.95 202.45 353.8
4 ADCY3 mouse Q8VHH7 129085 S1077-p NVASRMEsTGVMGNI 0.65 0.97 9.49 3.4
5 AMPKA1 human Q13131 64009 T183-p SDGEFLRtSCGSPNY 1 0.27 1.09 1.2
6 ANKRD28 human O15084 112966 S1011-p TNTSKTVsFEALPIM 0.611 0.5 10.86 0.5
7 APOBEC3G human Q9HC16 46408 T218-p WVRGRHEtYLCYEVE 0.607 0.39 1.6 4.6
8 APP rat P08592 86704 T729-p MLKKKQYtSIHHGVV 0.493 1.09 26.56 5.2
9 ASIC1 rat P55926 59641 S477-p QKEAKRSsADKGVAL 0.669 0.56 4.43 1.0
10 BAD mouse Q61337 22080 S170-p KGLPRPKsAGTATQM 0.669 1.07 10.75 4.3
11 BRSK1 rat BAG28183 85183 T189-p VGDSLLEtSCGSPHY 1 0.22 1.23 1.7
12 C/EBP-beta human P17676 36106 S325-p EQLSRELsTLRNLFK 1 1.4 24.3 14.3
13 CACNA1B rat Q02294 262256 S784-p RLQNLRAsCEALYSE 1 0.85 11.13 54.9
14 CACNA1B rat Q02294 262256 S896-p ERARPRRsHSKEAPG 1 25.53 712.06 73.4
15 CACNA1B rat Q02294 262256 S2126-p SEKQRFYsCDRFGSR 0.552 2.35 29.16 13.3
16 CACNA1C mouse Q01815 240138 S1487-p DYLTRDWsILGPHHL 1 2.49 19.27 7.4
17 CACNA1C mouse Q01815 240138 S1545-p VACKRLVsMNMPLNS 0.529 2 10.88 6.0
18 CACNA1C rabbit P15381 242784 S439-p GVLSGEFsKEREKAK 1 0.62 4.8 6.4
19 CACNA1C rabbit P15381 242784 S1700-p PEIRRAIsGDLTAEE 0.563 3.92 65.67 355.7
20 CACNA1C guinea pig BAA34185.2 242638 T1603-p RTALRIKtEGNLEQA 1 0.45 10.6 266.0
21 CACNB1 rat P54283 65680 T499-p WALSRQDtFDADTPG 0.405 164.78 523.8 335.8
22 CACNB2 iso2 human Q08289-2 68142 T499-p RGLSRQEtFDSETQE 0.298 356.13 633.96 314.5
23 caldesmon chicken P12957 88747 S26-p RLEAERLsYQRNDDD 1 3.31 11.64 121.4
24 caldesmon chicken P12957 88747 S59-p QKEEGDVsGEVTEKS 0.593 0.36 1.82 6.5
25 caldesmon chicken P12957 88747 S73-p SEVNAQNsVAEEETK 0.659 0.23 5.67 1.9
26 caldesmon chicken P12957 88747 T484-p QNGERELtTPKLKST 0.638 0.18 1.25 20.1
27 caldesmon chicken P12957 88747 S490-p LTTPKLKsTENAFGR 1 1.06 26.77 1.6
28 caldesmon chicken P12957 88747 S602-p CFSPKGSsLKIEERA 1 0.44 3.49 0.8
29 caldesmon chicken P12957 88747 S635-p AVVSKIDsRLEQYTS 1 0.05 1.27 1.9
30 caldesmon chicken P12957 88747 S741-p RNLWEKQsVEKPAAS 0.618 0.66 9.63 2.1
31 CaMK4 rat P13234 53151 S332-p AVKAVVAsSRLGSAS 1 0.9 4.83 3.8
32 CaMK4 rat P13234 53151 S333-p VKAVVASsRLGSASS 1 0.71 7.76 3.8
33 CaMK4 rat P13234 53151 S337-p VASSRLGsASSSHTN 0.652 0.47 7.48 20.7
34 CaMK4 rat P13234 53151 S341-p RLGSASSsHTNIQES 1 0.38 6.07 27.9
35 CARD11 human Q9BXL7 133284 S116-p KEPTRRFsTIVVEEG 0.573 0.15 3.67 12.9
36 CD44 human P16070 81538 S706-p LNGEASKsQEMVHLV 0.63 0.17 2.23 2.8
37 CDK5R1 rat P61810 34031 S91-p ENLKKSLsCANLSTF 0.554 2.94 56.61 1.7
38 ChAT iso3 human P28329-3 70394 T456-p VDNIRSAtPEALAFV 1 0.22 1.64 2.9
39 CLCN3 human P51790 90966 S109-p ERHRRINsKKKESAW 1 1.58 10.43 29.2
40 CPEB rat P0C279 62062 T171-p VRGSRLDtRPILDSR 1 1.28 18.53 26.0
41 cPLA2 human P47712 85239 S515-p SDFATQDsFDDDELD 0.54 54.54 569.23 523.0
42 CREB rat P15337 36633 S133-p EILSRRPsYRKILND 0.42 3.65 61.15 41.5
43 CREB rat P15337 36633 S142-p RKILNDLsSDAPGVP 1 1.12 13.56 4.9
44 CREM iso3 mouse P27699 38516 S133-p EILSRRPsYRKILNE 0.623 2.95 47.84 32.4
45 Cx43 rat P08050 43031 S244-p KDRVKGRsDPYHATT 1 0.91 5.75 7.1
46 Cx43 rat P08050 43031 S255-p HATTGPLsPSKDCGS 1 0.76 2.88 3.0
47 Cx43 rat P08050 43031 S257-p TTGPLSPsKDCGSPK 1 1.02 4.04 2.2
48 Cx43 rat P08050 43031 S296-p VTGDRNNsSCRNYNK 1 2.44 14.64 15.5
49 Cx43 rat P08050 43031 S297-p TGDRNNSsCRNYNKQ 1 2.4 10.73 6.9
50 Cx43 rat P08050 43031 S306-p RNYNKQAsEQNWANY 0.647 8.9 112.37 11.1
51 Cx43 rat P08050 43031 S314-p EQNWANYsAEQNRMG 1 0.34 2.46 1.1
52 Cx43 rat P08050 43031 S325-p NRMGQAGsTISNSHA 1 0.41 1.6 3.4
53 Cx43 rat P08050 43031 S328-p GQAGSTIsNSHAQPF 1 0.52 2.89 3.4
54 Cx43 rat P08050 43031 S330-p AGSTISNsHAQPFDF 1 0.28 2.03 3.8
55 Cx43 rat P08050 43031 S364-p AIVDQRPsSRASSRA 1 1.06 22.77 34.4
56 Cx43 rat P08050 43031 S365-p IVDQRPSsRASSRAS 1 1.61 29.68 51.9
57 Cx43 rat P08050 43031 S369-p RPSSRASsRASSRPR 1 2.63 34.09 44.1
58 Cx43 rat P08050 43031 S372-p SRASSRAsSRPRPDD 1 2.69 67.55 25.8
59 Cx43 rat P08050 43031 S373-p RASSRASsRPRPDDL 1 2.31 28.54 25.6
60 Cx45 mouse P28229 45666 S326-p AQEQQYGsHEEHLPA 1 1.71 8.84 9.8
61 Cx45 mouse P28229 45666 T337-p HLPADLEtLQREIRM 1 1.72 9.44 3.0
62 Cx45 mouse P28229 45666 S381-p SKSGSNKsSISSKSG 0.534 1.02 7.05 12.0
63 Cx45 mouse P28229 45666 S382-p KSGSNKSsISSKSGD 1 1.63 18.41 9.0
64 Cx45 mouse P28229 45666 S384-p GSNKSSIsSKSGDGK 1 1.48 12.62 8.1
65 Cx45 mouse P28229 45666 S385-p SNKSSISsKSGDGKT 1 1.17 9.25 9.3
66 Cx45 mouse P28229 45666 S387-p KSSISSKsGDGKTSV 1 1.18 13.23 7.6
67 Cx45 mouse P28229 45666 S393-p KSGDGKTsVWI____ 1 0.4 3.75 3.7
68 DAT human Q01959 68495 S2-p ______MsKSKCSVG 1 3.17 5.47 0.8
69 DAT human Q01959 68495 S4-p ____MSKsKCSVGLM 1 3.85 5.5 0.7
70 DAT human Q01959 68495 S7-p _MSKSKCsVGLMSSV 1 2.38 6.74 1.0
71 DAT human Q01959 68495 S12-p KCSVGLMsSVVAPAK 1 1.89 8.91 0.8
72 DLG1 rat Q62696 100571 S39-p SSIERVIsIFQSNLF 1 0.78 6.46 2.7
73 DRD3 rat P19020 49516 S229-p RILTRQNsQCISIRP 0.548 22.11 287.92 104.5
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Protein Organism ACC# MW (Da)Residue Site Sequence ScanSiteScore
CaMKIIm−P
Phosphorylation 
(PSL/mm2) 
CaMKIIm+P
Phosphorylation
(PSL/mm2) 
CaMKIIholo+P
Phosphorylation
(PSL/mm2) 
74 EGFR human P00533 134277 S768-p DEAYVMAsVDNPHVC 0.665 0.94 11.76 729.4
75 EGFR human P00533 134277 S1070-p DSFLQRYsSDPTGAL 1 0.38 3.68 4.7
76 EGFR human P00533 134277 S1081-p TGALTEDsIDDTFLP 1 0.54 10.35 8.3
77 EGFR human P00533 134277 S1166-p QKGSHQIsLDNPDYQ 0.571 10.18 183.49 8.4
78 Ets-1 human P14921 50408 S251-p GKLGGQDsFESIESY 0.531 24.06 382.54 548.9
79 Ets-1 human P14921 50408 S257-p DSFESIEsYDSCDRL 0.674 2.88 19.72 35.9
80 Ets-1 human P14921 50408 S282-p NSLQRVPsYDSFDSE 0.433 128.79 874.23 794.2
81 Ets-1 human P14921 50408 S285-p QRVPSYDsFDSEDYP 1 76.92 731.91 854.9
82 Ets-2 human P15036 53001 S246-p FPKSRLSsVSVTYCS 0.522 2.62 17.01 16.8
83 Ets-2 human P15036 53001 S310-p LDVQRVPsFESFEDD 0.442 33.41 431.82 760.2
84 Ets-2 human P15036 53001 S313-p QRVPSFEsFEDDCSQ 1 14.96 197.28 1054.1
85 FAK iso3 mouse P34152-3 119243 S843-p DVRLSRGsIDREDGS 1 26.35 378.7 967.7
86 FBX43 human C9J908 74448 T200-p FSQQKTStIDDSKDD 0.581 1.01 17.63 20.7
87 FLNA human P21333 280739 S2523-p VTGPRLVsNHSLHET 1 7.33 300.5 378.2
88 GABBR1 mouse Q9WV18 108216 S867-p ITRGEWQsEAQDTMK 1 0.45 9.2 15.9
89 GABRB1 mouse P50571 54100 S409-p IQYRKPLsSREGFGR 1 1.88 22.27 31.6
90 GABRB1 mouse P50571 54100 S434-p GRIRRRAsQLKVKIP 0.66 5.58 60.65 11.2
91 GABRB3 mouse P15433 54166 S406-p GIQYRKQsMPKEGHG 0.487 1.64 16.19 12.0
92 GABRG2 mouse P22723 55099 S381-p NPLLRMFsFKAPTID 0.503 21.24 347.58 73.6
93 GABRG2 mouse P22723 55099 S393-p TIDIRPRsATIQMNN 0.633 1.76 22.24 38.3
94 GFAT human Q06210 78806 S261-p CNLSRVDsTTCLFPV 1 2.62 29.84 173.9
95 GLO1 human Q04760 20778 T107-p ELTHNWGtEDDETQS 1 0.22 2.34 4.1
96 GluR1 human P42261 101506 S567-p FSPYEWHsEEFEEGR 1 0.92 8.83 34.3
97 GluR1 mouse P23818 101569 S849-p FCLIPQQsINEAIRT 0.637 1.5 19.14 151.4
98 GluR1 rat P19490 101579 S645-p LTVERMVsPIESAED 0.627 0.68 4.83 17.5
99 GluR4 rat P19493 100758 S862-p TRNKARLsITGSVGE 0.593 5.56 85.02 22.6
100 gp130 mouse Q00560 102452 S780-p QVFSRSEsTQPLLDS 1 6.59 101.75 781.9
101 GSK3A rat P18265 51027 S21-p SGRARTSsFAEPGGG 0.631 17.11 347.34 107.6
102 GSK3B rat P18266 46742 S9-p SGRPRTTsFAESCKP 0.643 8.1 118.83 107.7
103 H1R human P35367 55784 T140-p LRYLKYRtKTRASAT 1 2.05 21.87 46.5
104 H1R human P35367 55784 S396-p FTWKRLRsHSRQYVS 0.6 1.56 24.24 17.8
105 HDAC4 human P56524 119040 S210-p YGKTQHSsLDQSSPP 1 6.58 105.46 99.1
106 HER2 human P04626 137910 T1172-p ATLERPKtLSPGKNG 1 2.6 28.94 7.0
107 HSF1 human Q00613 57260 S230-p PKYSRQFsLEHVHGS 0.385 28.74 717.79 386.2
108 HSL rat P15304 116812 S865-p ESMRRSVsEAALAQP 1 1.09 18.26 11.8
109 ICAP1 human O14713 21782 T38-p GGLSRSStVASLDTD 0.581 38.07 371.85 297.4
110 ITGB1 human P05556 88415 T788-p PIYKSAVtTVVNPKY 1 1.79 16.66 2.6
111 ITPKA human P23677 51009 T311-p EHAQRAVtKPRYMQW 1 2.29 9.79 7.1
112 KCNMA1 cow Q28204 130063 T139-p PVDEKEEtVAAEVGW 1 1.03 6.16 1.8
113 KIF17 mouse Q99PW8 116373 S1029-p SKAKRKKsKNSFGGE 0.474 4.22 45.17 3.7
114 Kv4.2 rat Q63881 70549 S438-p ARIRAAKsGSANAYM 1 2.23 26.58 15.4
115 Kv4.2 rat Q63881 70549 S459-p LLSNQLQsSEDEPAF 1 0.92 13.88 8.5
116 Kv4.3 rat Q62897 73513 S569-p LPATRLRsMQELSTI 1 1.32 15.8 46.0
117 LRP4 rat Q9QYP1 211880 S1887-p TTPERRGsLPDTGWK 1 0.9 11.21 10.0
118 LRP4 rat Q9QYP1 211880 S1900-p WKHERKLsSESQV__ 0.581 2.67 26.88 4.0
119 LRRC7 rat P70587 166879 S826-p VPLELEQsTHRHTPE 1 0.54 3.12 8.9
120 LRRC7 rat P70587 166879 T827-p PLELEQStHRHTPET 1 0.77 5.09 86.6
121 LRRC7 rat P70587 166879 S1392-p IQTKGQRsMDGYPEQ 0.42 5.83 145.21 5.8
122 mAChR M4 rat P08485 52929 T145-p TYPARRTtKMAGLMI 1 1.51 9.24 23.0
123 MeCP2 rat Q00566 53047 S421-p EKMPRAGsLESDGCP 0.587 1.72 28.75 9.4
124 MOR-1 human P35372 44779 S268-p LKSVRMLsGSKEKDR 0.4774 7.93 234.34 219.1
125 MOR-1 rat P33535 44494 S261-p LMILRLKsVRMLSGS 0.549 3.34 25.26 11.2
126 myelin P0 cow P10522 27452 S210-p HKTAKDAsKRGRQTP 1 1.55 6.91 7.5
127 myelin P0 cow P10522 27452 S233-p SRSTKAAsEKKTKGL 1 1.74 11.73 8.6
128 MYH9 rat Q62812 226338 T1940-p RRIVRKGtGDCSDEE 0.655 2.57 39.8 188.4
129 myogenin mouse P12979 25203 T87-p VDRRRAAtLREKRRL 0.639 4.38 130.94 35.9
130 NEUROD1 rat Q64289 40001 S336-p IPIDNIMsFDSHSHH 0.621 2.49 25.08 7.0
131 NFL mouse P08551 61508 S58-p LSVRRSYsSSSGSLM 0.6 20.64 593.6 8.1
132 NFL cow P02548 62646 S67-p SSGSLMPsLESLDLS 0.647 2.67 22 134.2
133 NMDAR2B human Q13224 166367 S1303-p NKLRRQHsYDTFVDL 0.294 194.03 366.92 134.4
134 nNOS rat P29476 160559 S847-p SYKVRFNsVSSYSDS 0.46 4.32 35.32 8.0
135 NUMB human P49757 70804 S276-p EQLARQGsFRGFPAL 0.447 63.71 899.74 262.3
136 p27Kip1 human P46527 22073 S10-p NVRVSNGsPSLERMD 1 1.36 17.53 32.3
137 PEA-15 mouse Q62048 15054 S116-p KDIIRQPsEEEIIKL 0.568 16.42 294.65 467.5
138 phosducin mouse Q9QW08 28016 S54-p KEILRQMsSPQSRDD 0.511 7.8 203.17 145.2
139 phosducin rat P20942 28129 S6-p __MEEAAsQSLEEDF 1 0.66 7.62 270.6
140 phosducin rat P20942 28129 S36-p WRKFKLEsEDGDSIP 0.637 3.04 27.58 7.1
141 phosducin rat P20942 28129 S73-p ERMSRKMsIQEYELI 0.564 15.6 180.67 20.2
142 phosducin rat P20942 28129 S106-p QDMHQKLsFGPRYGF 1 1.67 15.99 4.2
143 PLB human P26678 6109 T17-p SAIRRAStIEMPQQA 0.513 21.67 359.19 165.0
144 PLCB3 human Q01970 138799 S537-p PSLEPQKsLGDEGLN 0.629 2.01 32.13 232.7
145 PPP1R14A human Q96A00 16693 S130-p GLRQPSPsHDGSLSP 1 0.99 10.3 15.5
146 PPP1R3A rabbit Q00756 124170 S48-p PQPSRRGsESSEEVY 1 1.26 17.77 68.2
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Table 2.2 PhosphoSitePlus information. List of all 217 peptides used from the 
PhosphoSitePlus database and phosphorylated by the various activation states of the kinase. 
Protein Organism ACC# MW (Da)Residue Site Sequence ScanSiteScore
CaMKIIm−P
Phosphorylation 
(PSL/mm2) 
CaMKIIm+P
Phosphorylation
(PSL/mm2) 
CaMKIIholo+P
Phosphorylation
(PSL/mm2) 
147 PSD-95 rat P31016 80465 S73-p ITLERGNsGLGFSIA 1 5.31 115.89 343.4
148 PSMC5 rat P62198 45626 S120-p RVALRNDsYTLHKIL 0.553 1.2 21.13 7.1
149 PTPRA mouse P18052 93698 S180-p QAGSHSNsFRLSNGR 1 2.72 44.15 51.3
150 PTPRA mouse P18052 93698 S204-p PLLARSPsTNRKYPP 1 45.19 679.74 116.5
151 rabphilin 3A rat P47709 75832 S274-p QGLRRANsVQASRPA 0.666 104.75 921.48 143.3
152 RCHY1 human Q96PM5 30110 T154-p ICLEDIHtSRVVAHV 1 2.37 9.9 6.1
153 RIMS1 rat Q9JIR4 179655 S241-p RLQERSRsQTPLSTA 1 4.53 45.02 21.1
154 RIMS1 rat Q9JIR4 179655 S287-p KQASRSRsEPPRERK 1 2.97 45.14 29.5
155 RRAD human P55042 33245 S273-p AGTRRREsLGKKAKR 0.5 2.61 21.14 23.5
156 RYR2 human Q92736 564567 S2808-p YNRTRRIsQTSQVSV 0.632 4.24 71.23 54.7
157 RYR2 human Q92736 564567 S2814-p ISQTSQVsVDAAHGY 0.589 1.35 16.09 10.9
158 SAPAP1 rat P97836 110178 S389-p YLKATQPsLTELTTL 0.629 1.51 12.65 5.7
159 SAPAP1 rat P97836 110178 S691-p KTSSKFQsVGVQVEE 1 1.53 10.86 8.1
160 SAPAP1 rat P97836 110178 S947-p APLIRERsLESSQRQ 0.599 18.91 419.01 288.7
161 SAPAP2 rat P97837 118978 S1012-p FPITREKsLDLPDRQ 0.459 86.18 610.98 391.6
162 SAPAP3 rat P97838 105990 S930-p GVPVKERsLDSVDRQ 0.599 3.1 30.57 9.2
163 sarcolipin human O00631 3762 T5-p ___MGINtRELFLNF 1 0.96 9.84 6.3
164 sarcolipin mouse Q9CQD6 3808 T5-p ___MERStQELFINF 1 0.54 7.34 3.9
165 SCN5A human Q14524 226940 S516-p LSLTRGLsRTSMKPR 0.607 17.83 402.89 162.6
166 SCN5A human Q14524 226940 T594-p LHGKKNStVDCNGVV 0.505 2.47 17.03 5.2
167 separase human Q14674 233175 S1501-p TDNWRKMsFEILRGS 0.389 8.9 185.89 42.7
168 SERCA2 rat P11507 114768 S38-p KLKERWGsNELPAEE 0.621 2.62 30.72 26.4
169 SHANK1 rat Q9WV48 226335 S783-p RLPPPAIsLRSKSMT 0.609 7.82 196.97 68.0
170 SHANK3 rat Q9JLU4 193258 S769-p TLTLRSKsMTAELEE 0.51 4.81 57.59 4.9
171 SHANK3 rat Q9JLU4 193258 S1586-p QLNKDTRsLGEEPVG 1 1.97 12.75 87.1
172 Smad2 human Q15796 52306 S110-p SFSEQTRsLDGRLQV 1 1.67 16.01 309.6
173 Smad2 human Q15796 52306 S240-p SDQQLNQsMDTGSPA 0.659 0.44 3.86 3.5
174 Smad2 human Q15796 52306 S260-p TLSPVNHsLDLQPVT 0.641 0.56 8.77 2.7
175 smMLCK chicken P11799 210446 S1749-p RAIGRLSsMAMISGM 0.618 3.27 79.41 47.5
176 smMLCK chicken P11799 210446 S1762-p GMSGRKAsGSSPTSP 0.629 1.08 10.21 4.1
177 SNCA human P37840 14460 S129-p NEAYEMPsEEGYQDY 1 1.35 2.41 3.0
178 Spinophilin rat O35274 89646 S99-p RLSLPRAsSLNENVD 1 52.73 716.37 517.3
179 Spinophilin rat O35274 89646 S100-p LSLPRASsLNENVDH 1 13.68 394.62 272.3
180 SPR human P35270 28048 S213-p QQLARETsVDPDMRK 0.58 8.62 213.67 554.1
181 SPR rat P18297 28128 S46-p LLSARSDsMLRQLKE 1 8 341.18 8.3
182 SPR rat P18297 28128 S196-p EPSVRVLsYAPGPLD 0.6 1.6 14.07 362.3
183 SRF human P11831 51593 S103-p RGLKRSLsEMEIGMV 0.639 55.34 986.25 449.5
184 STAT1 human P42224 87335 S727-p TDNLLPMsPEEFDEV 1 0.79 9.04 3.8
185 STMN1 mouse P54227 17274 S16-p KELEKRAsGQAFELI 1 0.87 8.79 5.3
186 STMN1 human P16949 17303 S16-p KELEKRAsGQAFELI 1 1.94 14.45 4.8
187 SYN1 mouse O88935 74097 S605-p AGPTRQAsQAGPGPR 0.577 49.64 904.98 105.5
188 SYN1 rat P09951 73988 S566-p PQATRQAsISGPAPP 0.434 26.85 454.77 203.9
189 SynGAP rat Q9QUH6 144722 S765-p YMMRDLNsSIDLQSF 1 1.2 13.07 2.5
190 SynGAP rat Q9QUH6 144722 S780-p MARGLNSsMDMARLP 0.66 3.31 24.81 3.0
191 SynGAP rat Q9QUH6 144722 S1073-p PPLQRGKsQQLTVSA 0.612 32.52 469.26 110.0
192 SynGAP rat Q9QUH6 144722 S1114-p QSLSKEGsIGGSGGS 0.625 1.52 10 16.3
193 SynGAP rat Q9QUH6 144722 S1118-p KEGSIGGsGGSGGGG 1 0.71 4.38 88.5
194 SynGAP rat Q9QUH6 144722 S1138-p PSITKQHsQTPSTLN 0.556 7.54 231.67 4.5
195 SYT1 rat P21707 47399 T112-p DVKDLGKtMKDQALK 1 0.89 4.95 2.0
196 tau cow P29172 46333 S423-p SNVSSTGsIDMVDSP 0.645 1.99 39.29 14.8
197 tau iso2 human P10636-2 36760 S307-p GAEIVYKsPVVSGDT 1 0.78 0.96 2.1
198 tau iso2 human P10636-2 36760 S315-p PVVSGDTsPRHLSNV 1 1.81 4.25 5.1
199 tau iso5 human P10636-5 42603 T231-p KKVAVVRtPPKSPSS 1 3.23 11.77 6.4
200 tau iso8 human P10636-8 45850 S262-p NVKSKIGsTENLKHQ 1 3.53 17.3 6.2
201 TH human P07101 58600 S19-p KGFRRAVsELDAKQA 1 14.59 547.64 205.9
202 TH human P07101 58600 S71-p RFIGRRQsLIEDARK 0.578 5.4 114.31 105.2
203 TH iso5 human EAX02491 56052 S35-p AIMVRGQsPRFIGRR 1 1.49 10.83 12.5
204 TNNT2 cow P13789 33914 T191-p GYIQKAQtERKSGKR 1 1.91 18.63 11.4
205 TPD52 human P55327 24327 S176-p KNSPTFKsFEEKVEN 0.587 8.51 147.78 242.6
206 TPH2 human Q8IWU9 56057 S19-p YWARRGFsLDSAVPE 0.454 26.85 523.92 259.7
207 TPH2 mouse Q8CGV2 55859 S19-p YWARRGLsLDSAVPE 0.454 24.76 673.01 319.8
208 Trad rat P97924 336587 T77-p DVCKRGFtVIIDMRG 0.402 1.32 11.22 3.7
209 TRPV1 rat O35433 94948 S502-p YFLQRRPsLKSLFVD 0.665 3.86 89.96 13.6
210 TRPV1 rat O35433 94948 T704-p WKLQRAItILDTEKS 0.666 9.91 102.3 13.8
211 VAMP2 mouse P63044 12691 S61-p LERDQKLsELDDRAD 1 6.17 3.96 3.8
212 vimentin human P08670 53652 S83-p GVRLLQDsVDFSLAD 0.602 4.72 27.42 9.6
213 vimentin mouse P20152 53688 S39-p TTSTRTYsLGSALRP 0.698 7.74 208.4 1.8
214 vimentin cow P48616 53728 S26-p GTASRPSsTRSYVTT 0.668 1.68 24.46 450.4
215 vimentin cow P48616 53728 S66-p GVYATRSsAVRLRSG 1 1.51 11.63 23.8
216 vimentin cow P48616 53728 S72-p SSAVRLRsGVPGVRL 1 1.61 7.16 21.4
217 vimentin cow P48616 53728 S412-p EGEESRIsLPLPNFS 1 2.11 0.47 61.8
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Figure 2.4 Degeneracy in CaMKII substrate selection/preference arising from 
autophosphorylation or multimerization. 
(A to D) The sum total of phosphoincorporation for all substrates above a threshold (11.5 
PSL/mm2) are shown in (A) or for substrates without a ScanSite score (i.e. set to 0.7) in (B).  The 
total number of substrates without a ScanSite score (C) are used to calculate the average 
phosphorylation for a non-consensus substrate in (D). 
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Furthermore, the best 5 substrates (i.e. exhibiting the highest extent of phosphorylation) 
for each state of the kinase possess rather distinct similarities toward the predicted 
consensus motif (Figure 2.5). Specifically, the average ScanSite scores for these substrates 
phosphorylated were: 0.368 for CaMKIIm−P, 0.602 for CaMKIIm+P, and 0.647 for 
CaMKIIholo+P. Extending this analysis to include the top ten phosphorylated substrates 
shows averages of 0.465 for CaMKIIm−P, 0.593 for CaMKIIm+P, and 0.590 for 
CaMKIIholo+P. These scores reflect the large differences in the sequence logos for the top 
ten phosphorylated substrates for each of these kinase activation states (Figure 2.3, right 
panels). Though multivalency appears to increase the overall level of phosphorylation, 
similarity in phosphorylation profiles of CaMKIIm+P and CaMKIIholo+P suggests that T287 
autophosphorylation is a critical driver for this switch-like change in substrate selectivity. 
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Figure 2.5 Alterations in preferential substrate usage among PhosphoSitePlus. 
(A and B) Comparative phosphorylation data for the substrates with the greatest extent of 
phosphoincorporation under different kinase conditions. CaMKIIm−P (blue circles), CaMKIIm+P
(green circles), and CaMKIIholo+P (red circles). (A) Top five substrates for each condition. (B). 
Top ten substrates for each condition. 
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2.3.3 T287 Autophosphorylation Produces Switch-like Behavior Toward Poor-
consensus Substrates. 
To study the role of T287 autophosphorylation in more detail, we selected four model 
substrates—a high-affinity substrate (GluN2BS1303, Km = 4.6±1.1 µM) from a glutamate 
receptor and three lower-affinity, weak substrates (Syntide, Km = 43.5±2.3 µM; vimentinS83 
and GluA1S849, Km > 1 mM) taken from an enzyme (glycogen synthase), a cytoskeletal 
protein (vimentin) and another glutamate receptor subtype, respectively. When we 
compared the phosphorylation of CaMKIIm−P for these four substrates in our SPOTs 
reaction, we observed that the extent of phosphorylation was correlated to substrate affinity 
(Figure 2.6). Greater substrate affinity led to greater phosphorylation. Upon 
autophosphorylation (CaMKIIm+P), we found that as seen for the PhosphoSitePlus 
substrates, an enhancement in substrate phosphorylation was observed for all substrates 
(Figure 2.6B). 
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Figure 2.6 CaMKII autophosphorylation enhances the phosphorylation of four diverse 
CaMKII substrates. 
(A and B) Phosphorylation analysis of four diverse CaMKII substrates (GluN2B, Syntide, 
GluA1, and vimentin). (A) Substrates ranked from lowest to highest Km obtained via soluble 
peptide phosphorylation assays. (B) Phosphorylation ([γ-32P] phosphate incorporation) of 
immobilized CaMKII substrates synthesized via SPOTs. CaMKIIm phosphorylation profiles with 
and without T287 autophosphorylation, represented as mean ±SD (n = 3). Unpaired/two-tailed t-
test used to compare to CaMKIIm−P; (*P < 0.05, **P < 0.01, ***P < 0.001). 
 
 
 
66 
It should be noted that autophosphorylation does not generate a linear increase in 
phosphorylation of all substrates, but rather a preferential increase in phosphorylation of 
weak substrates. To further address the specificity and potential for preferential changes in 
substrate phosphorylation with CaMKIIm+P, we focused on a small yet diverse subset of 
our phosphorylated substrate library from PhosphoSitePlus (Table 2.3). We included the 
well-known CaMKII substrate peptide AC-2 (Km = 5 µM) and Syntide for comparison as 
well; 15 substrates were analyzed in all. Table 2.3 (A to C) provides substrate information, 
representative phosphorimaging of the SPOTs, and absolute phosphorylation values as 
well as those scaled to the high-affinity substrate GluN2B for the two activation states. 
Again, as expected for CaMKIIm−P, the best substrates (i.e., greatest phosphorylation) 
possess lower ScanSite scores (Figure 2.7), consistent with being more likely to be high-
affinity.  To assess relative changes in kinase specificity associated with T287 
autophosphorylation, we calculated the relative enhancement in phosphorylation for each 
substrate in the presence versus absence of autophosphorylation (CaMKIIm+P / 
CaMKIIm−P). Because the extent of phosphorylation by CaMKIIm−P correlated with affinity 
(Km) of the four substrates previously examined, we plotted the enhancement factor as a 
function of CaMKIIm−P phosphorylation in lieu of kinetic information for all 15 substrates 
(Figure 2.8A). These enhancement scores were also presented as function of their ScanSite 
score (Figure 2.8B). While autophosphorylation (CaMKIIm+P) globally increases 
phosphorylation for all substrates, an autophosphorylation-dependent increase in relative 
phosphorylation is smaller for high-affinity substrates (i.e., low scores) (Figure 2.8). Weak 
substrates, exhibiting low phosphorylation or poor consensus motifs (i.e., high 
ScanSitescores) for the non-autophosphorylated state (CaMKIIm−P), show the greatest 
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enhancement of phosphorylation (Figure 2.8). Furthermore, we find that the altered 
substrate enhancement is dependent on the affinity of the substrate; the greater the affinity, 
the lower the enhancement. Taken together, we find that autophosphorylation broadens the 
target profile to decrease substrate specificity, meaning that the autophosphorylation state 
of CaMKII determines the substrate specificity of the kinase. Importantly, these effects are 
not attributable to non-linearity in assays due to limiting substrates or a loss in substrate 
access/availability as shown in the following section (Results 2.3.4).  
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Table 2.3 Monomeric CaMKII phosphorylation of SPOTs substrate peptides. 
(A to C) Table of substrate properties for immobilized SPOTs peptides representing 15 CaMKII 
substrates; 13 taken from PhosphoSitePlus as well as two classical CaMKII substrates Syntide 
and Autocamtide-2 (AC-2). (A) Phosphoacceptor site (P0), ScanSite score, and sequence. 
Substrates unrecognized by ScanSite algorithm given score of 1. (B and C) Phosphorylated 
SPOTs images analyzed by phosphoimaging (left), absolute substrate phosphorylation
(middle), and phosphorylation scaled to the high-affinity substrate GluN2B (right). (B)
CaMKIIm−P. (C) CaMKIIm+P. Data represents mean ±SD. 
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Figure 2.7 Extent of CaMKII phosphorylation is correlated to substrate similarity to 
consensus motif. 
Phosphorylation ([γ-32P] phosphate incorporation) of immobilized SPOTs peptides representing 
15 CaMKII substrates; 13 taken from PhosphoSitePlus as well as two classical CaMKII 
substrates Syntide and Autocamtide-2 (AC-2). Substrate phosphorylation of CaMKIIm−P (blue) 
as a function of ScanSite score. Error bars denote ±SD. 
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Figure 2.8 Autophosphorylation-associated expansion in CaMKII substrate selectivity.  
(A and B) Phosphorylation enhancement for 15 CaMKII SPOTs substrates. 
Autophosphorylation-induced enhancement of substrates (green) represents the ratio of substrate 
phosphorylation with and without T287 autophosphorylation (CaMKIIm+P / CaMKIIm−P). This 
value is represented either as a function of phosphorylation by CaMKIIm−P on a log scale in (A) 
or as a function of ScanSite similarity score in (B). Dashed line indicates no change. Error bars 
denote ±SD. Data points fit with linear regression (green line) exhibited R2 coefficient values of 
0.48 and 0.47 in (C) and (D), respectively. 
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Using this enhancement factor comparison, we reevaluated the PhosphoSitePlus 
substrates. We compared the phosphorylation of autophosphorylated CaMKII monomer or 
holoenzyme (CaMKIIm+P and CaMKIIholo+P, respectively) to the phosphorylation of non-
T287 autophosphorylated monomer (CaMKIIm−P). Like the 15 substrates, enhancement 
factors were ranked by the extent of CaMKIIm−P phosphorylation in lieu of kinetic 
information for all substrates or by ScanSite score. We found that the enhanced substrate 
phosphorylation for autophosphorylated kinase, both CaMKIIm+P and CaMKIIholo+P 
possessed similarities (Figure 2.9). Specifically, enhanced phosphorylation was greatest 
for substrates poorly phosphorylated in the non-autophosphorylated state (CaMKIIm−P) 
(Figure 2.9, A and B). Furthermore, this similarity in enhancement profile was also 
observed for substrates as function of their resemblance to a consensus phosphorylation 
motif (ScanSite score) (Figure 2.9, C and D). Again, enhanced phosphorylation was 
greatest for substrates that were less similar to the consensus motif. We also analyzed the 
sequence composition of the 10 substrates with best or worst enhancement factors. We 
found that while a basic residue at P-3 was the strongest determinate for the greatest 
enhancement in phosphorylation by CaMKIIm+P, while an acidic residue at P+2 was 
preferential for CaMKIIholo+P. Interestingly, basic residues at P-3 and P+3 were found to be 
associated with the substrates with the lowest enhancement for CaMKIIholo+P.  
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Figure 2.9 CaMKII substrate selectivity changes for PhosphoSitePlus CaMKII substrates. 
(A to H) Phosphorylation of CaMKII substrates from PhosphoSitePlus as measured by 
phosphoincorporation into immobilized SPOTs. (A to D) Enhancement of substrate
phosphorylation representing the ratio of substrate phosphorylation with and without T287
autophosphorylation either for monomeric CaMKIIm+P (green) or multimeric CaMKIIholo+P (red) 
compared to CaMKIIm−P (CaMKIIm+P / CaMKIIm−P in A and C or CaMKIIholo+P / CaMKIIm−P in B
and D). Enhancement as a function of phosphorylation by CaMKIIm−P in A and B or as a function 
of ScanSite similarity score in C and D.  CaMKIIm+P. (D) CaMKIIholo+P. (E to H) WebLogo to 
evaluate position-specific sequence conservation in the enhancement of phosphorylation. (E and
F) Top 10 enhanced substrates. (G and H) Lowest 10 enhanced substrates. (E and F) Monomeric 
CaMKII (CaMKIIm+P). (F and H) CaMKII holoenzyme (CaMKIIholo+P). 
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2.3.4 SPOTs phosphorylation reactions are linear 
The use of the SPOTs membranes is quite different from the typical reactions properties 
of standard soluble kinase assays typically governed by Michaelis-Menten kinetic 
parameters. Substrates are diffusion-restricted; the kinase either samples an environment 
with no substrate (i.e. kinase unbound) or highly saturating (i.e. kinase bound to SPOT). 
Yet, in comparing the phosphorylation profiles, we aimed for the linear portion of the 
reaction curve. Extending the reaction time from 4 to 10 minutes, the phosphorylation 
profiles remained quite similar (Figure 2.10, A and B). While the greatest change was the 
fold increase in GluN2B phosphorylation, after scaling the data to GluN2B the differences 
between naïve and T287 autophosphorylated CaMKIIm phosphorylation profiles was 
minimal. Corresponding solution assays indicated that the non-T287 autophosphorylated 
kinase (CaMKIIm−P) exhibited less than 3% autonomy by the end of SPOTs reaction. These 
findings show that these alterations in substrate selectively are observable at longer time 
points; provided the kinase is not autophosphorylated. Additionally, the decreased 
enhancement for GluN2B compared to other substrates is not due to limited substrate as 
less than 2% of the available peptide for each substrate (as compared to a 24 hour reaction 
for GluN2B , Syntide, GluA1, and Vimentin) was phosphorylated by CaMKIIm+P (Figure 
2.10C). This points to the fact the reactions were not saturated. Moreover, nearly identical 
levels of 32P incorporation are obtained when a secondary reaction (including additional 
kinase) occurs on the same SPOTs membrane immediately after an initial non-radioactive 
4 minute reaction (Figure 2.11D – 1 vs 2). By washing away unbound kinase in a primary 
reaction and withholding additional kinase in a secondary reaction (Figure 2.11D – 3), we 
observed that the bound kinase retained lateral-diffusion; phosphorylating any given 
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substrate at least 25% of a standard reaction. As expected, these percentages were higher 
for the high-affinity substrate (~70% of control) presumably due to retention of more 
kinase during the wash step. Therefore, peptides did not act as a sink for the kinase subunits 
following phosphorylation—subunits were able to phosphorylate multiple substrates. This 
was also suggested by the fact that no significant loss of enzymatic activity was observed 
over the course of the experiment (as measured in standard peptide solution assays; Figure 
2.1F). Taken together, these data suggest that our reactions involving the SPOTs membrane 
are linear and that the kinase is mobile within the web of immobilized substrates. 
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Figure 2.10 Controls for SPOTs phosphorylation reactions. 
(A to C) Substrate phosphorylation profiles ([γ-32P] phosphate incorporation of SPOTs peptides) 
by CaMKIIm. 4 or 10 min reaction in the presence (+) or absence (-) of T287 autophosphorylation; 
absolute phosphorylation values (A) or as autophosphorylation-induced enhancement factors 
representing the ratio of substrate phosphorylation with and without T287 autophosphorylation 
(CaMKIIm+P / CaMKIIm−P) (B) (n = 3). (C) Phosphorylation time-course of T287
autophosphorylated CaMKIIm (n = 3); expanded view of 4 min reaction in inset. Error bars in all 
panels denote ±SD.  Unpaired/two-tailed t-test, *P < 0.05, **P < 0.01, ***P<0.001.   
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Figure 2.11 CaMKII retains lateral diffusion with SPOTs environment. 
(A and B) Comparisons of SPOTs phosphorylation assays utilizing one or two reactions on a 
single membrane with or without additional kinase supplemented into the secondary reaction.
(A) Schematic workflow used in the assay setup for the various protocols. Protocol #1 represents 
a standard 4 min reaction with both kinase and radioactive ATP (32P) and no secondary reaction. 
For protocol #2 and #3, a primary reaction was performed with radioactive ATP included. For 
protocol #2, the membrane was immediately transferred to a standard 4 min reaction with both 
fresh kinase and radioactive ATP. However, for protocol #3, the membrane was washed twice to 
remove unbound kinase and then transferred to a secondary reaction which include radioactive 
ATP but lacked additional kinase. (B) Substrate phosphorylation profiles ([γ-32P] phosphate 
incorporation of SPOTs peptides) by CaMKIIm. T287 autophosphorylated CaMKIIm
phosphorylation of SPOTs comparing a normal 4 min reaction (B – 1) to reactions with only 
radioactive secondary 4 min reactions with (B – 2) or without (B – 3) additional kinase in the 
secondary reaction (n = 3).   
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The substrates in our SPOTs experiments were 15mers; however, we also wanted to 
see how longer peptides responded. We first compared CaMKIIm−P phosphorylation of 
GluN2B (a high-affinity substrate) by as a 15mer, 17mer, or 22mer. A significant decrease 
in the amount of phosphorylation was observed each time the peptide was extended (Figure 
2.12A). This could be result of increased substrate affinity of an already high-affinity 
substrate (GluN2BS1303, Km = 4.6±1.1 µM) such that the catalytic turnover is reduced. It 
could also be due to less substrate accessibility or degeneration of peptide synthesis as 
substrate sequence is extended. To try to distinguish between these possibilities, we 
compared the phosphorylation of the shorter peptides (either 15mer or 17mer) with those 
that had either an N- or C-terminal linkers. The linkers were composed of alternatively Ala 
and Gly residues.  We found that addition of a linker to extend the total length of the peptide 
to 22 residues decreased the phosphorylation (though not significantly for an N-terminal 
addition to the 17mer) (Figure 2.12, B and C). However, there was no significant difference 
between the N- or C-terminal placement of the linker, suggesting that the decrease was not 
due synthesis but rather accessibility. Because the decrease in phosphorylation associated 
with extended the native GluN2B sequence was less than the addition of the linkers, it 
suggests that this was due to increased affinity. Sequences for all the constructs are shown 
in Figure 2.12D. 
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Figure 2.12 Assessments of SPOTs substrate length and accessibility. 
(A to C) Relative phosphorylation of the high-affinity CaMKII substrate GluN2B. (A) 
Comparison of standard 15mer versus longer versions (17mer or 22mer) of GluN2B. (B and C) 
Comparison with either an N- or C-terminal linker of Ala-Gly repeats extending total peptide 
length to 22 amino acids for either the of GluN2B a 15mer in (B) or 17mer in (C). (D) Table of 
peptide sequences and with linkers italicized in bold. 
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2.3.5 Autophosphorylation-induced Alterations in Kinase Specificity Does Not 
Appear to Be Isoform Dependent for CaMKIIm 
Based on the limited differences seen in the sequence and structures of the catalytic 
surfaces and regulatory domains for all four CaMKII isoforms (see Figure 1.4) (Rellos, 
Pike et al. 2010), we predicted that there should be minimal differences in the ability of 
their ARD to generate substrate filtering for CaMKIIm in the absence of T287 
autophosphorylation. Though both Syntide and vimentin did exhibit statistical 
significance, the overall phosphorylation profiles for CaMKIIm−P for both α and δ CaMKII 
isoforms were quite similar, as expected (Figure 2.13). Similarly, the phosphorylation 
profiles for CaMKIIm+P were nearly identical for both α and δ CaMKII isoforms, except 
that GluN2B exhibited greater phosphorylation in the δ isoform (Figure 2.13). These data 
suggest that substrate filtering is a general mechanism in CaMKII and that isoform 
differences in the catalytic and autoregulatory domains, at least between α and δ isoforms, 
do not greatly alter this phenomena. 
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Figure 2.13 Similar phosphorylation profiles between alpha and delta isoforms of CaMKII.
(A and B) Substrate phosphorylation profiles of peptide substrates (SPOTs) by Ca2+/CaM-
stimulated CaMKIIm (+/- T287 autophosphorylation). CaMKIIm delta isoform in (A) or CaMKIIm
alpha isoform in (B) (n=3). Error bars in all panels denote ± SD. Unpaired/two-tailed t-test (*) 
compared to non-T287-autophosphorylated state (above error bar) or between isoforms (below 
panels), *P < 0.05, **P < 0.01, ***P < 0.001.  
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2.3.6 Substrate-dependent Enhancement of Phosphorylation is Not Limited to 
SPOTs Arrays 
The enzymatic properties of CaMKII have historically been studied using solution 
assays with soluble peptide substrates; therefore, we generated soluble peptide substrates 
to assess these findings in diffusion-limited reactions. We observed a similar substrate-
dependent enhancement seen previously with immobilized, diffusion-restricted SPOTs 
substrates (Figure 2.14, A and B). Specifically, enhancement increased as substrate affinity 
decreased, suggesting that this effect is not limited to substrates ability to diffuse. However, 
our finding were so far limited only to peptides comprised of the phosphorylation motif 
from known protein substrates. While peptides allow us to specifically dissect the effect of 
the amino acid composition surrounding the phosphorylation motif, we created a uniform 
protein backbone deviating only by a substrate adduct to mimic spatial and steric 
constraints typical of proteins. Thus, this artificial, yet advantageous GST-substrate-fusion 
model allows differences in substrate utilization by different autophosphorylation states of 
CaMKII to be attributed directly to substrate-catalytic interactions, rather than the 
structural diversity inherent to different protein substrates. We observed that 
autophosphorylation potentiates weak substrate phosphorylation within the context of a 
larger protein for diffusion-limited (soluble GST fusions) environments (Figure 2.14, C 
and D). A similar finding was observed for diffusion-restricted (GST-bound fusions) 
environments, which also was consistent with SPOTs peptides (Figure 2.15). These data 
support the idea that T287 autophosphorylation controls the ability of CaMKII to utilize 
weak peptide and protein substrates in both diffusion-limited and diffusion-restricted 
environments.  
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Figure 2.14 T287 autophosphorylation alters phosphorylation profile of soluble substrates. 
(A and B) Substrate phosphorylation profiles ([γ-32P] phosphate incorporation of soluble peptides 
by CaMKIIm. (A) Absolute phosphorylation values for CaMKIIm−P (blue) and CaMKIIm+P (green) 
(n=3). (B) Enhancement factor (white bars) (ratio of +/- T287 autophosphorylation) ranked in 
order of highest to lowest absolute phosphorylation (n = 3). (C and D) CaMKII phosphorylation 
of GST-fusion substrates in soluble phosphorylation assays using CaMKIIm. (C) Representative 
phosphoimage (top) along with total protein (middle) densitometry of Coomassie stained bands. 
Relative phosphorylation (lower) values expressed in phosphosignal per total protein (PSL/QL) 
(n = 4). (D) Enhancement factor (n = 4). Results are pooled from three independent experiments 
with error bars in panels (A) and (B) denoting ±SEM. Error bars in panel (B) denote ±SD for a 
representative blot.  
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Figure 2.15 T287 autophosphorylation alters phosphorylation profile of tethered substrates.
(A and B) Substrate phosphorylation profiles ([γ-32P] phosphate incorporation of SPOTs 
peptides) by CaMKIIm. (A) Absolute phosphorylation values for CaMKIIm−P (blue) and 
CaMKIIm+P (green) (n=3).  Representative SPOTs blots (lower) visualized by phosphorimaging. 
(B) Enhancement factor (white bars) (ratio of +/- T287 autophosphorylation) ranked in order of 
highest to lowest absolute phosphorylation (n = 3) with dashed line indicating no change. (C and 
D) CaMKII phosphorylation of GST-fusion substrates immobilized onto glutathione resin. (C) 
Representative phosphoimage (top) along with total protein (middle) densitometry of Coomassie 
stained bands.  Relative phosphorylation (lower) values expressed in phosphosignal per total 
protein (PSL/QL) (n = 4). (D) Enhancement factor (n = 4). Results are pooled from three 
independent experiments with error bars in panels (A) and (B) denoting ±SEM. Error bars in 
panel (C) and (D) denote ±SD for a representative blot.  
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2.3.7 The ARD of CaMKII is Responsible for Suppressed Phosphorylation of Poor 
Substrates in the Absence of T287 Autophosphorylation 
Our results have shown that substrate selectivity is limited in the absence of T287 
autophosphorylation and that following autophosphorylation, specificity is broadened. The 
T287 residue resides within the R1 segment of the ARD; a region N-terminal to the CaM-
target sequence (Figure 1.2A). Since the site of autophosphorylation resides within the 
ARD, we wanted to explore whether the ARD itself played a role in the altered substrate 
selectivity. To determine the contribution of the ARD in preventing weak substrate 
phosphorylation in the activated state, we generated a constitutively active catalytic 
fragment (CaMKIIcf) by removing the ARD completely (see Methods 2.2.1 and Figure 
2.16). Similarity in the phosphorylation profiles between the CaMKIIm+P and the CaMKIIcf 
(Figure 2.17) indicates that broad substrate specificity is realized upon full ARD 
displacement from the catalytic domain either from proteolysis of the ARD or upon T287 
autophosphorylation upon autophosphorylation. Surprisingly, autonomous CaMKII (i.e., 
Ca2+/CaM-independent activity following T287 autophosphorylation) maximizes 
phosphorylation only of strong substrates (Figure 2.17) suggesting that substrate selectivity 
is differentially impacted by different activation states of CaMKII. This finding may 
functionally explain the observation that T287 autophosphorylation alone is not sufficient 
for synaptic plasticity (Barcomb, Buard et al. 2014) suggesting that maximal substrate 
accessibility associated with coincident Ca2+/CaM binding and T287 autophosphorylation 
underlies the switch-like role of CaMKII in synaptic plasticity. Removal of the ARD via 
proteolysis exposes the default mode of CaMKII’s catalytic domain (i.e., maximal activity 
85 
with broad specificity). Autophosphorylation at T287 correlates with the high-affinity CaM 
binding mode termed CaM trapping (Meyer, Hanson et al. 1992, Singla, Hudmon et al. 
2001) and yields a similar broadening of substrate specificity consistent with the full 
disinhibition of the ARD. Thus, while the CaMKII catalytic domain is a classical 
multifunctional protein kinase with broad substrate specificity, the ARD imparts an 
intrinsic means of restricting phosphorylation of weak substrates. 
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Figure 2.16 Catalytic fragment is constitutively active. 
Enzymatic activity (katal/mol) of a catalytic fragment of CaMKII measured via standard soluble 
peptide assays with radioactive [γ32P]ATP. Ca2+-dependent (Ca2+/CaM) vs Ca2+-independent 
(EGTA) assays were used to assess the amount of constitutive activity (n = 3). Error bars denote 
±SD.  
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Figure 2.17 Role of the autoregulatory domain (ARD) and T287 autophosphorylation in 
regulating substrate selectivity. 
(A) Structural representations of CaMKIIm: catalytic domain (green) and ARD with subdivisions 
R1 (dark blue) and R2/R3 (blue) (Chao, Pellicena et al. 2010). Activation state indicated by the 
presence of calmodulin (CaM) (magenta) and/or autophosphorylation (yellow star) at T287 and 
T306/7. Also depicted is a catalytic fragment with truncated ARD. (B) Substrate phosphorylation 
profiles for the catalytic fragment versus Ca2+/CaM-stimulated CaMKIIm (+/- T287
autophosphorylation) or autonomous CaMKIIm (n = 3). (C) Enhancement factor of 
phosphorylation profiles compared to CaMKIIm−P (n = 3). B shows one-way ANOVA of log-
normalized data with Holm-Šídák post-test compared to CaMKIIm−P (P < 0.001), while C shows 
comparison to GluN2B (P < 0.001). 
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2.3.8 Differential Ability of Substrates to Enhance CaM Binding Suggests 
Competition Between Substrates and the ARD in the Absence of T287 
Autophosphorylation. 
Since T287 autophosphorylation exposes the default mode of CaMKII’s catalytic 
domain and leads to full displacement of the ARD from the catalytic domain, the data are 
consistent with a model whereby in the absence of autophosphorylation, Ca2+/CaM 
activation alone does not displace the ARD sufficiently for catalytic domain access by low-
affinity substrates. Because autophosphorylation fully displaces the ARD to allow CaM 
trapping, we reasoned that a substrate’s ability to compete with the ARD for the catalytic 
domain is reflected by changes in Ca2+/CaM binding affinity. To explore the potential for 
substrates to influence ARD/catalytic interactions, we used a conformationally sensitive 
fluorescent reporter of CaM binding (CaMIAEDANS) (Figure 2.18A) to test whether 
substrates differentially enhance Ca2+/CaM binding in the absence of autophosphorylation. 
We observed that, in contrast to the weak peptide substrate Syntide, high-affinity peptide 
substrates (AC-2 and GluN2B) increase Ca2+/CaM binding affinity as measured by 
enhanced fluorescent intensity  (Figure 2.18B) and decreased Koff (Figure 2.18, B and C). 
Therefore, the inability of weak substrates to influence Ca2+/CaM binding suggests that 
weak substrates cannot outcompete the ARD for access to the catalytic domain. Thus, while 
Km approximates a substrate’s ability to interact with the catalytic domain, a substrate’s 
ability to enhance Ca2+/CaM binding is a reflection of a substrate’s ability to displace the 
ARD from the catalytic domain. 
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Figure 2.18 The ARD of activated CaMKII competes with substrates for access to the 
catalytic domain in in the absence of T287 autophosphorylation. 
(A), Schematic of experimental paradigm used to assess the impact of high-affinity (solid red 
line) versus low-affinity (red dashed line) substrates on CaM binding. (B), Relative fluorescence 
intensity change upon Ca2+/CaMIAEDANS binding to CaMKIIholo in the presence of ADP; data 
normalized to free Ca2+/CaMIAEDANS (0) and Ca2+/CaMIAEDANS-bound CaMKIIm+P (10). Data 
represent mean ±SD (n = 3). Unpaired/two-tailed t-test used to compare to control (no substrate) 
(***P < 0.001). (C), Dissociation kinetics of CaMIAEDANS from CaMKIIm−P were measured by 
fluorometry initiated by rapid mixing of excess unlabeled Ca2+/CaM. Representative traces 
without substrate (black diamonds) or with Syntide (white diamonds), AC-2 (light blue 
diamonds), or GluN2B (dark blue diamonds).  Data normalized with intensity difference between 
kinase-bound Ca2+/CaMIAEDANS and free Ca2+/CaMIAEDANS to be 1.0, with the curve fit to single 
exponential equation. (D), Grouped dissociation data, representing mean ±SD (n = 3). One-way 
ANOVA of log-normalized data with Holm-Šídák post-test compared to no substrate (###P < 
0.001).  
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2.3.9 CaMKII Substrate Specificity is Differentially Altered by modification of T287 
If competition exists between substrates and the ARD for access to the catalytic domain 
while CaMKII is activated, yet not T287 autophosphorylated, and is then disengaged upon 
autophosphorylation, then weakening ARD binding should yield intermediate 
phosphorylation profiles. The electronegativity of the autophosphorylated T287 residue can 
be interpreted to create autonomous activity and CaM trapping by preventing re-association 
with the hydrophobic pocket in which T287 resides in the autoinhibited crystal structure  
(Figure 1.2A) (Singla, Hudmon et al. 2001, Rellos, Pike et al. 2010, Hoffman, Stein et al. 
2011). Thus, we manipulated the electronegativity of residue 287 (using site-directed 
mutagenesis; see Methods 2.2.1) and determined its ability to modulate substrate 
specificity. Side-chain modification at T287 (Val<Ala<Asn<Asp) produces a graded 
increase in constitutive activity of apoCaMKII (Figure 2.19)—consistent with weakened 
ARD–catalytic domain interactions. In the Ca2+/CaM-stimulated state (CaMKIIm−P), 
phosphorylation of the weak substrate (Syntide) increases in a graded fashion with 
mutation electronegativity (Val<Ala<Asn<Asp) (Figure 2.20). In contrast, substitutions 
less hydrophobic than Val produce maximal phosphorylation of high-affinity substrate 
GluN2B (Figure 2.20). Consistent with the autonomous form of CaMKII, minimal 
perturbation of the ARD allows high-affinity substrates to outcompete the weakened ARD 
in the absence of T287 autophosphorylation. In contrast, weak substrates do not have access 
to the catalytic domain following Ca2+/CaM binding until T287 autophosphorylation fully 
destabilizes the ARD. Interestingly, the non-phospho-acceptor substitution (T287A) that 
classically prevents T287 autophosphorylation enhances phosphorylation of weak substrates 
compared to CaMKIIm-P, suggesting that some functional deficits seen in transgenic animal 
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models and cell-based studies harboring the T287A mutation (Cho, Giese et al. 1998, Giese, 
Fedorov et al. 1998, Glazewski, Giese et al. 2000, Gustin, Shonesy et al. 2011) may involve 
unexpected alterations in substrate specificity. 
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Figure 2.19 T287 mutations generate constitutive activity in CaMKII. 
Ca2+/CaM-independent activity for CaMKIIm mutants expressed in molar terms (katal/mol) and 
measured via standard soluble peptide (AC-2) assays with radioactive [γ32P]ATP; mean ±SD (n
= 3). One-way ANOVA of log-normalized data with Holm-Šídák post-test (#) used to compare 
to wt apoCaMKIIm (#P < 0.05, ###P < 0.001). 
 
 
 
 
93 
  
Figure 2.20 T287 modification regulates substrate selectivity. 
Ca2+/CaM-stimulated phosphorylation of SPOTs substrates for T287 mutants of CaMKIIm. Data 
represent mean ±SD (n = 3). One-way ANOVA of log-normalized data with Holm-Šídák post-
test compared to wildtype (Thr) (###P < 0.001). 
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2.4 Conclusion 
Our data describe a novel and surprising finding for the function of the ARD of CaMKII 
to act a substrate selective gate regulated by T287 autophosphorylation. Initially, we 
explored the phosphorylation of immobilized peptide substrates made up of 217 known 
and validated substrate phosphorylation sites. As a way to control the state of T287 
autophosphorylation without requiring mutagenesis of the site, we utilized a monomeric 
version of the kinase which retained the ARD, yet was lacking the hub domain. Thus, while 
activation of this version of the kinase was still Ca2+/CaM-dependent, the 
autophosphorylation reactions could be controlled by limiting kinase concentration due the 
now biomolecular, trans nature of the reaction. We found that in the absence of 
autophosphorylation, monomeric CaMKII (CaMKIIm−P) exhibited narrow substrate 
specificity. As such, the best substrates were those most similar in sequence to that of a 
defined CaMKII consensus motif obtained using a non-biased library screen. This was not 
the case for autophosphorylated CaMKII, either for monomer (CaMKIIm+P) or the 
multimeric holoenzyme (CaMKIIholo+P). The best substrates shifted to those with less 
similarity to the consensus motif consistent with a broadening of substrate specificity. 
CaMKIIholo+P tended to shift the specificity even further towards more diverse substrates, 
likely the result of multivalent avidity, thereby increasing the relative affinity for normally 
low-affinity substrates. This change in substrate specificity was very similar between the 
α- and δ-isoforms of the monomeric kinase, which was consistent with the lack of sequence 
differences within the ATP and substrate binding grooves. We also confirmed that these 
findings using SPOTs peptides were not the result of limited peptide availability or 
accessibility, nor was it a result of limited kinase mobility. Furthermore, we found that this 
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phenomena was not limited to the SPOTs assays. Instead, we observed similar findings for 
soluble versions of the peptides. Thus, substrate specificity is broadened following 
autophosphorylation for substrates in both diffusion-restricted and diffusion-limited 
environments. By attaching these phosphorylation sites to identical protein fusions, we 
established that altered substrate specificity based on the state of autophosphorylation can 
occur in the context of larger proteins. To determine the role that the ARD itself plays in 
this process, we looked at the phosphorylation of a constitutively active catalytic fragment 
(CaMKIIcf) of CaMKII which was generated by chymotryptic digestion of the ARD. This 
construct should represent the default mode of CaMKII catalytic domain as there is no 
ARD present to affect to potentially affect the activity and/or specificity. Given that T287 
autophosphorylation is thought to lead to full displacement of the ARD from the catalytic 
domain, we expected that that phosphorylation profiles between the CaMKIIcf and 
CaMKIIm+P should be similar. Since they were nearly identical, it suggests that the 
broadened specificity of CaMKIIm+P is the result of autophosphorylation switching the 
kinase to its default mode. It also suggests that the ARD itself is responsible for narrowing 
of substrate specificity by preferentially limiting the phosphorylation of weak, low-affinity 
and/or poor consensus-like substrates. Importantly, we found that Ca2+/CaM was required 
to be bound to the ARD in addition to T287 autophosphorylation to fully expose the default 
mode. However, we did find that the autonomous form of the kinase (i.e. T287 
autophosphorylation followed by removal Ca2+/CaM leading to T306/7 
autophosphorylation) exhibits a general enhancement of catalytic activity compared to the 
non-T287 autophosphorylated kinase. The strength of CaM-binding in non-T287 
autophosphorylated state is inversely proportional to the strength of the interaction of the 
96 
ARD with the catalytic domain.  Thus, we were able to use CaM binding as an indirect 
readout of whether substrates could compete with the ARD for access to the catalytic 
domain. Consistent with the ARD limiting the phosphorylation of weaker substrates in the 
absence of T287 autophosphorylation, we found that weak substrates were unable to 
enhance CaM-binding. We then reasoned that if substrates compete with the ARD, then 
weakening the ARD-catalytic domain interaction should disrupt the ARD’s ability to 
preferentially limit the phosphorylation of weaker substrates. We found that by 
incrementally modifying the T287 residue from more hydrophobic to more electronegative, 
substrate specificity could be modulated to produce intermediate phosphorylation profiles. 
The ARD has classically been defined as a regulatory gate that prevents substrate 
accessibility and therefore phosphorylation in the naïve or inactive state. However, our data 
favors the idea that the ARD of CaMKII continues to modulate substrate accessibility even 
when activated by Ca2+/CaM. Thus, CaMKII utilizes its ARD to increase the dynamic 
range between high- and low-affinity substrates, with T287 autophosphorylation acting as a 
switch to disengage the ARD from preventing phosphorylation of weak substrates. One 
way to envision this process is a competition between the ARD and substrates for access 
to the catalytic domain. Tighter ARD binding to the catalytic surface prevents the high-
affinity binding more of CaM (i.e. trapping). On the other hand, increased displacement of 
the ARD leads to enhanced CaM binding. Thus, substrates capable of displacing the ARD 
in the absence of T287 autophosphorylation lead to enhanced CaM binding in addition to 
preferential phosphorylation.  
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Figure 2.21 Model of ARD selectivity filter. 
In the autoinhibited state, the autoregulatory domain (ARD) prevents substrate phosphorylation. 
Ca2+/calmodulin (CaM) binding partially displaces the ARD, allowing preferential 
phosphorylation of high-affinity substrates. Partial retention of ARD–catalytic domain contacts 
in the absence of T287 autophosphorylation prevents CaM-trapping, and submaximal catalytic 
activity results from ARD oscillations between bound and unbound states. Ca2+/CaM-associated 
T287 autophosphorylation fully disengages the ARD, expanding substrate specificity to low-
affinity substrates. Model phosphorylation profiles below show how changes in CaMKII state 
affect substrate phosphorylation. An inverse relationship exists between the amount of ARD 
inhibition and the affinity of CaM-binding. 
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Solution EPR studies measuring the conformational changes of the ARD interacting 
with the catalytic domain indicate a multistep, dynamic process (Hoffman, Stein et al. 
2011). More specifically, these analyses on the micro second time-scale show that the 
region of the ARD defined as the R2 domain, containing F294, actually maintains coupling 
to the catalytic domain when activated by Ca2+/CaM but does not fully uncouple until T287 
autophosphorylation (or phosphomimetic substitution) completely destabilizes the R1 
region. Such a phenomena likely explains the transition from low- to high-affinity CaM 
binding and the mechanism by which T287 autophosphorylation controls this process. While 
partial tethering of the ARD appears to serve as the structural mechanism to prevent CaM-
trapping, our data show that a novel functional consequence of ARD tethering is to 
modulate substrate selectivity. 
 
Filtering Model Description  
The autoinhibited crystal structures of CaMKII demonstrates that the ARD makes 
intramolecular contacts within the autoinhibitory-groove (Rellos, Pike et al. 2010, Chao, 
Stratton et al. 2011); a hydrophobic channel on the catalytic surface whereby the helical 
ARD makes tertiary contacts around the R1 segment (i.e. T287) and the R2 segment of the 
ARD (Figure 1.2A). This mode of binding likely prevents the transitioning of the D-helix, 
which is required for exposure of the active site and substrate binding groove (Figure 2.22). 
Binding of Ca2+/CaM to the R3 segment of the ARD induces the R1 segment to uncoil for 
presentation of the T287 site for an intermolecular autophosphorylation event (Figure 1.3); 
a cooperative reaction due to the dual requirement of CaM binding to both subunits acting 
as kinase and substrate (Hanson, Meyer et al. 1994). Based on crystal structure data of the 
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naïve versus activated CaMKII, activation induces a shift in the D-helix which deforms the 
autoinhibitory groove and opens the active site for substrate binding and the 
phosphotransferase reaction (Figure 2.22).  
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Figure 2.22 Transition of the catalytic surface between closed and open states. 
In the closed state (hCaMKIIδ11-309; PDB ID: 2VN9), the substrate binding groove (yellow) of 
the catalytic domain is autoinhibited by the ARD. The ARD is stabilized in the autoinhibitory 
groove (cyan) by the αD helix (violet). Full displacement of the ARD in the open state 
(hCaMKIIδ11-335; PDB ID: 2WEL) following T287 autophosphorylation induces the collapse of 
the autoinhibitory groove as the αD helix shifts toward the substrate binding groove (bound 
substrate illustrated in black). 
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The substrate binding groove makes an obvious site to afford the ARD to function as a 
competitive inhibitor with substrates, thereby preferentially inhibiting low-affinity poor 
consensus substrates in the activated non-T287 autophosphorylated state. However, such a 
binding interaction would likely promote preferential T287 autophosphorylation prior to 
substrate phosphorylation, due to this motif (T287 phosphorylation site) being a high-
affinity consensus type substrate. In fact, the ScanSite score of this site is similar to the 
high-affinity exogenous CaMKII substrate GluN2B (0.388 vs 0.294, respectively). We 
ruled out interactions of the ARD with the substrate groove based on the fact that, 1) the 
R3 segment of the ARD is not available in the Ca2+/CaM bound state, 2) a peptide 
consisting of the ARD (CaMKII281-309) is preferentially an inhibitor toward a catalytic 
fragment of CaMKII (Colbran, Fong et al. 1988), with T287 phosphorylation occurring in 
this peptide only in the Ca2+/CaM bound state, suggesting that the R1 and R2 segments 
preferentially bind to the autoinhibitory groove in the absence of Ca2+/CaM and 3) T287 
autophosphorylation has been demonstrated to occur almost exclusively through an 
intersubunit interaction (Hanson, Meyer et al. 1994, Rich and Schulman 1998); therefore, 
even though T287 is clearly targeted for phosphorylation in the Ca2+/CaM bound state of 
the ARD, an intrasubunit mode of phosphorylation is not permissible. Direct support for 
our data indicating that the substrate binding groove is not the binding site for the ARD in 
producing substrate selection, is that the percent autonomy remained constant from the start 
to the end of our phosphorylation reactions (Figure 2.1F); evidence that rules out both intra- 
and intersubunit interactions with the substrate binding groove to mediate substrate 
selectivity.  
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In contrast, ARD interactions with the autoinhibitory groove have the distinct 
advantage of regulating substrate binding without risking dysregulated T287 
autophosphorylation. Such a mechanism may not be intuitive based on the preconception 
that CaM binding to the ARD functions to disinhibit autoinhibition. However, T287 
autophosphorylation requires a CaM-bound ARD to interact with the catalytic surface and 
active site, indicating that steric constraints induced by CaM’s bi-lobed architecture do not 
prevent the ARD from interacting with the catalytic domain. Thus, stable docking of the 
ARD with inhibitory groove maintain the autoinhibited state; dynamic contacts between 
the ARD and autoinhibitory groove could function to limit low-affinity weak consensus 
substrate access. Such a mechanism maintains a trans-autophosphorylation reaction (i.e. 
permit high-affinity substrate phosphorylation), while punishing low-affinity substrates. 
Changes in substrate selectivity are predicted to accompany T287 autophosphorylation due 
to a loss of ARD interactions with the autoinhibitory groove; a process that results from 
conformational changes in the ARD stabilized by CaM-trapping to the T287 
autophosphorylated subunit. Elements of this model can be gleaned from EPR solution 
data (Hoffman, Stein et al. 2011) showing that Ca2+/CaM binding to the ARD (R3 segment) 
yields a reversible unfolding of the R1 segment associated with increased mobility. These 
changes in R1 are not accompanied by any major mobility changes in the R2 segment 
(specifically F294). Furthermore, a phosphomimetic mutation of T287 (T287E) yielded 
additional flexibility within the R1 segment, with F294 in the R2 region displaying a loss of 
catalytic surface contacts (Hoffman, Stein et al. 2011); a consequence of F294 being 
required for CaM-trapping (Waxham, Tsai et al. 1998). Therefore, a previously unexplored 
consequence of this complex interplay between R1 and R2 in the activated and non-T287 
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autophosphorylated state is that low-affinity substrates should have poor accessibility due 
to the ARD dynamically binding to the autoinhibitory groove until T287 
autophosphorylation disables this interaction. Thus, ARD-catalytic surface interactions not 
only couple CaMKII activity to the Ca2+ signal, they also permit T287 autophosphorylation 
to switch substrate phosphorylation preferences from high- to low-affinity targets. As this 
point, we simply do not have information to separate whether ARD binding to the 
autoinhibitory groove will be dominated by intra-subunit versus inter-subunit contacts. 
While our pre-autophosphorylation reactions were designed to control the level of T287 
autophosphorylation, our exogenous substrate phosphorylation reactions were designed to 
minimize intermolecular events between CaMKII monomeric subunits (5-10 nM). In fact, 
previous studies have found that activation of CaMKII through Ca2+/CaM binding yields 
weak dimeric interactions between subunits (KD of 50-120 μM) (Rellos, Pike et al. 2010) 
or were not detected (Hoffman, Stein et al. 2011). These contacts likely reflect the trans-
autophosphorylation event occurring through active site interactions and disfavor the 
possibility of these inter-subunit reactions from dominating in our substrate 
phosphorylation conditions. However, in the native multimeric holoenzyme, it is 
conceivable that the ARD might be available to interact in an intrasubunit or an intersubunit 
mode to produce substrate filtering in the activated, non-T287 autophosphorylated state by 
dynamically interacting with the autoinhibitory groove. 
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CHAPTER 3. Multimeric Control of Substrate Specificity in CaMKII 
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3.1 Introduction 
CaMKII is a multifunctional serine/threonine kinase which plays a role in maintaining 
neuronal viability and integrating intracellular Ca2+ transients. The most well-known role 
of CaMKII is the regulation of synaptic plasticity, particularly within the post-synaptic 
neuron as signals from the presynaptic neuron are integrated in the macromolecular 
signaling complex known as the post-synaptic density (PSD). CaMKII targets, 
phosphorylates, and regulates a large number of substrates within the PSD to direct distinct 
outcomes (e.g. LTP and LTD). However, what substrate selectivity mechanisms govern 
the ability of CaMKII to perform these crucial functions in this macromolecular structure 
are unknown.  
CaMKII exists as a multimeric holoenzyme generally thought to be a dodecamer, 
though some studies have suggested it may also form tetradecamers (Kolb, Hudmon et al. 
1998, Rellos, Pike et al. 2010 Hoelz, 2003 #981, Chao, Stratton et al. 2011, Stratton, Lee 
et al. 2014, Bhattacharyya, Stratton et al. 2016). This multimeric architecture is rather 
unique among kinases and gives CaMKII some interesting properties. First, T287 
autophosphorylation occurs through a trans, intersubunit reaction requiring coincident 
Ca2+/CaM binding to both subunits (contributing either the kinase or the ARD substrate) 
(Hanson, Meyer et al. 1994, Rich and Schulman 1998). Thus, intersubunit intraholenzyme 
autophosphorylation functions as a Ca2+ spike frequency encoder (De Koninck and 
Schulman 1998). Such a feature has been viewed as a critical property of CaMKII in 
synaptic plasticity, where the frequency of cellular activity in neurons is directly related to 
Ca2+ frequency which tunes the strength of synaptic contacts (Lisman, Schulman et al. 
2002, Lisman, Yasuda et al. 2012). Second, the multimeric assembly of the CaMKII 
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holoenzyme affords the kinase with the ability to interact with multiple substrates 
simultaneously; a feature which may in turn regulate CaMKII enzymatic function and 
localization. We postulate that in macromolecular complexes such as the post-synaptic 
density (as well as at the plasma membrane, sarcolemma, and endoplasmic reticulum) 
where many substrates exist in a diffusion-restricted environment, that these multivalent 
interactions in conjunction with T287 autophosphorylation alter phosphorylation patterns 
and provide a temporal regulatory function that is dependent on the affinity of the substrate. 
Thus, there are several fundamental questions about CaMKII signaling that we would like 
to address: 1) What role does the multimeric structure play in the substrate selection? 2) 
Can substrates in a complex environment affect CaMKII localization and/or activity? 
In this study, we used inhibitory autophosphorylation to titrate the number of 
activatable subunits within the holoenzyme to explore how limited holoenzyme activation 
alters substrate specificity. Using immobilized peptide substrates (SPOTs), we found that 
an individual subunit within the holoenzyme behaves like a monomer in the absence of 
autophosphorylation, displaying narrowed substrate specificity similar to that observed in 
Chapter 2. Further activation of subunits within the holoenzyme preferentially enhanced 
the phosphorylation of weaker substrates beyond simply the contribution of T287 
autophosphorylation alone. We found that the holoenzyme led to a large increase in the 
total amount of phosphorylation in purified rat PSDs as assessed by 32P-incorporation. 
Subsequent analysis by mass spectrometry also displayed similar increases in the number 
of substrates detected by the holoenzyme. These findings are consistent with enhanced 
phosphorylation of weaker substrates by T287 autophosphorylation and was further 
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increased by multivalent avidity, which as we show affords high-affinity targeting 
substrates to broaden specificity through localization.  
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3.2 Materials and Methods 
3.2.1 Expression and Purification of CaMKII and Calmodulin 
Recombinant human CaMKIIδ (NCBI RefSeq: NP_742113.1) with an N-terminal 
6xHN tag was integrated into a baculoroviral construct (BacPAK9-6xHN), amplified in 
Sf9 insect cells, and expressed in Hi5 (T. ni) insect cells (Takeuchi-Suzuki, Tanaka et al. 
1992) (Brickey, Colbran et al. 1990). Site-directed mutagenesis was used to generate 
monomeric hCaMKIIδ1-317 (i.e. CaMKIIm) (by truncation through the addition of stop 
codon at aa318) as well point mutants. Kinases were purified under reducing conditions by 
affinity chromatography (NiNTA resin) followed by size exclusion chromatography 
(Sephacryl S-400 [holoenzyme] or S-300 [CaMKIIm]) using an Äkta Purifier (Amersham) 
(Bradshaw, Hudmon et al. 2002, Ashpole, Herren et al. 2012). SDS-PAGE of the purified 
proteins revealed a single band with purities >98%. Recombinant sea-urchin calmodulin 
was expressed and purified in E.coli as described previously via boiling, ammonium sulfate 
precipitation, and phenyl-sepharose affinity chromatography (Singla, Hudmon et al. 2001, 
Gaertner, Kolodziej et al. 2004). 
 
3.2.2 CaMKII Holoenzyme Inactivation via Inhibitory Pre-Autophosphorylation 
CaMKIIholo [600 nM] was exposed to inhibitory autophosphorylation (T306/7 capping) 
for 0, 5, or 15 minutes in the presence of 50 mM HEPES pH 7.4, 100 mM NaCl, 10 mM 
MgCl2, and 500 μM ATP. Inactivated states of CaMKII were then diluted to 60 nM for 
SPOTs substrate phosphorylation reactions (described below). For all states of pre-
inactivation (0, 5, or 15 min), the SPOTs phosphorylation was normalized to the number 
of active subunits per holoenzyme. The number of active subunits per holoenzyme was 
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assessed by measuring the Ca2+/CaM-dependent activity of each inactivation condition in 
standard soluble peptide substrate phosphorylation assays using AC-2 peptide. These 
activity assays were performed at the beginning and end (4 min) of the SPOTs 
phosphorylation assay, their values averaged together. The activity from naïve CaMKIIholo 
(i.e. 0 min pre-inactivation) was considered to maximal (i.e. all 14 subunits activated) and 
was thus used to calculate the average enzymatic activity per subunit.  
 
3.2.3 Pre-Autophosphorylation Reactions 
For reactions involving T287 autophosphorylated CaMKII, a pre-reaction was 
performed in the presence of 20 mM HEPES pH 7.4, 100 mM NaCl, 10 mM MgCl2, 0.5 
mM CaCl2, 5 μM CaM, 500 μM cold ATP and 500 nM kinase for 10 minutes on ice. To 
achieve varying numbers of T287 autophosphorylated subunits, similar pre-reactions were 
used with 50nM kinase incubation times of 0, 5, or 20 minutes on ice, or 10 minutes at 
30°C (Figure 3.6A; states 1-4, respectively). 
 
3.2.4 Post-Synaptic Density Purification 
PSDs were acquired from female adult rats (Sprague-Dawley) using previously defined 
procedures involving differential centrifugation with various sucrose gradients followed 
by Triton X-100 extraction and collection of the Triton-insoluble fraction (Ehlers 2003, 
Swulius, Kubota et al. 2010). Several steps were taken to limit and reduce the Ca2+/CaM 
stimulated and autonomous activity of endogenous CaMKII within the PSDs. Rat brains 
were extracted and snap-frozen in liquid nitrogen within 90 secs after sacrificing the 
animal, as CaMKII is known to activate and translocate to the PSDs within minutes in 
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response to cell death (Suzuki, Okumuranoji et al. 1994). In order to dephosphorylate T287 
to prevent autonomous activity of endogenous CaMKII as well as to reduce the 
phosphorylation state of endogenous substrates, purified PSDs were dephosphorylated 
with 1.5 µM PP1α (6xHis purified) overnight at 4°C or at RT for 2 hours with shaking in 
the presence of 50 mM HEPES pH 7.4, 100 mM NaCl, 1 mM MnCl2, 0.015 Brij 35, 2.5 
mM DTT, 10 µM KN-93, and 2X Calbiochem Protease Inhibitor Cocktail Set V. 
 
3.2.5 Post-Synaptic Density Dephosphorylation and Phosphorylation 
The PSDs were dephosphorylated to prevent autonomous activity of endogenous 
CaMKII (resulting from prior T287 autophosphorylation), as well as to reduce the 
phosphorylation state of endogenous substrates. This was accomplished with 1.5 µM PP1α 
(6xHis purified) overnight at 4°C or at RT for 2 hours with shaking in the presence of 50 
mM HEPES pH 7.4, 100 mM NaCl, 1 mM MnCl2, 0.015 Brij 35, 2.5 mM DTT, 10 µM 
KN-93, and 2X Calbiochem Protease Inhibitor Cocktail Set V. Phosphorylation reactions 
were carried out on dephosphorylated PSDs in the presence of 2X phosphatase inhibitor 
cocktail (Calbiochem) as well as the small molecule CaMKII inhibitor KN93 which only 
inhibits the autoinhibited kinase (naïve). PSD phosphorylation reactions were carried out 
on ~50 µg of dephosphorylated PSDs (see above) in the presence of 20 mM HEPES pH 
7.4, 100 mM NaCl, 10 mM MgCl2, 0.5 mM CaCl2, 5 μM CaM, 100 μM cold ATP, 
120 μCi/ml [γ-32P]-ATP, and 350 nM CaMKII (per subunit). For reactions involving T287 
autophosphorylated CaMKII, a pre-reaction was performed in the presence of 20 mM 
HEPES pH 7.4, 100 mM NaCl, 10 mM MgCl2, 0.5mM CaCl2, 5 μM CaM, 500 μM ATPγS, 
and 3.5 µM kinase for 10 min at 30°C (for monomer) or on ice (for the holoenzyme). PSD 
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phosphorylation reactions (60 µl total) were incubated at room temperature for 4 min 
unless otherwise noted. Reactions were terminated with the addition of 500 μl of 100 mM 
sodium phosphate pH 7.0, 1 M NaCl, 10 mM EDTA) followed by centrifugation to obtain 
a PSD pellet. Pellet was three times in the same termination buffer. The PSD pellet was 
resuspended in 2X LDS sample buffer and resuspended using a horn sonicator. SDS-PAGE 
was performed followed by Coomassie staining and drying of the gel. Total protein was 
assessed by densitometry of the Coomassie signal while the extent of radioactive phosphate 
incorporation was quantified using a Fujifilm phosphorimager and profiles measured as 
photostimulated luminescence (PSL/mm2). The densitometric intensity data was converted 
to area under the curve (AUC) to determine to protein or total phosphorylation. 
 
3.2.6 Mass Spectrometric Analysis for Phosphorylation of Post-Synaptic Density 
PSD phosphorylation reactions similar to those using 32P incorporation were performed 
(see Method 3.2.5). Instead of both ATP and [γ-32P]-ATP in the phosphorylation reaction, 
ATPγS was used. The reactions were incubated at room temperature for 4 min, 30 min, or 
24 hours with shaking and were terminated by the addition of 50 mM EDTA. The samples 
were then alkylated via the addition of 2.5 mM p-nitrobenzyl mesylate/5% DMSO (Abcam 
#ab138910), incubated for 1 hr at room temperature, and analyzed by western blotting 
using a Thiophosphate Ester specific RabMAb (Abcam #92570) at 1:5,000 in TBST/5% 
Milk visualized using IRDye® 800CW goat anti-mouse secondary antibody and quantified 
using LI-COR. For mass spectrometry, following the termination of the phosphorylation 
reaction with EDTA, samples were snap frozen and transferred to Indiana University 
Bloomington (Dr. Jon Trinidad) for analysis. 
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3.2.6 Double Synthesis SPOTs (DS-SPOTs) 
In experiments where the addition of a targeting peptide along with a substrate peptide in 
a single spot was required, we utilized a technique called Double Synthesis SPOTs (DS-
SPOTs) which takes advantage of differentially protected amino acids. During the first 
amino acid coupling, a mixture of differentially-protected alanine (Fmoc-Ala and Alloc-
Ala) was spotted on the membrane. Synthesis of the first peptide follows normal solid-state 
synthesis from the Fmoc-Ala. After completion of the peptide synthesis on the blot, the 
blot was removed from the apparatus and deprotection of the Alloc-Ala in tributyltin 
hydride and palladium is performed overnight (Espanel, Walchli et al. 2003). 
Subsequently, the blot is washed and carefully realigned in the synthesizer, where a second 
round of peptide synthesis will be performed using standard Fmoc chemistry to form the 
second peptide. This technique allows two different peptides be created within a single spot 
by sequential solid-phase synthesis reactions.  
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3.3 Results 
 
3.3.1 The Effect of Multimerization in CaMKII Substrate Selectivity 
In our studies concerning the phosphorylation of CaMKII substrates from the known 
pool of substrates from PhosphoSitePlus, we observed that while autophosphorylation 
alone (CaMKIIm+P) led to decreased substrate specificity, the specificity of 
autophosphorylated holoenzyme (CaMKIIholo+P) appeared be even further diminished. To 
further explore the effect of the holoenzyme assembly of CaMKII on substrate specificity, 
we focused on the phosphorylation of a set of 15 CaMKII substrate peptides. Table 3.1 
shows representative SPOTs for each substrate as well as both the absolute phosphorylation 
values as well as those scaled to the high-affinity CaMKII substrate GluN2B. Similar to 
our analysis of the effect of T287 autophosphorylation on substrate phosphorylation, we 
measured an enhancement factor for each substrate compared to the non-T287 
autophosphorylated monomeric CaMKII (CaMKIIholo+P / CaMKIIm−P). Then, in lieu of 
kinetic information for all substrates, we expressed these enhancement factors as a function 
of the extent of phosphorylation by non-T287 autophosphorylated CaMKII monomer 
(CaMKIIm−P). This metric correlates to the relative substrate affinity as well as similarity 
to a non-biased consensus motif represented by a ScanSite score. Similar to the 
PhosphoSitePlus data, the enhanced substrate phosphorylation for autophosphorylated 
kinase, both CaMKIIm+P and CaMKIIholo+P were greatest for substrates poorly 
phosphorylated CaMKIIm−P (i.e. weak, low-affinity substrates) (Figure 3.1A). 
Furthermore, the enhancement profile for substrates as function of their similarity to a 
consensus phosphorylation motif (ScanSite score) showed that enhanced phosphorylation 
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was greatest for substrates that were less similar to the consensus motif (Figure 3.1B). 
However, to concentrate only the added effect of multimerization, we instead compared 
the phosphorylation of the autophosphorylated CaMKII holoenzyme to the 
autophosphorylated CaMKII monomer (CaMKIIholo+P / CaMKIIm+P) (Figure 3.2). Beyond 
the effect of T287 autophosphorylation alone, preferential phosphorylation was exhibited 
towards weak, non-consensus substrates. Thus, our findings indicate that the multimeric 
holoenzyme complements the effect of T287 autophosphorylation in broadening substrate 
specificity. 
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Table 3.1 Multimeric CaMKII phosphorylation of SPOTs substrate peptides. 
(A to C) Table of substrate properties for immobilized SPOTs peptides representing 15 CaMKII 
substrates; 13 taken from PhosphoSitePlus as well as two classical CaMKII substrates Syntide 
and Autocamtide-2 (AC-2). (A) Phosphoacceptor site (P0), ScanSite score, and sequence. 
Substrates unrecognized by ScanSite algorithm given score of 0.7. (B) Phosphorylated SPOTs 
images analyzed by phosphoimaging (left), absolute substrate phosphorylation (middle), and 
phosphorylation scaled to the high-affinity substrate GluN2B (right) for T287 autophosphorylated 
CaMKII holoenzyme (CaMKIIholo+P). Error bars denote ±SD. 
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Figure 3.1 T287 autophosphorylation of multimeric CaMKII broadens substrate specificity.
(A and B) Phosphorylation ([γ-32P] phosphate incorporation) of immobilized SPOTs peptides 
representing 15 CaMKII substrates; 13 taken from PhosphoSitePlus as well as two classical 
CaMKII substrates Syntide and Autocamtide-2 (AC-2). Enhancement in phosphorylation of the 
T287 autophosphorylated CaMKII holoenzyme compared to non-T287 autophosphorylated 
CaMKII monomer (CaMKIIholo+P / CaMKIIm−P). This value is represented either as a function of 
phosphorylation by CaMKIIm−P on a log scale in (A) or as a function of ScanSite similarity score 
in (B). Dashed line indicates no change. Error bars denote ±SD. Data points fit with linear 
regression (red line) exhibited R2 coefficient values of 0.34 and 0.31 in (C) and (D), respectively. 
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Figure 3.2 Multimeric CaMKII broadens substrate specificity beyond T287
autophosphorylation alone. 
(A and B) Phosphorylation ([γ-32P] phosphate incorporation) of immobilized SPOTs peptides 
representing 15 CaMKII substrates; 13 taken from PhosphoSitePlus as well as two classical 
CaMKII substrates Syntide and Autocamtide-2 (AC-2). Multimerization-induced enhancement 
represented as the ratio of substrate phosphorylation between the T287 autophosphorylation states 
of holoenzyme and monomeric CaMKII (CaMKIIholo+P / CaMKIIm+P). This value is represented
either as a function of phosphorylation by CaMKIIm−P on a log scale in (A) or as a function of 
ScanSite similarity score in (B). Dashed line indicates no change. Error bars denote ±SD. Data 
points fit with linear regression (red line) exhibited R2 coefficient values of 0.26 and 0.23 in (A) 
and (B), respectively.   
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To confirm that these findings were not due to limited substrate availability (due to 
poor synthesis, inaccessibility, etc.), we generated a phosphorylation time-course for a set 
of immobilized SPOTs peptides. We found that like the phosphorylation by CaMKIIm+P 
(Figure 2.10C), CaMKIIholo+P phosphorylation at 4 min (or standard reaction time) was less 
than 4% of the extent of a 24hr phosphorylation (Figure 3.3). Thus, substrates do not appear 
to be limiting under our assay conditions. In addition, the kinase concentrations used in our 
assays were within the linear range for both a high-affinity substrate (GluN2BS1303, Km = 
4.6±1.1 µM) and a lower-affinity substrate (Syntide, Km = 43.5±2.3 µM (Figure 3.4). 
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Figure 3.3 CaMKII holoenzyme SPOTs phosphorylation time-course. 
(A and B) Substrate phosphorylation profiles ([γ-32P] phosphate incorporation of SPOTs 
peptides). (A) Phosphorylation time-course of T287 autophosphorylated CaMKII holoenzyme 
(CaMKIIholo+P) (n = 3); expanded view of 4 min reaction in inset. Error bars in all panels denote 
±SD. (B) Percent of substrate phosphorylated of a standard 4 min reaction versus a 24 hr 
phosphorylation reaction. 
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Figure 3.4 Autophosphorylation-associated expansion in CaMKII substrate specificity. 
Kinase concentration dependent phosphorylation curve for T287 autophosphorylated CaMKII 
holoenzyme (CaMKIIholo+P). Substrate phosphorylation profiles ([γ-32P] phosphate incorporation 
of SPOTs peptides) comparing the high-affinity substrate GluN2B (A) and lower-affinity 
substrate Syntide (B). Error bars denote mean±SD. 
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3.3.2 Graded Subunit Activation within CaMKII Holoenzymes 
The unique structure and autoregulation make CaMKII an ideal sensor to encode 
calcium-spike frequency into graded levels of activity and T287 autophosphorylation within 
the holoenzyme (Hudmon and Schulman 2002, Smedler and Uhlen 2014). This process is 
influenced by calcium-spike duration and amplitude (De Koninck and Schulman 1998) as 
well as phosphatase activity (Colbran 2004), alternative spliced linker length and CaM 
availability (Estep, Alexander et al. 1989, Persechini and Stemmer 2002). Each of these 
factors described in previous studies should contribute to production of different numbers 
of activated subunits per holoenzyme depending the frequency and amplitude of the Ca2+ 
transient associated with cellular activity. Thus, our goal was to test how the number of 
activated subunits and/or extent of autophosphorylation elicits different functional outputs. 
To determine how graded CaMKII activity influences substrate phosphorylation and 
selectivity, we prepared holoenzymes in which different numbers of subunits remained 
activatable (human CaMKIIδ holoenzyme is tetradecameric (Rellos, Pike et al. 2010)). 
This was accomplished using the natural mechanism by which non-activatable CaMKII 
subunits are generated in vivo, namely through basal, inhibitory (Ca2+/CaM-independent) 
autophosphorylation in the CaM binding domain (T306 in CaMKIIδ) that blocks subsequent 
Ca2+/CaM binding/activation (see Methods 3.2.2). Autophosphorylation at T306/7 was 
induced by the addition of Mg2+/ATP and allowed to proceed in a time-dependent manner 
in order to titrate the level of T306/7 autophosphorylation. This is a biological mechanism to 
limit the ability of Ca2+/CaM to bind to its target sequence to disinhibit the ARD (Colbran 
1993). We then activated these holoenzyme preparations with saturating Ca2+/CaM which 
led to different levels of activity to a soluble peptide substrate (AC-2) (Figure 3.5). Using 
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these activities, the average number of activated subunits per holoenzyme was calculated 
by dividing by the activity of a naïve subunit (see Method 3.2.3). 
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Figure 3.5 Time-dependent inactivation of CaMKII by basal autophosphorylation. 
Ca2+/CaM-stimulated activity of CaMKIIholo expressed in molar terms (katal/mol) and measured 
via standard soluble peptide (AC-2) assays with radioactive [γ32P]ATP. Enzymatic activity was 
measured following 0, 5, or 15min pre-inactivation reactions (see Methods) both at the start (0 
min) and end (4 min) of the SPOTs assays; mean±SD (n = 3). 
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We estimated that if the autophosphorylation reaction to cap CaM binding was 
stochastic, then we should have prepared holoenzymes in which on average 1, 5 or all 14 
subunits remained activatable. We then characterized the phosphorylation of multiple 
substrates simultaneously via SPOTs arrays (see Methods) using the four peptide substrates 
as before (GluN2BS1303, Syntide, vimentinS83 and GluA1S849). CaMKII with one active 
subunit per holoenzyme (CaMKIIholo1/14) displays preferential phosphorylation for the 
high-affinity substrate GluN2B (Figure 3.6A). Compared to GluN2B, increasing the 
number of activatable subunits per holoenzyme significantly increases relative 
phosphorylation of weak substrates. Scaling factors for different substrates are shown in 
Figure 3.6B compared to CaMKII with one active subunit per holoenzyme 
(CaMKIIholo1/14). While minimal changes in GluN2B phosphorylation were seen, we 
observed a 20-fold increase in Syntide phosphorylation by submaximally-activated 
CaMKIIholo5/14. Maximally-activated CaMKIIholo14/14 produced the greatest increase (12-
fold) in phosphorylation of the weakest substrates, GluA1 and vimentin. Again, these 
effects are not attributable to non-linearity in assays due to limiting substrates (Figure 3.3). 
Importantly, the relative substrate phosphorylation profile for maximally-activated 
CaMKIIholo14/14 remained consistent even when diluted to possess the same number of 
active catalytic subunits as CaMKIIholo1/14 (Figure 3.6A – CaMKIIholo14/14 vs Figure 3.3A – 
4 min reaction). This again argues that our assays are linear within the range of 5-60nM 
kinase. More importantly, it augments our previous data (Chapter 2) on monomeric 
CaMKII to show that the substrate phosphorylation profile is also governed by the 
activation state of CaMKII for the native, multimeric holoenzyme. Because the number of 
activatable subunits per holoenzyme could influence this intraholenzyme, intersubunit 
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reaction occurring between neighboring Ca2+/CaM-activated subunits (Hanson, Meyer et 
al. 1994), this furthers the concept that broadened substrate specificity is attributed to the 
state of T287 autophosphorylation (as established in Chapter 2). Thus, this data suggests 
that individual subunits within the holoenzyme operate via similar substrate selective 
mechanisms compared to the individual subunits and that differences observed when 
greater number of subunits are activated are the result of multimeric avidity. 
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Figure 3.6 Enhanced phosphorylation of weak substrates with increasing number of active 
subunits per holoenzyme. 
(A to C), Phosphorylation ([γ-32P] phosphate incorporation) of immobilized CaMKII substrates 
(GluN2B, Syntide, GluA1, and vimentin) synthesized via SPOTs. (A) Phosphorylation profiles 
of CaMKIIholo exhibiting varying numbers of activated subunits per holoenzyme (see Method 
3.2.3). Substrates ranked from lowest to highest Km. Raw phosphorylation (PSL/mm2) 
represented as mean ±SD (n = 3). (B) Phosphorylation normalized by the number of subunits 
activated per holoenzyme and represented as mean ±SD (n = 3). (C) Enhancement of 
substrate phosphorylation representing the relative change in substrate phosphorylation scaled to 
the phosphorylation of a given substrate by a holoenzyme with 1 active subunit (CaMKIIholo1/14); 
mean ±SD (n = 3). One-way ANOVA of log-normalized data with Holm-Šídák post-test used to 
compare to GluN2B (#P < 0.05, ###P < 0.001). 
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3.3.3 CaMKII Substrate Specificity is Differentially Altered by Extent of T287 
Autophosphorylation. 
To further explore how degrees of activated/autophosphorylated subunits within the 
holoenzyme affect substrate specificity, we utilized monomeric CaMKII (CaMKIIm) to 
allow us to maintain tight control over the ratio of T287 autophosphorylated to non-T287 
autophosphorylated subunits (i.e. CaMKIIm−P : CaMKIIm+P). To establish this ratio, we 
utilized soluble substrate peptide phosphorylation assays to measure the increase in Ca2+-
independent activity associated with T287 autophosphorylation (i.e. autonomous activity). 
We used the high-affinity substrate AC-2, as it generates 100% autonomous activity 
(Figure 2.1A) and exhibits a 1:1 correlation with the number of T287 autophosphorylated 
subunits (Ikeda, Okuno et al. 1991). Using varying time and temperature for pre-
autophosphorylation assays with concentrated CaMKIIm, we generated submaximal T287 
autophosphorylated subunits within the population of Ca2+/CaM activated subunits (see 
Methods 3.2.3 and Figure 3.7A). Using the populations of CaMKIIm, we compared their 
ability to phosphorylate immobilized peptide substrates (SPOTs). Importantly, the 
percentage of autophosphorylated subunits did not change over the course of the SPOTs 
reaction (Figure 3.7A, 0 min vs 4 min). Substrate-selective enhancement of weak substrates 
was observed, with the level of enhancement directly correlated to proportion of T287 
autophosphorylated subunits (Figure 3.7, B and C). 
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Figure 3.7 Phosphorylation profile of CaMKII is differentially altered by extent of T287
autophosphorylation. 
(A) Percent autonomy of calcium-independent CaMKII activity compared to maximal activity 
corresponding to the beginning (0 min) or end (4 min) of SPOTs assays was used as a readout of 
T287 autophosphorylation (n = 3). Error bars denote ±SEM. (B) Phosphorylation profiles for T287
autophosphorylation states generated in (A). Error bars denote ±SD for a representative blot. (C) 
Enhancement factor of phosphorylation profiles compared to CaMKIIm−P (n = 3). Error bars 
denote ±SEM. Results represent one-way ANOVA of log-normalized data with Holm-Šídák 
post-test compared to 0% autonomy (B) or to GluN2B (C). #P < 0.05; ##P < 0.01; ###P < 0.001.
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3.3.4 Activation States of CaMKII Alter the Phosphorylation of Substrates within 
the Post-Synaptic Density 
CaMKII is known to play a major role in the regulation of a number of important targets 
with the post-synaptic density (PSD), a macromolecular complex contain the machinery 
involved in the transmission of neuronal activity. Within the web of proteins, CaMKII 
phosphorylates greater than 40 known targets (Yoshimura, Aoi et al. 2000, Yoshimura, 
Shinkawa et al. 2002). While numerous reports have studied CaMKII enzymology using 
classical solution kinetics experiments, the role of the multimeric structure to influence the 
phosphorylation of diffusion-restricted substrates (e.g. PSD) has remained largely 
unstudied. In order to begin to understand these relationships, we first examined the global 
ability of CaMKII to phosphorylate substrates within the PSD.  
PSDs were acquired from female adult rats (Sprague-Dawley) using previously defined 
procedures involving differential centrifugation with various sucrose gradients followed 
by Triton X-100 extraction and collection of the Triton-insoluble fraction (See Methods 
3.2.4) (Figure 3.8) (Ehlers 2003, Swulius, Kubota et al. 2010). Figure 3.8A shows a 
Coomassie stained SDS-PAGE of a typical PSD preparation. We further characterized our 
PSDs with the help of Dr. Neal Waxham (University of Texas – Houston) who verified 
their structural integrity of our preparations using cryo-transmission electron microscopy 
(Figure 3.8B). Because our intent was focus on characterize exogenously added CaMKII 
in PSD phosphorylation reactions, several steps were taken to limit and reduce the 
Ca2+/CaM stimulated and autonomous activity of endogenous CaMKII within the PSDs. 
First, rat brains were extracted and snap-frozen in liquid nitrogen as rapidly as possible 
(~90 secs) after animal sacrifice, as CaMKII is known to activate and translocate to the 
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PSDs in response to ischemic insult produced by decapitation (Suzuki, Okumuranoji et al. 
1994). Second, in order to dephosphorylate T287 to prevent autonomous activity of 
endogenous CaMKII as well as to reduce the phosphorylation state of endogenous 
substrates, purified PSDs were dephosphorylated with PP1α (6xHis purified) overnight. 
This allows for a greater dynamic range in the phosphorylation measurement in the assay. 
Finally, the small molecule CaMKII inhibitor KN93 which only inhibits the autoinhibited 
kinase (naïve, non-T287 autophosphorylated) was included in the PSD phosphorylation 
reaction itself. This, in combination with dephosphorylation of the PSD preps serves to 
limit activation of endogenous kinase and since the exogenously added kinase was first 
pre-autophosphorylated at T287, only the activity of endogenous, co-purified CaMKII 
within the PSD. 
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Figure 3.8 Characterization of purified PSDs. 
(A) SDS-PAGE and Coomassie staining of a typical PSD preparation. (B) Cryo-transmission 
electron microscopy showing several examples of our isolated rat PSDs imaged by Dr. Neal 
Waxham (University of Texas – Houston).  
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To explore the effect of the of the multimeric structure of the CaMKII holoenzyme, we 
phosphorylated the PSDs (see above) with T287 autophosphorylated CaMKIIholo+P or 
CaMKIIm+P in the presence of [γ-32P]-ATP. The amount of enzymatic activity (both 
Ca2+/CaM stimulated and autonomous) was confirmed for the reactions before and after 
the experiment a standard radioactive assay with a soluble peptide substrate to verify that 
any instability of the monomer/multimer did not account for the observed phosphorylation 
differences (Figure 3.9). Similar amounts of catalytic activity of the monomer and 
multimer were added to the PSD reactions (4 min) and subsequent SDS-PAGE gels were 
quantified by phosphorimaging of the 32P-incorporation. Our PSDs preparations are by 
definition the Triton-insoluble fraction of a synaptosomal preparation. This makes them 
especially difficult to process, transfer, etc. Great care was taken to ensure that equal 
amounts of PSD were loaded onto SDS-PAGE. We observed nearly identical levels of 
protein as well as profiles of the Coomassie stained samples (Figure 3.10A). Regardless, 
we still scaled the corresponding phosphorylation data (autoradiography of 32P 
incorporated bands) (Figure 3.10B) to the total PSD protein in a given sample based on the 
area under the curve (AUC). Under these conditions, the addition of Ca2+/CaM alone 
produced less than a 2-fold increase in the total phosphorylation (measure as AUC) 
compared to other Ca2+/CaM-independent kinases (Figure 3.10). The inclusion of 
exogenous CaMKIIm+P produced ~2-fold increase in the phosphorylation compared to 
Ca2+/CaM activated PSDs alone, suggesting that phosphorylation sites were available to 
exogenously added kinase (Figure 3.9). When then added CaMKIIholo+P, which produced a 
6.4-fold increase in phosphorylation compared to Ca2+/CaM activated PSDs (Figure 3.10). 
More importantly, compared to the T287 autophosphorylated monomer, there was a 4.4-
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fold increase in total phosphorylation when corrected for endogenous Ca2+/CaM stimulated 
phosphorylation (Figure 3.10). Thus, even though the holoenzyme might be expected to 
have less accessibility to substrates in the PSD compared to the monomer because of their 
size difference (~750kDa vs 35kDa, respectively), the multimeric assembly of native 
CaMKII significantly enhances the ability to phosphorylate substrates. As mentioned 
above, these two kinases produce the same level of activity at the end of the PSD 
phosphorylation assay when assessed by the phosphorylation of a soluble, high-affinity 
peptide substrate (AC-2) in a classical diffusion-limited reaction environment (Figure 3.9). 
Overall, these findings indicate that a feature related to the multimeric nature of the 
holoenzyme alters its ability to interact many of the substrates within this diffusion-
restricted environment.  
  
134 
 
Figure 3.9 CaMKII activity measurement before and after PSD phosphorylation. 
Enzymatic activity (katal/mol) assays measured via standard soluble peptide (Autocamtide-2) 
assays with radioactive [γ32P]ATP. Measurements taken as secondary assays from the PSD 
phosphorylation reactions. Ca2+-dependent (Ca2+/CaM) vs Ca2+-independent (EGTA) assays 
were measured for kinase. CaMKII, monomer or holoenzyme was pre-T287 autophosphorylated 
prior to the PSD phosphorylation (and activity measurement). Activity of CaMKIIm at the start 
(0 min) and end (4 min) of the PSD phosphorylation assay (n = 3). Error bars denote ±SD. 
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Figure 3.10 CaMKII phosphorylation of PSD proteins. 
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(A to F) Isolated rat PSDs were phosphorylated under various conditions. These included low 
(EGTA) or high calcium (Ca2+/CaM) to assess endogenous, co-purified kinases. PSDs were also 
phosphorylated exogenous addition of equal molar catalytic subunits of T287 autophosphorylated 
CaMKII holoenzyme (CaMKIIholo+P = star) or monomer (CaMKIIm+P = circle). (A) Coomassie-
stained gel illustrating the PSD profile and the purified proteins used in the reaction. Square 
indicates CaM. (B) Phosphorimaging of the SDS-PAGE showing 32P-phosphoprotein bands. (C
and D), Quantification of the PSD phosphoprotein profile using phosphorimaging to assess either 
the total protein (C) or phosphorylation signal (D). The diamond indicates purified δCaMKII 
potentially complexed to the PSD. (E) Molecular weight markers indicated along the scaled axis 
(pixels) representing the scaled lane of the SDS-PAGE. (F) Total phosphorylation for each 
condition assessed using the area under the curve (AUC) as arbitrary intensity units.  
 
 
 
 
 
 
 
137 
To explore the phosphorylation of individual substrates within the PSD, reactions 
similar to the 32P incorporation assay (above) were performed. Instead of both ATP and [γ-
32P]-ATP in the phosphorylation reaction, ATPγS was used. To first address the linearity 
of the reaction, we compared a time-course of phosphorylation. To assess these 
phosphorylation reactions, the samples were alkylated with 50mM (PNBM) and western 
blotting was performed using a thioesters-specific antibody to visualize the sites of 
thiophosphate incorporation (Figure 3.11A). We found that background kinase 
phosphorylation (i.e. in the presence of EGTA) was linear for the 4, 15, and 30 min (Figure 
3.11B). Addition of exogenous CaMKIIholo+P drastically increased the total PSD 
phosphorylation for all timepoints, but was not completely linear at 30 min (Figure 3.10B). 
This analysis provides a general overview of the linearity of the phosphorylation reaction 
for substrates; however, we recognize that this analysis will not likely hold for all CaMKII 
substrates. Individual substrates would be affected not only by the rate of the reaction but 
also their individual concentrations.  
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Figure 3.11 CaMKII phosphorylation of PSD proteins using thiolATP. 
(A to F) Isolated rat PSDs were phosphorylated either with low calcium (EGTA) or exogenously 
added T287 autophosphorylated CaMKII holoenzyme (CaMKIIholo+P) in the presence of thiolATP 
(ATPγS) for 4, 15, or 30 min. (A) Western blotting of alkylated samples with a thiophosphate 
ester specific antibody and visualized via LI-COR with intensities scaled differentially between 
left and right image. (B) Quantification of the total PSD phosphorylation signal.  
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We selected a 15 min reaction for subsequent analysis by mass spectrometry through 
collaboration with Dr. Jon Trinidad, Director of Biological Mass Spectrometry in the 
Department of Chemistry at Indiana University (Bloomington). In our initial comparisons 
(and analysis by Dr. Jingwei Meng in the Hudmon lab), we found that CaMKIIm+P 
phosphorylated 74 proteins covering 193 different regions while CaMKIIholo+P 
phosphorylated 240 proteins covering 475 different regions (Figure 3.12). Between the 
two, 28 protein we common including 144 regions. Similar to the fold-change in total 
phosphorylation assessed via 32P-incorporation for the multimeric holoenyzme, a 3.2-fold 
increase in the number of proteins phosphorylated was observed. Based on overlapping 
individual peptides, a 2.5-fold increase in the number of phosphorylated regions. 
  
140 
  
Figure 3.12 Enhanced phosphorylation of substrates in the PSD by the CaMKII 
holoenzyme measured by mass spectrometry. 
(A and B) Mass spectrometry analysis of isolated rat PSDs phosphorylated with either equimolar 
amounts of exogenously added T287 autophosphorylated CaMKII monomer (CaMKIIm+P) or 
holoenzyme (CaMKIIholo+P) in the presence of thiolATP (ATPγS). Peptides were considered 
putative substrates if they exhibited thiophosphorylation. (A) Venn-diagram of the overlapping 
proteins phosphorylated by CaMKIIm+P or CaMKIIholo+P. (B) Tabulated numbers of 
phosphorylated proteins and/or regions of proteins (peptides harboring potential 
thiophosphorylation on the same site) for the two kinase states. The total multimeric enhancement 
(fold) for the holoenzyme is calculated as the ratio of total substrates (CaMKIIholo+P / CaMKIIm+P).
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3.3.5 Role of Targeting on CaMKII Substrate Phosphorylation 
Localization of protein substrates into diffusion-restricted subcellular compartments 
enhances the importance of targeting and translocation of enzymes to execute their 
function. Kinases are often targeted to specific regions through secondary interaction sites, 
whether they be docking sites, targeting domains, or scaffolds (see Chapter 1). Previous 
studies have shown that GFP-CaMKII translocates to the PSD and that CaMKII binding to 
GluN2B within this compartment is required for maintaining CaMKII levels in the PSD 
(Shen and Meyer 1999, Shen, Teruel et al. 2000, Gleason, Higashijima et al. 2003, 
Otmakhov, Tao-Cheng et al. 2004, Halt, Dallapiazza et al. 2012). However, unlike other 
kinases with require accessory domains/subunits, the oligomeric architecture of CaMKII 
could allow the catalytic domains to function as a targeting domains for the holoenzyme. 
We hypothesize that the targeting of CaMKII to the PSD by high-affinity attractors 
ultimately enhances the phosphorylation of low-affinity substrates by maintaining the 
dwell time of the kinase within this compartment. Based on our PSD phosphorylation 
experiments, we observed a unique band in the multimer phosphorylation of PSDs that was 
of similar molecular weight to the exogenously added CaMKIIholo+P (Figure 3.10); 
consistent with previous data for an association of the multimeric holoenzyme with the 
PSD. However, no band similar to the size of exogenously added monomeric CaMKII was 
detected. These findings suggest the enhanced binding of the CaMKII holoenzyme is a 
result of avidity interactions possibly created between multiple active subunits per 
holoenzyme and that while monomer is quite capable of transiently interacting with targets 
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for the phosphotransferase reactions, monomeric CaMKII does not bind with sufficient 
affinity to pull-down with the PSD during wash steps. 
The PSD experiments are limited in that we cannot specifically test the contribution of 
a substrate protein versus another protein or domain that is not a substrate but functions to 
attract or target CaMKII to impact its localization. To study this in a highly-reduced yet 
controllable system, we implemented a modified SPOT synthesis protocol whereby two 
different peptides are synthesized within a single spot on the membrane in order to study 
the effects of targeting of the kinase by a high-affinity substrate and its effect on 
phosphorylation of a locally-tethered, low-affinity substrate. Previous studies have used 
this strategy to identify docking domains important for the selectivity of extracellular 
signal-regulated kinase (ERK2), a mitogen-activated protein kinase (MAPK)  (Espanel, 
Walchli et al. 2003). Using this technique with CaMKII phosphorylation, we show that a 
high-affinity targeting peptide (a phosphomimetic peptide of a CaMKII substrate, 
GluN2BS1303D) enhances the phosphorylation of low-affinity substrates for both 
CaMKIIm−P and CaMKIIholo+P (Figure 3.13). Interestingly, Syntide, a substrate with 
intermediate affinity and some sequence similarity to CaMKII’s consensus motif exhibited 
a moderate increase in phosphorylation with the CaMKIIm−P when the targeting peptide 
was present. However, CaMKIIholo+P showed an 80% decrease in phosphorylation when 
the targeting peptide was present. We believe this phenomenon likely results from the high-
affinity targeting peptide locking down the kinase to prevent lateral diffusion and hindering 
the phosphorylation by the holoenzyme. We expect that within a certain range, the 
holoenzyme would exhibit phosphorylation increases for intermediate- and low-affinity 
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substrates multivalent avidity counteracts the lower-affinity of individual substrate 
molecules. 
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Figure 3.13 Enhanced phosphorylation of poor substrates in the presence of a targeting 
peptide/substrate. 
Immobilized substrate phosphorylation in the absence (−) or presence (+) of a targeting peptide. 
The targeting peptide is a phosphomimetic version of the high-affinity CaMKII substrate 
GluN2B (GluN2BS1303D). Two peptides were synthesized within a single SPOT using the double 
synthesis SPOT method (DS-SPOTs) described in Method 3.2.6. Phosphorylation reactions and 
quantification were performed as described for a standard SPOTs reaction (see Method 2.2.4.   
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3.4 Conclusion 
In these studies, we focused on the role of that holoenzyme architecture plays on the 
phosphorylation of substrates. We began by exploring the extent to which substrate 
phosphorylation increased above and beyond that of autophosphorylated CaMKII 
monomer (CaMKIIm+P). Therefore, to test the full contribution of the multimeric effect, we 
maximally activated CaMKII. We used a set of 15 diverse CaMKII substrates and found 
that the specificity of the kinase was further broadened such that low-affinity, non-CaMKII 
consensus-like substrates were preferentially phosphorylated. These findings were not due 
to poor access to substrates by the holoenzyme, as substrates were not limiting in these 
assays. While the broadened pattern of phosphorylation was nearly identical for the various 
concentrations used in our assays under maximal holoenzyme activation, a very different 
pattern was observed when holoenzymes were generated such that only one subunit was 
activated. In that case, the phosphorylation was very similar to the limited, narrow substrate 
specificity produced by non-T287 autophosphorylated monomer. We clearly demonstrate 
that individual subunits within holoenzyme operate in a manner similar to separated 
subunits. The changes in substrate specificity as more subunits were activated are produced 
by a combination of both autophosphorylation and multimeric effects. Based on our 
knowledge of the role of autophosphorylation to function as a switch to change substrate 
specificity (Chapter 2), we were interested in how graded levels of autophosphorylated 
subunits within the holoenzyme might contribute to substrate specificity. However, as T287 
autophosphorylation occurs through a rapid intersubsunit process within the holoenzyme 
(Hanson, Meyer et al. 1994, Rich and Schulman 1998), controlling this process within the 
native holoenzyme is not possible with current technology. We elected to again reduce the 
146 
complexity by again using the monomeric CaMKII (CaMKIIm) to model the process in 
holoenzymes. We clearly observed an incremental broadening of substrate specificity in 
response to intermediate levels of autophosphorylation (i.e. mixed populations of 
CaMKIIm+P and CaMKIIm−P). 
While our previous experiments focused on individual substrates, we were also 
interested in how this multimeric effect contributes to the phosphorylation of actual PSDs. 
Rat PSDs were isolated and purified in our lab and then verified for structural integrity 
using cryo-transmission electron microscopy by Dr. Neal Waxham’s lab (University of 
Texas – Houston). Using 32P-incorporation as measure of phosphorylation, we found the 
multimeric structure of the native CaMKII holoenzyme led to a considerable increase in 
the overall phosphorylation of the PSDs. We attempted to gain a more detailed 
understanding of the specific substrates phosphorylated and therefore turned to mass 
spectrometry. We observed increases in both the total number of proteins phosphorylated 
and more importantly the regions of the protein, even though the amount of active kinase 
added to the reaction was controlled for. Thus, not only is this consistent with the general 
increase in phosphorylation that we observed using 32P-incorporation, but more 
importantly, it also is indicates that substrate selectivity is broadened by maximal 
activation/autophosphorylation of the holoenzyme within the subcellular compartments in 
which CaMKII plays a critical function. This is interesting in light of the role of CaMKII 
in the generation of LTP. High-frequency Ca2+ spikes associated with higher neuronal 
activity would not only produce greater numbers of subunits activated and T287 
autophosphorylated within each holoenzyme, but would in turn lead to the preferential 
enhancement of phosphorylation of weaker substrates; some of which are known to be  
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important for LTP (e.g. GluA1). Additionally, the targeting peptide data argues that even 
when different substrates are in close proximity and must compete for access to the kinase, 
this type of mechanism is able to regulate selectivity.  
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CHAPTER 4. Discussion 
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4.1 General Conclusions 
Like other multifunctional protein kinases, CaMKII exhibits broad substrate 
specificity, targeting many different substrates involved in a host of cellular functions. 
These include diverse processes such as carbohydrate, amino acid and lipid metabolism, 
neurotransmitter synthesis and release, ion channels, receptors, transcription and 
translation, cytoskeletal organization and dynamics, cell cycle control and calcium 
homoeostasis (Hudmon and Schulman 2002). CaMKII is found throughout the cell 
including the nucleus, cytoplasm and cytoskeletal domains. Thus, mechanisms must be in 
place which allow for proper signaling and substrate specificity. While it is believed that 
CaMKII autophosphorylation encodes Ca2+ spike frequency into graded levels of 
activity/autophosphorylation, how this process impacts substrate selectivity and processing 
remains unclear. Given the unique multimeric structure of the holoenzyme and the well-
studied forms of autophosphorylation that are known to control the kinase, we endeavored 
to understand how these features might contribute to the enzymatic output of the kinase.  
Overall, our data suggest a model whereby CaMKII utilizes its ARD to increase the 
dynamic range between high- and low-affinity substrates, with T287 autophosphorylation 
acting as a switch to disengage the ARD from preventing phosphorylation of weak 
substrates (Figure 2.21). We find that this mode of substrate specificity generation occurs 
for substrates in both diffusion-limited and diffusion-restricted environment, suggesting 
that this mechanism may function in with various subcellular locations in which CaMKII 
operates. In the context of the majority of known CaMKII sites (i.e. PhosphoSitePlus), our 
data argues that T287 autophosphorylation is the major contributor of altered substrate 
150 
specificity, while effects related to the multimeric holoenzyme structure tends to broaden 
the specificity further for diffusion-restricted substrate environments. 
Structurally, while our data indicates that T287 autophosphorylation functions to 
regulate substrate selectivity, we hypothesize that the origins of this mechanism are rooted 
in preventing intrasubunit autophosphorylation of this site. While other CaM kinases 
(CaMKI and CaMKIV) have an autoregulatory domain, they also have activation loops 
that require phosphorylation by an upstream kinase, CaMK kinase (CaMKK), to allow for 
full activation (Swulius and Waxham 2008). They can undergo autophosphorylation at 
various sites; however, they do not occur within the autoinhibitory portion of their ARD in 
a manner similar to CaMKII. CaMKII’s activation loop is already in the active 
conformation and therefore does not require phosphorylation by an upstream kinase. 
Without partial tethering of CaMKII’s ARD following Ca2+/CaM activation, one might 
expect that autophosphorylation of T287 (which conforms closely to the consensus 
phosphorylation motif) would be autophosphorylated in an intrasubunit fashion. This 
would limit the ability of CaMKII to function as a Ca2+ spike frequency detector. Thus 
Partial ARD tethering is likely responsible for establishing a threshold of sustained 
activation to allow for coincident CaM binding on neighboring subunits that is required for 
intersubunit autophosphorylation. As a byproduct of retained interactions of the ARD, 
substrate phosphorylation is limited such that high affinity substrates are preferentially 
phosphorylated.  
We hypothesize that this mechanism: 1) enables a unique form of autoregulation to 
counteract multivalency and mass action consequences of CaMKII’s unique multimeric 
structure in substrate-rich environments; 2) allows calcium-spike frequency detection by 
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CaMKII to translate into substrate selectivity (De Koninck and Schulman 1998); 3) utilizes 
the ability of different CaMKII isoforms/splice variants harboring unique thresholds for 
T287 autophosphorylation to differentially regulate substrate selectivity (Bayer, De Koninck 
et al. 2002, Gaertner, Kolodziej et al. 2004, Chao, Stratton et al. 2011); and 4) functions as 
a switch to allow CaMKII signaling to generate complex patterns of substrate 
phosphorylation in response to graded levels of autophosphorylation within the 
holoenzyme. Thus, the potential unique characteristics of CaMKII in regulating substrate 
selection appears to afford this kinase with a dominant role in regulating synaptic plasticity 
and learning, possibly functioning as an overall facilitator of global phosphorylation. 
 
4.2 Historical Perspectives of T287 Autophosphorylation 
Our data describe a new and surprising finding for the function of the ARD of CaMKII 
to act a substrate selective gate regulated by T287 autophosphorylation. Classically, the 
phenomena most studied concerning the function of T287 autophosphorylation was the 
generation of autonomous activity (Schworer, Colbran et al. 1988, Lou and Schulman 
1989). Autonomous activity (i.e. substrate phosphorylation in the absence of Ca2+/CaM 
following T287 autophosphorylation) has been used as an indirect readout of T287 
autophosphorylation for over 30 years (Saitoh and Schwartz 1985). Autonomous (Ca2+-
independent) activity can reach 100% of the Ca2+-dependent activity in in vitro assays for 
certain substrates. While autophosphorylation of CaMKII has been studied for over three 
decades in regards to the autoregulation of CaMKII, the role this post-translational 
modification plays on substrate phosphorylation has been inconclusive. Nearly 25 years 
ago, Katoh and Fujisawa reported a lag-phase in substrate phosphorylation in the absence 
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of prior autophosphorylation (Katoh and Fujisawa 1991) suggesting that 
autophosphorylation may proceed substrate phosphorylation. However, others have argued 
against this lag-phase at higher ATP concentrations (100µM, which is an order of 
magnitude below measured cellular ATP concentrations) (Coultrap, Barcomb et al. 2012). 
In fact, the same lab subsequently showed that autothiophosphorylation at T287 produced 
no change in the kinetic parameters for the total, Ca2+/CaM-dependent activity (i.e. 
CaMKII−P versus CaMKII+P) of the kinase for several different substrates with saturating 
ATP (100 μM) (Ikeda, Okuno et al. 1991). Around the same time, Yasugawa et al. found 
that there was no change in the total activity, though subsequently they showed that 
autophosphorylation increased the activity for certain substrates (including Syntide) (S., K. 
et al. 1988, Yasugawa, Fukunaga et al. 1991). More recently, autophosphorylation has been 
shown to have only a small effect on the dependent activity (Coultrap, Buard et al. 2010, 
Coultrap, Barcomb et al. 2012). Specifically, when the phosphoacceptor site was mutated 
to prevent autophosphorylation, the activity was similar to the autophosphorylated kinase. 
It was therefore concluded using this T287A mutant that T287 autophosphorylation 
contributes minimally to the phosphorylation of substrates (Coultrap, Barcomb et al. 2012). 
However, our data suggests that the T287A mutation itself produces Ca2+/CaM-dependent 
substrate phosphorylation patterns much different than the wild-type kinase (Figure 2.20). 
Thus, it remains unclear how animal models harboring these knock-in mutations should be 
interpreted in terms of the role of T287 autophosphorylation (Cho, Giese et al. 1998, Giese, 
Fedorov et al. 1998, Glazewski, Giese et al. 2000, Gustin, Shonesy et al. 2011). We 
postulate that ARD mutagenesis, an inability to control T287 autophosphorylation, or the 
use of limited/biased substrates likely masked the ability of previous studies to report 
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confounding conclusions regarding T287 autophosphorylation and substrate specificity. Our 
data provide compelling evidence for the ARD restricting substrate phosphorylation in the 
absence of T287 autophosphorylation.  However, while all substrates benefit from T287 
autophosphorylation, our data clearly show that low-affinity, weak substrates benefit from 
a disproportional enhancement in their phosphorylation.  
Although autonomous activity (which has been used as an indirect measure of T287 
autophosphorylation) can reach 100% in vitro, for in situ measurements, the level of 
autonomous activity generated in neurons by various stimulation protocols appears to be 
15-50% of the total CaMKII activity (Gorelick, Wang et al. 1988, MacNicol, Jefferson et 
al. 1990, Molloy and Kennedy 1991, Lengyel, Cammarota et al. 2001). Submaximal T287 
autophosphorylation/autonomy of CaMKII may be attributed to: 1) limiting free CaM in 
cells (Estep, Alexander et al. 1989, Persechini and Stemmer 2002), 2) phosphatase activity, 
and 3) T306/7 capping. Thus, it appears that in vivo, there exists the dynamic range in which 
subunits of CaMKII are or are not T287 autophosphorylated such that new stimuli capable 
of producing autophosphorylation are therefore able to direct changes in substrate 
specificity. Furthermore, prior activity levels such as those that could lead to T306/7 
autophosphorylation (i.e. CaM binding domain capping that prevents subsequent 
Ca2+/CaM activation of the subunit) would also be expected to affect future 
activation/autophosphorylation (T287) within the holoenzyme, and therefore contribute to 
selectivity (Figure 4.1). 
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Figure 4.1 Autophosphorylation-associated expansion in CaMKII substrate specificity. 
Schematic representations of CaMKII holoenzymes depicting variable states of 
activation/autophosphorylation as a function of both prior inhibitory autophosphorylation 
(T306/307) and cellular activity (i.e. Ca2+ spike frequency). 
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4.3 SPOTs Model of Phosphorylation 
As much of the work described here involved exploring changes in substrate 
specificity, it was critical that I establish a direct and cost efficient means of assessing these 
changes using diverse substrates. The SPOT technique for peptide synthesis was the perfect 
solution to our quest to explore many substrates simultaneously. For a single synthesis run, 
we could easily generate 600 peptides per membrane in an automated fashion with our 
robotic peptide synthesizer. This allowed for flexibility in the number of substrates 
synthesized, the number of individual replicate SPOTs, and the number of replicate arrays 
to be assayed under varying kinase conditions to all be generated within the same synthesis 
run to minimize potential variations. Since these peptides were synthesized directly on the 
derivatized cellulose membranes, peptides were not able to be purified away from 
degenerate peptides. This limitation is inherent to any micro-scale solid state chemistry. 
We therefore enacted multiple precautions to ensure the maximal efficiency throughout the 
synthesis, including storing reagents under argon, replacing activators through the 
synthesis (typically 60-72hr for 15mers), using slightly smaller initial deposition of first 
amino acid to prevent degenerate peptides at the outer edge, and repeated couplings for 
each round of synthesis. We found that even between membranes, phosphorylation profiles 
were rather robust. It should be noted that even though the SPOTs peptides may be 
susceptible to substrate availability issues stemming from synthesis or access to the 
substrates, comparisons between kinase states would have the same issues for an individual 
substrate. Therefore, individual enhancement factors for a given substrate provide a good 
measure of the changes associated with the state of the kinase. 
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To assess substrate specificity, we compared both the absolute and relative 
enhancement of phosphorylation between substrates. We consistently found that the 
greater the phosphorylation in the non-T287 autophosphorylated state, the lower the 
enhancement associated with autophosphorylation. This same finding could be achieved if 
only a general enhancement to kinase activity was produced by T287 autophosphorylation. 
It addition, it could have been compounded by limiting amounts of substrate within a given 
SPOT peptide which would tend to depress the observed enhancement in high-affinity 
substrates. However, we ruled out a simple interpretation of a general enzymatic 
enhancement by showing that substrates were in fact not limiting (< 2% of a 24hr 
phosphorylation; Figure 2.10C) and that there were no differences in the relative 
phosphorylation profiles for a 4 vs 10 min phosphorylation reaction (Figure 2.10, A and 
B). Furthermore, repeated phosphorylation reactions on a single membrane, which was 
transferred at the end of an initial phosphorylation reaction to a second reaction with new 
kinase exhibited a nearly identical phosphorylation profile (Figure 2.11). By comparing 
SPOTs data to other kinase reaction formats, we were able to complement the high-
throughput strengths of SPOTs substrates with other classical strategies for studying kinase 
interactions. Using soluble peptides as well as soluble and immobilized versions of GST-
fusion substrates, we clearly observed similar changes in substrate specificity in response 
to changes in the autophosphorylation state of the kinase. Thus, we believe that the SPOT 
peptide method, when used in conjunction with proper control reactions, provides an 
effective method for rapidly assessing changes in the substrate specificity of an enzyme. 
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4.4 CaM Trapping and the Autonomous State of CaMKII 
The classical function of an ARD is to couple enzyme activity with second messenger 
signaling or its upstream effectors. CaMKII is an unusual enzyme in that it has a 
modulatory (not required for is activity) autophosphorylation site within the R1 segment 
of CaMKII’s ARD (T286/287) that can uncouple its activity from its second messenger and 
activator (Saitoh and Schwartz 1985, Lou and Schulman 1989, Waxham, Aronowski et al. 
1990). Thus, Ca2+-independent autonomous activity (i.e. CaMKII substrate 
phosphorylation following the removal of bound CaM) has been used in vitro as a direct 
readout of this uncoupling associated with T287 autophosphorylation (Saitoh and Schwartz 
1985). Our functional data showing that following T287 autophosphorylation, bound CaM 
is required for the broadening of substrate specificity is consistent with previous structural 
EPR data which showed that bound CaM was also required for the full ARD displacement 
associated with T287 autophosphorylation. Based on our understanding of CaM dynamics 
and intracellular Ca2+ concentrations and fluctuations, it seems that CaM would tend to 
remain bound to the ARD following T287 autophosphorylation. The fact that T287 
autophosphorylation leads to a 20,000-fold enhancement in Ca2+/CaM binding affinity 
(Meyer, Hanson et al. 1992, Singla, Hudmon et al. 2001) along with concomitant changes 
in the Ca2+-binding properties of CaM (Gaertner, Putkey et al. 2004), is consistent with 
CaMKII attempting to enhance, not eliminate its coupling to its second messenger. Even 
as calcium levels return to basal levels in the cell, the rate of dissociation for trapped CaM 
seems sufficiently slow such that it would be unlikely for “autonomous” (T287 + T306/7 
autophosphorylated) subunits to be generated, especially in regions such as the PSD where 
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one might expect more regular elevations in Ca2+ signaling associated with neuronal 
activity. 
 
4.5 Implications 
CaMKII is critical to a number of cellular processes and as such is connected to many 
different pathophysiological conditions including neurodegenerative and cardiac disease 
as well as cancer. Often, CaMKII contributes to these aberrant processes due to 
dysregulated calcium signaling. Therapeutic strategies which target CaMKII are 
potentially promising. Recent advances stemming from structural characterizations of 
CaMKII through crystallography as well as dynamic changes throughout the various 
activation states through the use of EPR provide valuable information for developing 
inhibitors/activators through rational drug design methods. However, beyond simply the 
understanding the three-dimensional structure and dynamics, understanding how the 
various activation states contributes to the output of the kinase is key to determining the 
structure-function relationship. Our studies provide valuable insight into the translation of 
activation and autophosphorylation into distinct changes in substrate specificity. 
Specifically, our model of ARD substrate filtering can be viewed as a functional outcome 
of the partial tethering of an activated CaMKII ARD in the absence of T287 
autophosphorylation described in solution via EPR. In addition, we find that mutagenesis 
of this autophosphorylation site alone is able to disrupt the ARD. Specifically T287A, a 
mutation frequently used as a non-phosphorylatable substitution in animal models, was 
found in our studies to significantly alter the substrate specificity of the kinase. 
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4.6 Future Directions 
While our studies focused on the effects of autophosphorylation and holoenzyme 
structure in terms of its effects on substrate specificity, many of the same techniques could 
be used to study how other regulatory processes might contribute (Figure 4.2). Though 
CaMKII has been studied for over three decades, the interplay between holoenzyme 
architecture, multisite autoregulatory phosphorylation, other PTMs, and 
isoform/alternative splicing differences have contributed to the complexity of CaMKII’s 
regulation. For example, it is interesting to speculate that other post-translational 
modifications in the ARD of CaMKII that also generate an form of autonomous activity, 
including oxidation, nitrosylation, and glycosylation (Mattiazzi, Bassani et al. 2015), may 
also function independently or in conjunction with T287 autophosphorylation to regulate 
substrate selectivity. Most of the sites shown to be important in generating these non-
canonical forms of autonomous activity are within close proximity to the T287 in the R1 
segment of the ARD. Therefore, one might expect that these PTMs would generate similar 
increases on CaM binding affinity and broadened substrate specificity. Such convergence 
of post-translational modifications associated with diverse signaling pathways could make 
a powerful set of modulators to produce a gain of signaling as well as to direct the 
specificity and targets for multifunctional kinases like CaMKII. We recognize that ARD 
domains for other CaM-kinases may also provide intrinsic selectivity gates to maintain 
substrate specificity. Thus, future endeavors should look at how these and potential other 
non-CaM-dependent kinase regulate specificity through post-translational modification. 
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Figure 4.2 Mechanisms contributing to CaMKII substrate specificity. 
Schematic depicting some of the actual and potential mechanisms important for controlling 
substrate utilization and specificity in CaMKII. 
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One of the interesting potential functions of alternative splicing in CaMKII is the ability 
to regulate sensitivity to CaM and thus T287 autophosphorylation. This centers on the fact 
that most of the variants (close to 40 variants across the four isoforms) come from changes 
in the length of the linker between the region between the ARD and the hub domain (Figure 
1.2A). Thus, models were developed such that the length of the linker determined to the 
equilibrium of the catalytic domain’s proximity to the hub domain (either compact or 
extended) (Chao, Stratton et al. 2011). Longer linkers yielded more extended structures 
with greater access for CaM (and lower EC50) and thus different Ca2+ spike frequency 
thresholds required for autophosphorylation. Combining these ideas with our data, it 
suggests that various CaMKII isoforms and their splice variants would have different 
response characteristics that are manifested into specific thresholds for changing substrate 
specificity. Thus, it’s possible that this feature is part of the reason various isoforms/splice 
variants and developmentally regulated or cell-type specific is that they are precisely 
designed and tuned for specific functions; whether it be in neurons, astrocytes, pancreatic 
islet beta cells, cardiomyocytes, etc.  
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